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ABSTRACT
The human gastro-intestinal (GI) tract comprises a series of complex and dynamic organs ranging from the stomach to the distal colon, which harbor immense 
microbial assemblages, with considerable diversity and significant metabolic activity 
that are vital for human health. For understanding the functionality of microbial 
communities, it is necessary to elucidate the role of individual species within a 
community. The aim of the current study was to explore the functionality of the 
human GI tract microbiota, particularly in the conversions of dietary carbohydrates, 
in the human large intestine using in vitro as well as in vivo experiments. 
The functional capacity of the human intestinal microbiota in the fermentation of 
relevant [13-C]-labeled dietary carbohydrates was analyzed using 16S ribosomal RNA 
(rRNA)-based Stable Isotope Probing (SIP). Integrated application of RNA-based 
SIP with high-throughput diagnostic microarray-based phylogenetic profiling and 
metabolic flux analysis resulted in identification of the primary degraders of potato 
starch, inulin and lactose under human colon-like conditions. Furthermore, metabolic 
cross-feeding networks were proposed, involving secondary fermentation processes. 
Ruminococcus bromii was identified as the key player in the degradation of potato 
starch based on molecular analysis of samples taken during the fermentation under 
human colon like conditions, but also through fermentation studies in mono-culture 
or co-culture with Eubacterium rectale. The latter experiments revealed a cross-
feeding relationship between R. bromii and E. rectale that involved the H2 produced 
by R. bromii from the starch degradation to increase production of propionate 
and acetate by E. rectale. Furthermore, species related to Dorea longicatena and 
Bifidobacterium adolescentis were identified as key members in inulin degradation, 
and Actinobacteria, particularly Bifidobacterium spp. and Collinsella spp., were 
found to be the main taxa involved in lactose fermentation under human colon like 
conditions. Moving beyond in vitro studies we explored the role of the gut microbiota 
in lactose fermentation with a pioneering study, where [U-13C]-lactose was delivered 
directly to the terminal ileum of healthy human volunteers using a multi-lumen 
catheter that was also used for sampling of luminal content, which was further 
examined by RNA-SIP and phylogenetic microarray analysis. Individual patterns of 
the microbiota involved in lactose fermentation were observed, showing that in both 
volunteers different microbial populations were involved, which could be attributed 
to differences in the sampling location. A population related to Lactobacillus 
plantarum was found to be most actively involved in fermentation in one of the 
volunteers during the trial, while in the other volunteer most probably members of 
the genera Bifidobacterium and Colinsella were the primary lactose degraders, in 
agreement with the in vitro model study. Further analysis on the metabolites that 
accumulated during the lactose degradation will help to reconstruct the metabolic 
pathways involved in intestinal metabolism.
Based on our exploratory research using RNA-based stable isotope probing 
together with high throughput phylogenetic analysis and metabolite profiling we 
could expand our knowledge on key microbial functions related to a healthy gut 
status.
Key words: gut bacteria, dietary carbohydrates, digestion, RNA-SIP, TIM-2, 
HITChip, human trial
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12 OUTLINE
OUTLINE OF THIS THESIS
The human gut microbiota play a central role in health and well-being. Hippocrates was the first who in about 400 BC postulated the importance of the gut in human 
physiology. “Death sits in the bowels: a bad digestion is the root of all evil”, which, 
translated in the current research, underlines the importance of gut microbiota 
functionality to human health. With the work presented in this thesis we address 
specific metabolic activities of microbial groups active in the human gut and further 
describe microbe interactions, central for defining microbial food webs. 
Chapter 1 provides a state of the art overview of the recently developed 
molecular approaches, used in different ecosystems, and their contribution to 
describe the functionality of the human gastrointestinal tract, with special attention 
for the residing microbiota. Furthermore, available in vitro models of the human 
gastrointestinal tract, including the TNO model of the human large intestine (TIM-
2), are described and compared.
A substantial part of the human diet is represented by the daily intake of 
dietary carbohydrates, such as resistant starch and other carbohydrates which are not 
digested in the small intestine. Chapter 2 details the application of RNA-based Stable 
Isotope Probing (SIP) in linking metabolic activity to microbial identity. Here, RNA-
based SIP in combination with T-RFLP fingerprinting analysis of samples obtained 
from the TIM-2 in vitro model of the human colon revealed Ruminococcus bromii 
as the primary degrader of [13-C]-labeled potato starch. Additionally, molecular and 
metabolic analyses suggested metabolic cross-feeding in the studied system, where 
populations related to Ruminococcus bromii are the primary starch degraders, while 
those related to Prevotella spp., Bifidobacterium adolescentis and Eubacterium 
rectale might be further involved in the trophic chain.
In Chapter 3 we further explore the potential of RNA-based SIP to 
identify bacterial populations responsible for the degradation of [13-C]-labeled 
lactose and inulin. In this study, the T-RFLP fingerprinting was complemented by 
a detailed phylogenetic analysis using the Human Intestinal Tract Chip (HITChip), 
a comprehensive phylogenetic microarray for the human intestinal tract microbiota. 
The results indicated the involvement of members of Clostridium cluster XIVa and 
Actinobacteria in the fermentation of inulin and lactose, either as a direct degrader 
of the studied substrates or involved in the trophic chain. 
Defined pure and mixed cultures are excellent model systems to study 
the metabolism of individual bacterial populations but also their interactions with 
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other species. In Chapter 4 we examine the ability of two bacterial species that are 
abundant in the human colon, Eubacterium rectale and Ruminococcus bromii, to 
convert potato starch in mono- and co-cultures. A cross-feeding relationship between 
the two species was observed that was described in detail.
To explore the potential of RNA-based SIP for the application in in vivo 
studies, as described in Chapter 5, [13-C]-labeled lactose was delivered to the 
human intestine through a catheter. Further analysis of intestinal fractions containing 
RNA with low and higher density revealed the microbiota involved in the lactose 
fermentations in vivo. 
Finally, Chapter 6, provides a general discussion of experiments described 
in this thesis. Furthermore, taking into account the impact of the gut microbiota 
on human well-being, we further discuss potential future research directions that 
will contribute to filling the gaps in the knowledge on the functionality of the gut 
microbiota.
14
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Tools for the Tract: Understanding the 
Functionality of the Gastro-Intestinal Tract
Petia Kovatcheva-Datchary
Erwin G. Zoetendal
Koen Venema
Willem M. de Vos
Hauke Smidt
Abstract
The human gastro-intestinal tract comprises a series of complex and dynamic organs ranging from the stomach to the distal colon, which harbor immense microbial assemblages that are known to be vital for human health. Until recently, most of the details concerning our gut 
microbiota remained obscure. Over the past several years, however, a number of crucial technological 
and conceptual innovations have been introduced to bring more light into composition and functionality 
of human gut microbiota. Recently developed high-throughput approaches, including next generation 
sequencing technologies and phylogenetic microarrays targeting ribosomal RNA gene sequences, allow 
for comprehensive analysis of diversity and dynamics of gut microbiota composition. Nevertheless, 
most of the microbes especially in the human large intestine still remain uncultured, and in situ functions 
of distinct groups of the gut microbiota are therefore largely unknown, but pivotal to understand their 
role in human physiology. Apart from functional and metagenomics approaches, stable isotope probing 
is a promising tool to link the metabolic activity and diversity of microbial communities, including 
yet uncultured microbes, in a complex environment. Advancements in current stable isotope probing 
approaches and integrated application with high-throughput diagnostic microarray-based phylogenetic 
profiling and metabolic flux analysis may facilitate application in human microbial ecology and will 
enable the development of innovative strategies to treat or prevent intestinal diseases of yet unknown 
etiology.
Part of this chapter has been published in Therapeutic Advances in Gastroenterology (2009) 2 (Suppl 1) S9-S22.
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Introduction
The human body typically harbors ten times more microbial cells than human cells, 
which is mainly due to the extremely high density of microorganisms found to be 
present in the human gastro-intestinal (GI) tract (Savage, 1977; Berg, 1996; Backhed 
et al., 2005). The vast majority of this microbiota is located particularly at the distal 
region of the human GI tract, the colon (Suau et al., 1999; Eckburg et al., 2005). From 
medical perspective, the importance of this part of the human GI tract as central to 
host health was acknowledged even by the earliest observers like Hippocrates 400 
bc, who stated that “death sits in the bowel” (Kolida et al., 2000). Most of the clinical 
knowledge is focusing on the pathogenesis of a given disease and respectively on 
the proper therapies for medical treatments, which does not give a clear definition 
of health (Tannock, 2006; Arebi et al., 2008; Neish, 2009). However, there is 
growing evidence of the imperative impact of the colonic microbiota on human gut 
physiology and health, strongly affected by a number of microbial activities. These 
activities include, but are not restricted to, fermentation of dietary compounds that 
escape digestion in the upper GI tract, processing of mucosal cells shed in the small 
intestine, and degradation of intestinally secreted mucus (Xu and Gordon, 2003; 
Noverr and Huffnagle, 2004; Fava et al., 2006; Srikanth and McCormick, 2008). 
For understanding the functionality of microbial communities, it is necessary to 
elucidate the role of individual species within a community. However, it is estimated 
that approximately 80% of species comprising the human gut microbiota are yet 
to be cultured (Egert et al., 2006; Rajilic-Stojanovic et al., 2007). Hence, insights 
into the function and metabolic potential of these uncultured microbes are lacking. 
This indicates that culture-independent approaches are crucial to comprehensively 
study the ecology of the GI tract microbiota. In addition, our knowledge on the gut 
microbiota is in general restricted to the luminal part at the end of the colon, as this 
is excreted as feces. The other parts of the GI tract can so far only be accessed using 
invasive procedures. However, minimally invasive experimental techniques that can 
be used in vivo, can now be applied in combination with stable isotope probing (SIP) 
(Radajewski et al., 2000; Whiteley et al., 2006; Kreuzer-Martin, 2007) to link in situ 
microbial activity and diversity of GI tract microbiota. SIP is a powerful tool that 
can be used in human studies to delineate bacterial food webs that may ultimately 
influence human welfare (Pouteau et al., 2003; Kelleher, 2004; Dolnikowski et al., 
2005).
This review presents promising strategies to delve into the functionality of the 
GI tract microbiota, including fermentation processes in the human colon. Recent 
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scientific advances discussed here could assist in expanding the knowledge of 
microbial determinants for a healthy gut defined based on key functional properties of 
gut microbiota. This will also enable the development of direct nutritional strategies 
for intestinal disease prevention and health promotion. 
Overview of the human gut microbiota – microbial diversity
The human gut is one of the most densely populated ecosystems, comprising 
members of the three domains of life on Earth – Bacteria, Archaea and Eucarya 
(Finegold et al., 1983). Bacteria dominate this complex ecosystem, where > 90% 
of the phylotypes are member of two bacteria divisions: the Bacteroidetes and the 
Firmicutes (Backhed et al., 2005; Zoetendal et al., 2006; Turroni et al., 2008). The 
Gram-positive Firmicutes include numerous different phylogenetic clusters of 
Clostridia, with clusters IV, IX and XIVa being the most abundant clusters. The 
predominant genera are Clostridium, Eubacterium, Roseburia and Ruminococcus. 
Furthermore, the Actinobacteria, including the genera Bifidobacterium and 
Atopobium, represent important members of the gut microbial community (Franks et 
al., 1998; Harmsen et al., 2002; van der Waaij et al., 2005; Turroni et al., 2008). In 
terms of functional diversity recent metagenomics-based studies indicated that the 
gut microbiome has a coding capacity that vastly exceeds that of the human genome 
and encodes biochemical pathways that humans have not evolved (Backhed et al., 
2005; Gill et al., 2006; Ley et al., 2006; Kurokawa et al., 2007; Turnbaugh et al., 
2007). 
Recent studies of the gut microbial ecosystem identified more than 1000 
species and possibly over 7000 strains, of which the largest part (~80%) remains 
uncultured (Backhed et al., 2005; Blaut and Clavel, 2007; Rajilic-Stojanovic et al., 
2007; Zoetendal et al., 2008). However, new approaches for culturing previously 
uncultured colonic microbes are being developed (Duncan et al., 2007a; Ingham 
et al., 2007; Zoetendal et al., 2008). In addition to this, new powerful tools for 
amplification and sequencing of genomic DNA from minute quantities of sample and 
barcoded pyrosequencing can be expected to give new insight in the composition of 
the gut microbiota at high spatio-temporal resolution (Marcy et al., 2007; Andersson 
et al., 2008). 
Almost sterile at birth (DiGiulio et al., 2008), the development of the infant gut 
succeeds to extremely dense colonization, reaching at the age of two years a climax 
mixture of microbes similar to the microbiota found in the adult intestine (Wall et al., 
2009). The composition of infant gut microbiota is determined by several factors that 
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include the mode of delivery, maternal microbiota, diet and environmental hygiene 
(Fanaro et al., 2003; Favier et al., 2003; Hallstrom et al., 2004; Palmer et al., 2007). 
In contrast to the developing infant gut microbiota, each healthy adult’s gut appears 
to have a unique and stable microbiota, as evidenced by molecular fingerprinting, on 
the time scale of months (Zoetendal et al., 1998; Turnbaugh et al., 2007; Frank and 
Pace, 2008). Recent studies have also indicated aberrations in the composition of the 
human microbiome in obese individuals (Ley et al., 2006), as well as in individuals 
with a variety of other diseases (Zoetendal et al., 2008; Turnbaugh et al., 2009). 
Furthermore, Ley et al. (2006) reported that the composition of the human gut 
microbiota is responsive to dietary modulation for weight reduction. 
Metabolic roles of gut microbiota
An important role of the human gut microbiota is that of a metabolic “organ”, which 
delicately affects our physiology with functions that we have not had to evolve 
on our own (Backhed et al., 2005; Gill et al., 2006; Turnbaugh et al., 2007). The 
ability to process otherwise indigestible components of our diet is one of these vital 
microbial activities that significantly influences the gut environment and the host, 
such as energy source and in the maintenance of gut health (Savage, 1986; Guarner 
and Malagelada, 2003; Xu and Gordon, 2003). 
Microbial performance, growth and metabolism, in the human colon depends 
to a large extent on the supply of substrates that resist digestion in the upper GI tract, 
and endogenous substrates, such as mucin, secreted by the host (Blaut and Clavel, 
2007). The main dietary products, which serve as food for the colonic microbiota, 
are complex carbohydrates (starches, non-starch polysaccharides) and proteins 
(Cummings and Englyst, 1987). The majority of microorganisms in the human colon 
ferment carbohydrates and then switch to protein fermentation when these are not 
available anymore (Ouwehand et al., 2005). Carbohydrate metabolism is of great 
importance in the large intestine, as in terms of absolute numbers, the vast majority 
of culturable microorganisms are saccharolytic (Macfarlane and Macfarlane, 1997). 
Numerous different types of carbohydrates reach the colon, where their rates of 
fermentation are affected by the transition time and vary according to substrate 
availability, chemical structure and composition (Englyst et al., 1992). Several 
studies suggest that dietary carbohydrates are protective agents against several GI-
disorders such as colorectal cancer (Topping and Clifton, 2001; Guarner, 2005). 
However, these studies were performed with animal models (Cassidy et al., 1994; 
Pool-Zobel, 2005; Young et al., 2005; Le Leu et al., 2007; Le Leu and Young, 2007). 
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The underlying mechanism of protection could be associated with the end products of 
these anaerobic bacterial fermentations, but other than metabolic interactions can not 
be excluded (Roediger, 1988). In the human colon, the end products of fermentation 
are short-chain fatty acids (SCFAs) such as butyrate, acetate, propionate, as well 
as other terminal products such as lactate. SCFAs lead to lowering of the luminal 
pH, increase in bacterial biomass and fecal bulk, and modification of the microbial 
composition, especially by stimulating the growth of beneficial bacteria including 
bifidobacteria and lactobacilli (Le Leu et al., 2005). 
Butyrate, one of the major SCFAs, is the subject of studies aiming to 
understand its role in nourishing the colonic epithelium and in prevention of colon 
cancer (Cummings and Bingham, 1987; Bauer-Marinovic et al., 2006; Sengupta et 
al., 2006; Hamer et al., 2008). Recently, it was observed in healthy individuals that 
colonic butyrate application resulted in reduced visceral pain perception (Vanhoutvin 
et al., 2009). In contrast, colonic protein fermentation is often associated to an 
increased colon cancer risk as this fermentation results in the production of branched 
chain fatty acids and potentially toxic metabolites, such as amines, ammonia, 
phenolic compounds and thiols (Cummings et al., 1979; Bingham et al., 1996). 
This is also indicated by the fact that colon cancer mostly occurs at the distal end 
of the colon (Bufill, 1990; Muir et al., 2004). Therefore, an intake of more slowly 
fermentable carbohydrates could result in prolongation of the potentially beneficial 
saccharolytic activity, which would lead to an increased production and delivery of 
SCFA, particularly butyrate, to the distal colon (Jacobasch et al., 1999; Topping and 
Clifton, 2001; Wong et al., 2005).
Obviously, the diet affects colonic nutrition mainly through its effects on the 
gut microbiota. Growing evidence defined the roots of many colonic diseases and 
particularly colonic cancer risk to be determined by interactions between the diet and 
the gut microbiota. However, further studies should focus on unraveling the in situ 
functionality of the gut microbiota and improved understanding of the impact of the 
microbiota on host health and well-being. These must cope with the individuality 
and complexity of a microbial community in a largely inaccessible environment. 
In vitro models of the human colon
The human colon is a largely inaccessible part of the GI tract, and a difficult area 
to study the gut microbiota and microbial activities in vivo. To this end, in vitro 
modeling represents an elegant way to study the microbial processes, such as 
carbohydrate and protein fermentation (Macfarlane and Macfarlane, 2007). In vitro 
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studies are less expensive in comparison to in vivo studies with human studies, 
and usually pure cultures, defined mixed cultures and stool material are used as 
inoculum. Furthermore, in vitro models allow for fast and reproducible experiments 
under standardized conditions. The strength of in vitro models, however, has also 
been questioned with respect to several issues. The degree to which the inoculum 
represents the human colonic microbiota (Drasar, 1988) and the precise mimicking 
of the colonic conditions (Edwards and Rowland, 1992) are recurring points of 
discussion. Another limitation of in vitro modeling is that it does not represent 
the colon as an open system with respect to the absence of fecal content removal, 
inevitably resulting in changes in bacterial composition and subsequently metabolic 
activity (Christian et al., 2003). Similarly, in vitro models lack host cells, their 
activity and interaction with the colonic microbiota. Nevertheless, besides these 
constraints, in vitro model systems can serve as tools (Table 1) to study microbe-
mediated processes going on in the human colon and estimate the consequences of 
these activities on gut health.
Table 1. In vitro systems used to study the human gut microbiota.
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Many studies on fermentation characteristics of dietary relevant carbohydrates 
have been performed with the use of in vitro models of the gut (van Nuenen et al., 
2003; Probert et al., 2004; van de Wiele et al., 2007; Jiménez-Vera et al., 2008). 
Additionally, in vitro modeling systems are also used to study human intestinal 
microbes able to colonize mucus and to establish biofilm communities (Macfarlane 
et al., 2005). Recently the TNO in vitro model of the large intestine – termed 
TIM-2 (Minekus et al., 1999) -was used in combination with isotopically labeled 
substrates to identify colonic populations actively involved in the fermentation of 
glucose (Egert et al., 2007) and potato starch (Kovatcheva-Datchary et al., 2009). 
An important advantage of this in vitro system is the fact that metabolites and water 
can be constantly removed from the module. In this computer-controlled model, 
parameters such as transit time and pH are regulated and, for example, age-dependent 
colon simulations can be realized. Moreover, peristaltic mixing is simulated and 
microorganisms reach physiological densities (~109–1010 ml−1). 
We have recently used high-throughput phylogenetic microarray analysis to 
compare the microbial community that colonized the TIM-2 model with the fecal 
community of randomly selected adult volunteers. The data indicated that TIM-2 
microbiota is not significantly different from the fecal microbial community of the 
human volunteers with respect to composition and diversity of the major microbial 
groups (Fig. 1). This further reinforces the assumption that TIM-2 system well 
represents the human large intestinal microbiota (Kovatcheva-Datchary et al., 2009).
Figure 1. Similarity of the 
total microbiota and ma-
jor phylogenetic groups 
between TIM-2 profile 
and human faecal profiles. 
Samples were analyzed us-
ing the Human Intestinal 
Tract Chip (HITChip) (Ra-
jilic-Stojanovic et al., 2009)
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Diagnostic tools to assess microbial diversity of the human gut
Our current knowledge about the microbial composition of the colonic ecosystem in 
health and disease is still limited. In order to be able to diagnose the presence and 
abundance of key players of the gut microbiota, a number of culture-independent 
approaches has been applied. 
The gut microbiota composition is likely to be influenced by complex 
interactions between host, microbes and the environment. Diet is an important factor, 
which undoubtedly shape the gut microbiota, and has been explored in detail using 
the power of the molecular fingerprinting techniques and 16S ribosomal RNA gene 
sequencing (Hayashi et al., 2002; Bartosch et al., 2005; Abell et al., 2008). Recent 
work has reviewed some important aspects of the mammalian host-gut microbial 
relationship that could link gut microbiome to the human obesity (Ley, 2010; Musso 
et al., 2010; Vrieze et al., 2010). The influence of dietary factors was studied by 
Ley et al. (2006), where a high throughput sequencing approach was applied to 
characterize the fecal microbiota of 12 obese individuals who received either fat-
restricted or carbohydrate-restricted low-caloric diets. It was shown that the stool 
samples of obese subjects were significantly enriched in Firmicutes and depleted in 
Bacteroidetes, in comparison to samples obtained from lean individuals. Recently, 
the differences in the human intestinal microbiota and fecal SCFA concentration of 
98 lean and obese subjects were studied. The authors report higher proportion of 
Bacteroidetes in overweight and obese subjects versus lean individuals, and higher 
concentration of Methanobrevibacter in lean participants (Schwiertz et al., 2010). 
However, it has been concluded that not ratio of Firmicutes and Bacteroidetes is 
decisive to the development of obesity, but rather the metabolism of SCFA might 
play a considerable role (Schwiertz et al., 2010). In a separate study fluorescent in 
situ hybridization (FISH) analysis was applied to investigate the effect of reduced 
carbohydrate intake on fecal microbiota composition of twenty obese individuals 
(Duncan et al., 2007b). Progressive decrease as a fraction of total bacterial cells was 
observed in populations related to Roseburia spp., E. rectale and Bifidobacterium 
spp., after decreasing the carbohydrates intake. These data showed that dietary 
carbohydrate supply is an important factor for these microbial groups in order to 
maintain their populations in the human colon (Duncan et al., 2007b). 
The two primary human inflammatory bowel diseases (IBD), Crohn’s disease 
(CD) and ulcerative colitis (UC), are usually associated with unstable and disturbed 
composition of the gut microbiota in comparison with healthy individuals. In the last 
few years, a number of research groups have focused their activities on determining 
24 CHAPTER 1
the gut microbial composition in patients and to define how it is impacted by disease. 
The composition of the gut microbiota in concordant and discordant identical twins 
with CD, and healthy twins, was studied to identify members of the microbiota, which 
could be linked to CD incidence or development (Dicksved et al., 2008). Molecular 
fingerprinting analyses based on terminal-restriction length polymorphism (T-RFLP) 
of the 16S rRNA sequences revealed higher microbial diversity in the healthy twins 
compare to the CD twins. Moreover, the fecal microbiota of the healthy individuals 
was found to be less variable than those of CD twins. The microbial community 
profiles of individuals with ileal CD were significantly different from healthy 
individuals and those with colonic CD. Furthermore, a lower relative abundance of 
B. uniformis and higher abundance of B. ovatus was observed in all patients with 
ileal involvement in comparison to both healthy twins and twins with colonic disease 
(Dicksved et al., 2008). In another study, temperature gradient gel electrophoresis 
(TGGE) of PCR-amplified 16S rRNA gene fragments was applied to investigate the 
effect of enteral nutrition therapy on fecal microbiota in children with CD (Lionetti et 
al., 2005). This revealed differences in the microbial composition of healthy subjects 
and CD patients, but also within the latter, between patients in remission and relapse. 
Recently, 16S rRNA sequence data were collected from fecal and biopsy samples from 
CD and UC patients, and compared to those from healthy individuals (Frank et al., 
2007). Significant differences between the gut microbiota of the two patient groups 
were detected, including a depletion in the level of Firmicutes and Bacteroidetes 
in comparison with the health control. Determining the differences in microbial 
composition in patients and healthy controls may thus provide novel therapeutic 
targets. For this purpose, high-throughput, cost-effective methods for microbiota 
characterization are needed. Recently the application of 454-pyrosequencing of 
hyper-variable regions of the 16S rRNA gene revealed taxonomic richness of the gut 
microbiota that exceed any previously reported estimates (Andersson et al., 2008; 
Dethlefsen et al., 2008). Pyrosequencing analyses were applied recently to study 
the role of the gut microbiota in the development of obesity. High bacterial diversity 
and particular enrichment of H2-producing Prevotellaceae accompanied with high 
abundance of H2-utilizing methanogenic Archaea was reported (Zhang et al., 2009). 
Phylogenetic microarrays are high-throughput analytical tools, which can be 
used to measure diversity and abundance of the human gut microbiota. Recently, 
such a DNA microarray, the Human Intestinal Tract Chip (HITChip), was developed, 
combining the power of fingerprinting, phylogenetic and quantitative community 
analysis (Rajilic-Stojanovic et al., 2009). The HITChip targets over 1,000 phylotypes 
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of intestinal microbiota, and its application for the analysis of intestinal samples of 
patients and healthy individuals can provide novel insights into the relation between 
the gut microbiota and health or disease (Zoetendal et al., 2008). In a recent study the 
potential of HITChip approach was further explored, after comparative analysis of 
the phylogenetic array and pyrosequencing technologies. Additionally, it confirmed 
their high capacity for in-depth profiling of complex microbial communities 
(Claesson et al., 2009). 
Diagnostic tools to assess microbial functionality of the human gut 
To understand the complex changes in the gut microbiota composition that may 
predispose towards intestinal disorders or promote human health, techniques that 
can assay and link metabolic activity to the diversity of intestinal bacteria are needed. 
Recently explored metagenomics approaches allow the comprehensive study of 
phylogenetic, physical and functional properties of complex microbial communities, 
providing a full picture of microbiota dynamics (Handelsman, 2004). Because 
metagenomic analyses allow to study the phylogenetic diversity, as well as can 
provide an inventory of potential functions of gut microbiota, it can be used as a tool 
to link diversity to functionality (Booijink et al., 2007). Metagenomics screening 
approaches can be divided into functional and sequence-based driven analyses 
of collective microbial genomes in complex environments (Gabor et al., 2007). 
Sequence-based metagenomic investigations have started to reveal core metabolic 
functions of the gut microbiota. An early metagenomic study on two healthy adults 
showed that their fecal microbial metagenomes were enriched in genes involved in 
energy metabolism, which include also the production of short-chain fatty acids as 
pivotal energy supply for the intestine (Gill et al., 2006). Additionally, a recent study 
where metaproteomics analyses were applied to study the distal gut microbiota of a 
healthy twin pair, indicated more than 50% of the detected proteins to be involved 
in translation, energy production and carbohydrate metabolism (Verberkmoes et al., 
2009). Comparison of metagenomics (Gill et al., 2006) and metaproteomics data 
(Verberkmoes et al., 2009) indicated matches in the fucose and butyrate colonic 
fermentation pathways. Recent large-scale comparative metagenomic analyses 
demonstrated a clear effect of diet and age on the gut microbiome (Kurokawa et al., 
2007). Very recently a gene catalogue of all prevalent genes of the gut microbiome 
was generated by illumina-based metagenomic sequencing from the fecal material 
of 124 European individuals (Qin et al., 2010). This analysis provided a broad 
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overview of functions crucial for the bacteria in the human gut, but also pointed out 
the existence of a bacterial core for the different individuals (Qin et al., 2010).
However, an ongoing challenge for microbiologists is to be able to identify, which 
microbes in the human gut carry out a specific metabolic conversion, the products of 
which may promote intestinal disorders and/or gut health. Recently, isotope probing 
approaches have been developed, offering great potential to identify microbes that are 
involved in the metabolism of specific substrates. These molecular tools involve the 
usage of commercially prepared substrates highly enriched in a stable isotope (e.g. 
13C) or radioisotope (e.g 14C), which is added to an environmental sample. Endogenous 
microbes that metabolize the labeled substrate will incorporate the isotope into 
components of the microbial cells that provide phylogenetic information (Radajewski 
et al., 2000; Manefield et al., 2002; Lueders et al., 2004b; Dumont et al., 2006a; 
Manefield et al., 2006). Such components are often referred to as biomarkers, and 
most commonly nucleic acids and fatty acids are used. FISH-microautoradiography 
(FISH-MAR) and isotope array technology both use radioactive tracers to study the 
incorporation of substrate. With FISH-MAR a direct monitoring of the incorporation 
of the substrate labeled with a radioactive isotope into single microbial cells is 
performed (Lee et al., 1999). In a different way the analyses with the isotope arrays 
are performed, requiring the isolation of the labeled biomarker. Ribosomal RNA 
is hybridized to oligonucleotide arrays to target the 16S rRNA of the bacteria of 
interest (Adamczyk et al., 2003). However, since both methods use radioisotopes, 
their application is limited, especially in animal and human subjects, and therefore 
stable isotopes can offer a safe and convenient alternative for in vivo analysis. SIP 
methodologies vary in the use of biomarker, but also the means by which biomarkers 
are analyzed for isotopic and phylogenetic content (Fig. 2). The first application of 
SIP was in the analysis of phospholipid fatty acids (PLFA) that can be extracted from 
environmental samples and analyzed by isotope-ratio mass spectrometry (IRMS) 
(Boschker et al., 1998). Microbial populations often have signature PLFA molecules, 
which allow identification of microbes that have incorporated the 13C-substrate. 
However, the interpretation of the PLFA patterns of microbes for which there are no 
cultivated representatives remain still limited, which is the main restriction of the 
PLFA-SIP (Dumont and Murrell, 2005). 
Nucleic acids (NA) have a higher phylogenetic resolution than PLFA-SIP and 
enable identification of active but, as yet uncultured, populations at the species level. 
NA-based SIP works on the principle of separation of isotopically labeled DNA or 
RNA from unlabeled NA. The isolated labeled DNA/RNA represents the microbial 
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populations that incorporated the isotope into the biomarker through metabolic 
sequestration. NA-based SIP experiments have been applied in a large number of 
environmental studies focused on identification of bacteria that carry out specific 
degradative functions. Different culture independent techniques were used to monitor 
the 13C-DNA/RNA. DNA-based SIP studies reported the application of polymerase 
chain reaction (PCR) analyses, targeting functional or taxonomic marker genes 
(Radajewski et al., 2000; Morris et al., 2002; Radajewski et al., 2002). As culture-
independent microbial taxonomic marker the 16S rRNA and the encoding gene have 
been applied most frequently. Subsequent fingerprinting (e.g. denaturing gradient gel 
electrophoresis (DGGE) or T-RFLP), 16S rRNA clone library construction and/or 
microarray analyses, are further used to reveal the microbial populations involved in 
the degradation of the particular substrate (Dumont et al., 2006b; Cupples et al., 2007; 
Neufeld et al., 2007). DNA-SIP enables analysis of isotopically labeled functional 
genes (Dumont and Murrell, 2005), which provides a further functional view of 
Figure 2. Summary of stable isotope probing (SIP) approaches, suitable diagnostic tools, to assess gut microbiota 
functionality and link it to phylogeny. 
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the active microbiota. Moreover, DNA-SIP in combination with metagenomics 
can provide broad insight into the genetic potential of microorganisms that were 
attributed to the in situ use of specific substrates (Egert et al., 2006). An important 
limitation of DNA-SIP is the requirement for DNA synthesis and cell division in order 
to obtain sufficient incorporation of the label into the DNA for gradient separation. 
Conversely, RNA occurs in greater cellular copy numbers, has a higher turnover rate 
than DNA and is produced independent of cellular replication. For this reason RNA 
will be labeled more rapidly than DNA, making it a highly responsive biomarker in 
SIP analyses (Manefield et al., 2002). Due to  its greater buoyant density, isopycnic 
centrifugation of RNA is performed in cesium trifluoroacetate (CsTFA) rather than 
CsCl. Additionally, based on the reduced loading capacity of CsTFA, lower RNA 
loading amounts (250 - 500 ng ml-1) (Lueders et al., 2004a; Whiteley et al., 2006; 
Egert et al., 2007) are essential for a successful separation in comparison with the 
DNA-SIP, where 5 µg ml-1 of DNA is an optimal concentration (Lueders et al., 2004a; 
Jensen et al., 2008). To analyze the fractionated RNA qualitative analyses as reverse 
transcriptase PCR-based fingerprinting methods (DGGE T-RFLP) and subsequent 
cloning and sequencing, or phylogenetic microarray analysis, are applied, which 
enable phylogenetic identification of the active microbial population (Lueders 
et al., 2004b; Egert et al., 2007; Kovatcheva-Datchary et al., 2009). Additionally, 
quantitative evaluation of the isopycnic RNA gradients can be performed using 
reverse transcriptase quantitative PCR (RT-qPCR), which leads to high precision 
and better resolution for recovery of the labeled nucleic acids (Lueders et al., 
2004a). The success of NA-SIP depends mostly on the sufficient degree of labeling 
required for the separation of labeled and unlabeled nucleic acids by buoyant 
density centrifugation. To this end, extended incubation times are often required. 
However, increasing the time of nucleic acids enrichment has to be balanced in order 
to avoid changes that can occur in the bacterial community after addition of the 
substrate of interest. An example could be the effect of secondary degradation of the 
substrates (cross-feeding), which can affect bacterial diversity and metabolic activity 
(Belenguer et al., 2006). However, such cross-feeding effects can be instrumental 
in identifying food chains in the human intestinal systems. Recent studies with 16S 
rRNA-based SIP performed at in vitro conditions of the human intestine showed that 
a high concentration of labeled tracer is necessary to have good separation between 
the labeled and unlabeled fractions of the nucleic acids (Egert et al., 2007). 
Protein-based stable isotope probing (Protein-SIP) is a novel approach, which 
analyzes specific metabolic activity of a single bacterial species within a community 
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which incorporate the labeled substrate using proteins as biomarker (Jehmlich et al., 
2008; Jehmlich et al., 2010). The most important advantages of the protein analysis 
are its direct connection to physiological function, as proteins are known to catalyze 
the biochemical reaction. Thus, proteins are source of phylogenetic and functional 
information, making them ideal biomarkers for monitoring community structure and 
function. 
Recently, new elegant tools have been developed that combine single-cell 
technologies with stable isotope analysis of microbial communities to monitor 
stable-isotope uptake at the single-cell level. These include technologies such 
as Raman microspectroscopy (Huang et al., 2004) and nano-secondary ion mass 
spectrometry (nano-SIMS) (Kuypers and Jørgensen, 2007). Raman spectroscopy 
analyses enable the detection of clear shifts in key regions (phenylalanine, proteins 
and nucleic acids) of bacterial Raman spectral profiles, which allow detection of 
the incorporation of the stable isotope into individual cell. Further, the Raman 
approach can be combined with FISH (Raman-FISH), which enables to establish 
the link between individual bacterial cells and their metabolic functions (Huang et 
al., 2007). Raman microspectroscopy is a nondestructive technique and allows the 
identification and the further physical separation of a single isotope-label cell for 
further subsequent cultivation or single cell genomic approaches (Wagner, 2009). 
The nano-SIMS technology analyses both stable- and radioactive-isotope content at 
single cell resolution (Kuypers and Jørgensen, 2007). Additionally, the nano-SIMS 
instruments are more sensitive as allow the quantification of several elements or 
their isotopes on a single cell level simultaneously, but also subcellular analysis 
can be also performed as their spatial resolution is much higher, which exceeds the 
capacity of a Raman microspectroscopy (Wagner, 2009). Combination of FISH-
nanoSIMS allows the phylogenetic and isotopic analysis of a sample in a single scan. 
Nevertheless, this technology is far from becoming commonplace and affordable, 
mostly because of the high cost of the infrastructure required for nanoSIMS analysis. 
Furthermore, SIP techniques are suitable for obtaining qualitative and quantitative 
information about metabolic fluxes in the colon. Isotopically labeled compounds 
enable the selective study of that part of the microbial or host metabolism that 
involves the isotopic tracer. NMR and gas- or liquid-chromatography can be use 
to measure the labeled compounds and further identify active metabolic pathways 
(Bacher et al., 1998; Egert et al., 2006). RNA based-SIP was used to identify primary 
carbohydrate degrader at in vitro and in vivo condition and further provide the global 
idea off all different chapters where SIP approach was involved. 
30 CHAPTER 1
SIP in vivo
Further moving towards stable isotope probing in vivo, in which the labelled substrates 
of interest will be delivered to the human colon, will allow the exploration of the real 
power of this molecular approach. Moreover, SIP in vivo will lead to the development 
of a dynamic picture of the metabolic activity and diversity of the gut microbiota in 
health and disease. Optimizations on several limiting issues of the SIP application 
in vivo are required in order to be able effectively to explore the in situ function of 
the gut microbiota. The possibility to deliver labelled substrates effectively to the 
desired site of the human colon and the substrate homogenous distribution is an 
important once. Another key point is the origin of the sample, in most of the case 
biopsy, or luminal and /or faecal contents will be used to identify metabolically active 
phylogenetic groups through their degree of nucleic acid enrichment. Additionally 
the concentration of the labelled substrate is a further important factor, however 
recent in vitro studies (Egert et al., 2007; Kovatcheva-Datchary et al., 2009) could 
serve as a starting point and further if required the concentration can be adjusted 
in order to prevent dilution within the colon and ensure sufficient labeling of the 
microbial biomarkers.  
The complete understanding of the metabolic activity of the gut microbiota 
will enable the development of direct strategies to treat or prevent intestinal diseases 
caused by microorganisms.
Future perspectives
Identification of prime functions of the human gut microbiota in maintaining human 
health inquire better understanding of its diversity and functionality, which can 
facilitate its manipulation. Most intestinal microbes have not been cultured and 
the in situ functions of distinct groups of the gut microbiota are largely unknown 
but pivotal to understand their role in health and disease. Technological advances 
in culture-independent microbiology have revolutionized gastroenterological 
microbiology. Recently introduced metagenomics approaches become extremely 
useful in addressing knowledge gaps on gut microbiota composition and started to 
reveal core metabolic functions of the gut microbiota. However, it is not known 
which members of the gut microbiota are involved in specific metabolic activities in 
situ. An important function of the gut microbiota is related to fermentation of non-
digestible dietary residue, metabolites of which are considered to be essential for the 
intestinal health. New developments in stable isotope-based approaches can be used 
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in the identification of key players of the gut microbiota, which functions may have 
direct impact on human well being. Furthermore, extending the in vitro models to 
human feeding trials, in which relevant dietary oligo- and polymeric carbohydrates 
will be delivered to the human colon, will allow the exploration of the real power of 
these molecular approaches.
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Abstract 
Carbohydrates, including starches, are an important energy source for humans, and are known for their interactions with the microbiota in the digestive tract. Largely, those interactions are thought to promote human health. Using 16S ribosomal RNA (rRNA)-based stable isotope 
probing (SIP) we identified starch-fermenting bacteria under human colon like conditions. To the 
microbiota of the TIM-2 in vitro model of the human colon 7.4 g/l of [U-13C]-starch was added. RNA 
extracted from lumen samples after 0 h (control), 2 h, 4 h and 8 h was subjected to density-gradient 
ultracentrifugation. Terminal-restriction fragment length polymorphism (T-RFLP) fingerprinting 
and phylogenetic analyses of the labeled and unlabeled 16S rRNA suggested populations related to 
Ruminococcus bromii, Prevotella spp. and Eubacterium rectale to be involved in starch metabolism. 
Additionally, 16S rRNA related to that of Bifidobacterium adolescentis was abundant in all analyzed 
fractions. While this might be due to the enrichment of high-GC RNA in high-density fractions, it 
could also indicate an active role in starch fermentation. Comparison of the T-RFLP fingerprints 
of experiments performed with labeled and unlabeled starch revealed Ruminococcus bromii as the 
primary degrader in starch fermentation in the studied model, as it was found to solely predominate 
in the labeled fractions. LC-MS analyses of the lumen and dialysate samples showed that, for both 
experiments, starch fermentation primarily yielded acetate, butyrate and propionate. Integration of 
molecular and metabolite data suggests metabolic cross-feeding in the system, where populations 
related to Ruminococcus bromii are the primary starch degrader, while those related to Prevotella spp., 
Bifidobacterium adolescentis and Eubacterium rectale might be further involved in the trophic chain. 
Adapted from Environmental Microbiology (2009) 11: 914-926.
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Introduction
The human colonic microbial community comprises a vast number of microbes 
representing a complex ecosystem, which has beneficial effects on the host (Finegold 
et al., 1983). Fermentation of dietary carbohydrates such as dietary fibers and resistant 
starch (RS) is an essential function of this community (Guarner and Malagelada, 
2003). The end products from these microbial fermentations are short-chain fatty 
acids (SCFA) such as butyrate, propionate and acetate, which have an important 
function in host physiology (Scheppach, 1994). It has been suggested that specific 
SCFA reduce the risk of gastrointestinal disorders, cancer, and cardiovascular disease 
(Jenkins et al., 2000; Kendall et al., 2004). Particularly butyrate is subject of studies 
aiming to understand its role in nourishing the colonic epithelium and in prevention 
of colon cancer (Cummings and Bingham, 1987; Bauer-Marinovic et al., 2006; 
Sengupta et al., 2006). An intake of more slowly fermentable carbohydrates could 
result in prolongation of these beneficial fermentations and an increased production 
and greater delivery of SCFA, particularly butyrate, to the distal colon (Jacobasch et 
al., 1999; Topping and Clifton, 2001; Wong et al., 2005). 
Over the last decade the introduction of molecular techniques in microbial ecology, 
especially the 16S rRNA-based approaches, has emphasized the extreme diversity 
of the human colonic microbiota and has indicated the limitations of culture-based 
approaches (Zoetendal et al., 2004). The most abundant bacterial groups shown 
by molecular screening to colonize the large intestine belong to Bacteroidetes, 
Clostridium clusters XIVa and IV, and Actinobacteria (Franks et al., 1998; Hold 
et al., 2002). However, one limitation of the rRNA-based techniques is that they 
do not provide a direct link to physiology and metabolic capacities. A recently 
introduced molecular approach, which allows linking the phylogenetic identity of 
a microorganism with its ecological function in a complex microbial community, is 
nucleic acid-based stable isotope probing (SIP) (Radajewski et al., 2000; Dumont 
and Murrell, 2005; Egert et al., 2006; de Graaf et al., 2007; Neufeld et al., 2007). This 
approach involves the incorporation of stable-isotope label into cellular biomarkers 
(including DNA and RNA), which are used to identify the microorganisms 
assimilating a labeled substrate and are involved in particular processes of interest. 
Especially the introduction of RNA-based SIP represents a significant advancement, 
as it does not require microbial growth, and has been used to link microbial function 
with phylogeny in a broad spectrum of different environments. Studies addressed 
phenol remediation in bioreactor systems (Manefield et al., 2002), identification 
of methylotrophs (Lueders et al., 2004b) or syntrophs (Lueders et al., 2004a) in 
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paddy soil, analysis of active methanogens in rice field soil (Lu and Conrad, 2005), 
and pentachlorphenol degraders in pristine grassland soil (Mahmood et al., 2005) 
or rhizosphere microbes (Rangel-Castro et al., 2005). Recently, RNA-based SIP 
was also used to investigate glucose-fermenting bacteria in an in vitro model of 
the human colon with microbial community representing the human small intestinal 
microbiota (Egert et al., 2007).
In the present study, 16S rRNA-based SIP was applied to identify the microbes 
involved in starch fermentation under conditions simulating the in situ situation in 
the human colon. The microbial community of an in vitro model of the large bowel 
was fed 13C-labeled potato starch and the active populations were identified. We 
detected incorporation of the 13C-label into the rRNA after 4 and 8 h of incubation. 
Terminal-restriction fragment length polymorphism (T-RFLP) fingerprinting and 
phylogenetic analyses of the labeled and unlabeled 16S rRNA revealed pronounced 
differences in the community structure of the analyzed microbiota. LC-MS analyses 
of the metabolites produced during starch fermentation showed strong increase of 
the measured SCFAs particularly after 4 h of incubation. Our study showed that 
RNA-based SIP combined with metabolic analyses is a useful tool for identifying 
metabolically active colonic bacteria and linking these to metabolites in the course 
of in vitro experiments. The current study also provides the basis for experimental 
approaches to determine microbial functionality in human subjects.
Experimental Procedures
In vitro model of the large intestine
The validated TNO in vitro model of the human colon (TIM-2), representing the 
conditions in the proximal colon and tested with a variety of fermentable substrates 
(Minekus et al., 1999; Rajilic-Stojanovic, 2007) was used in the current study. The 
inoculation of the in vitro colon model with a fresh standardized microbiota and the 
further preparation of the microbiota was performed as described (van Nuenen et 
al., 2003; Egert et al., 2007). Briefly, approximately 20 gram of faecal material from 
each of 7 individuals (healthy adults on a regular diet, who had not received antibiotic 
treatment for at least 2 months prior to faecal collection) was mixed in an anaerobic 
glove box and used to inoculate the TIM-2 system. After overnight stabilization and a 
2 h starvation (Egert et al., 2007), 7.4 g/l of 98% [U-13C]-labeled starch, isolated from 
potatoes grown in the presence of 13CO2 (IsoLife, Wageningen, The Netherlands), 
was administered to the in vitro model, corresponding to a concentration of 40 mM 
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glucose-units. Luminal and dialysate samples (each approximately 2 ml) were taken 
at the time points 0 (control) h, 2 h, 4 h and 8 h after starch addition and stored at 
-80°C. A control experiment was performed with non-labeled potato starch (Sigma) 
as well. 
RNA-extraction, purification and fractionation by density
Total RNA was extracted and purified from 250 µl luminal sample collected at the 
different time points as described previously (Egert et al., 2007). After purification 
and quantification approximately 1 mg of total RNA were loaded in cesium 
trifluoroacetate (CsTFA) centrifugation medium and resolved by density gradient 
centrifugation (Egert et al., 2007). 
Gradients were subsequently fractionated as described by (Egert et al., 2007), 
albeit using a KDS200 syringe pump (KD Scientific Inc., Holliston, MA, USA). 
Afterwards, RNA from each fractions was precipitated for subsequent community 
analyses.
Amplification and fingerprinting of 16S rRNA
Amplification of the bacterial 16S rRNA for terminal restriction fragment length 
polymorphism (T-RFLP) analyses was done using a one-step reverse transcription-
PCR (RT-PCR) system (Access Quick, Promega, Leiden, The Netherlands) as 
described previously (Egert et al., 2007). To detect all bacteria, 5’ 6-carboxyfluorescein 
(FAM) labeled forward primer 35f (CCT GGC TCA GGA TGA ACG) (Hayashi et 
al., 2004) and a modified reverse primer 907r (CCG TCA ATT YCT TTR AGT TT) 
(Muyzer et al., 1995) were used, where in the reverse primer a C was replaced by a Y. 
Both primers were used in order to increase Bifidobacteria detection at the analyzed 
samples. Subsequently, the fluorescently labeled RT-PCR amplicons were purified 
and quantified as described previously (Egert et al., 2007). 
For T-RFLP analysis, aliquots (75 ng) of purified PCR products were digested 
for 3 h at 37ºC with 2.5 U of AluI or MspI (Promega) in a 10 µl reaction mixture 
following instructions of the supplier. To check for pseudo-T-RFs, which can lead 
to overestimation of the microbial diversity, mung bean nuclease treatment prior to 
the restriction digest was performed as described previously (Egert and Friedrich, 
2003), except that the digestion was terminated with the PCR-purification kit. Size 
separation of terminal restriction fragments (T-RFs) was performed using an ABI 
377 DNA sequencer (Applied Biosystems) as described earlier (Egert et al., 2007). 
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Fragments between 50 and 1000 base pairs were analysed using Genescan 3.1 
analytical software (Applied Biosystems), T-RFs ≤ 50 bp were excluded from the 
analysis to exclude artifacts caused by primer-dimers. The relative abundance of the 
T-RFs within a given T-RFLP profile was calculated as the peak area of the respective 
T-RF divided by the total peak area of all T-RFs detected within a fragment length 
range between 50 and 900 bp.
Cloning, sequencing and phylogenetic analysis of bacterial 16S rRNA 
fragments
Amplicons for sequence analyses were generated from rRNA of fractions 4 and 8 (4 h 
gradient) with the above mentioned primer set as described earlier (Egert et al., 2007). 
Subsequently, the PCR-products were purified using the NucleoSpin Extract II kit 
(Macherey-Nagel). Fragment cloning and the selection of the clones for sequencing 
were performed according to (Egert et al., 2007). Bi-directional sequencing of 
SP6-T7 PCR products was performed by BaseClear (Leiden, The Netherlands) using 
SP6 and T7 primers. Phylogenetic analyses were conducted using the ARB software 
package (Ludwig et al., 2004) as previously described (Egert et al., 2007). For tree 
construction with distance matrix-based neighbor joining, 773 sequence positions 
(E. coli positions 28-906) and a base-frequency filter for Bacteria, provided with the 
ARB package, were used.
To test for the significance of differences observed between both libraries, a Chi 
Square test of independence was performed (Mathbeans Project, http://math.hws.
edu), using abundance of sequences in 4 phylogenetic groups (Clostridium clusters 
IV, XIVa, Bacteroidetes, Actinobacteria). In addition, the LibraryCompare software 
available at the RDP II website was used to assess the significance of differences 
observed for the individual groups (Cole et al., 2007). A confidence threshold of 80% 
was applied. 16S rRNA gene sequences obtained in this study have been deposited at 
the GenBank database under accession numbers EU202927 – EU202948.
HITChip analysis
For phylogenetic analysis of TIM-2 microbiota from [U-13C]-starch and [U-13C]-
inulin studies, the HITChip was used. This phylogenetic microarray consists of more 
than 4,800 oligonucleotides based on 16S rRNA gene sequences targeting over 1,100 
intestinal microbial phylotypes. The procedure for hybridization and analysis was 
performed as described before (Rajilic-Stojanovic, 2007) with the only difference 
that a one-step reverse transcription-PCR (RT-PCR) system (Access Quick, Promega, 
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Leiden, The Netherlands) was used to amplify 16S rRNA fragments from RNA from 
selected gradient fractions, extracted from TIM-2 luminal samples collected at 0 
h and 4 h after substrate addition, with the primers T7prom-Bact-27-for (5’-TGA 
ATT GTA ATA CGA CTC ACT ATA GGG GTT TGA TCC TGG CTC AG-3’) and 
Uni-1492-rev (5’-CGG CTA CCT TGT TAC GAC-3’). After purification of the PCR 
products (NucleoSpin Extract II kit, Macherey-Nagel, Düren, Germany) the DNA 
concentration was measured using a NanoDrop spectrophotometer (NanoDrop® 
Technologies, Wilmington, USA). 
The 16S rRNA genes were transcribed in vitro from the T7 promoter using the 
Riboprobe System (Promega, La Jolla, USA) with a mix containing aminoallyl-
rUTP (Ambion Inc., Austin, Texas, USA) at room temperature. The template DNA 
was digested with RNAse-free DNAse (Qiagen, Hilden, Germany), and RNA was 
purified (RNeasy Mini-Elute Kit, Qiagen, Hilden, Germany). Subsequently, the 
amino-allyl-modified nucleotides were labeled with CyDye (Post-Labeling Reactive 
Dye, Amersham Biosciences, Little Chalfont, UK). After stopping the reaction, 
labeled RNA was purified and quantified as described before. 
Microarrays synthesized by Agilent Technologies (Agilent Technologies, Palo Alto, 
CA) in 8×15K format were used for hybridization with two samples, labeled with 
Cy3 and Cy5, respectively. The Cy3/Cy5 labeled target mixes were fragmented with 
10× fragmentation reagent (Ambion Inc., Austin, Texas, USA). Hybridization on the 
arrays was performed at 62.5°C for 16 h in a rotation oven (Agilent). Slides were 
washed at room temperature in 2× SSC with 0.3% SDS for 10 min, followed by 0.1× 
SSC with 0.3% SDS at 38°C for 10 min and 0.06× SSPE for 5 min (Sambrook et 
al., 1989). 
Data were extracted from microarray images using the Agilent Feature Extraction 
software, version 9.1 (www.agilent.com). Data normalisation and the further 
microarray analysis were performed using a set of R based scripts (http://r-project.
org) in combination with a custom designed relational database which runs under 
the MySQL database management system (http://www.mysql.com). Similarity of 
the total microbiota composition based on the HITChip profiles was assessed by 
calculating Pearson’s product moment correlation (Pearson’s correlation) between 
hybridisation signals obtained for two samples for unique HITChip probes, and 
for different phylogenetic groups between signals obtained for two samples for 
phylogenetic group - specific HITChip probes. Pearson’s correlation reflects the 
degree of linear relationship between analysed data sets. Ward’s minimum variance 
method was used for the generation of hierarchical clustering of probe profiles by 
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calculating a distance matrix between the samples based on the squared difference 
between each pair of profiles (squared Euclidian distance – E2) (Carter, 1989).
Quantitative Real-Time PCR
Real-time PCR was performed on an iCycler IQ real-time detection system 
associated with the iCycler optical system interface software version 2.3 (Bio-Rad, 
Veenendaal, the Netherlands). A reaction mixture (25 µL) consisted of 12.5 µL of 
IQ SYBR Green Supermix (Bio-Rad), 0.2 µM of each primer set and 5 µL of the 
template cDNA diluted in water (10-fold) to avoid PCR inhibition. The cDNA was 
synthesized from the RNA collected in different fraction with different density. 
Reaction mixtures consisting of SuperScript™ III Reverse Transcriptase (Invitrogen), 
8 μl RNA solution, 1 μl 50 µM random hexamer primer and 1 μl 10 mM dNTPs were 
incubated at 65°C for 5 min and then placed on ice for at least 1 min. The cDNA 
synthesis mix containing 4 μl 5 × First-Strand Buffer, 1 μl rRNasin® (40 U/μl), 1 μl 
SuperScript™ III RT (200 U/μl) and 1 μl 0.1 M DTT was then added to each RNA/
primer sample which were then incubated first at 25°C for 5 min and afterwards 
at 55°C for 60 min. Reactions were terminated by exposure to 70°C for 15 min. 
Subsequently the cDNA was purified (High Pure PCR Cleanup Micro Kit, Roche 
Diagnostics GmbH, Mannheim, Germany) and used for qPCR analysis. A standard 
curve for quantification of total bacteria and Ruminococcus bromii was generated by 
using serially diluted 16S rRNA gene amplicons obtained from Ruminococcus bromii 
51896 ATCC. For the quantification of methanogenic Archaea, Methanobrevibacter 
smithii 861T was used as reference strain. In this assay, mcrA forward and reverse 
primers (Luton et al., 2002) were used to amplify the mcrA gene, known to be 
alternative to 16S rRNA in phylogenetic analysis of methanogen populations. All 
qPCR assays were performed in triplicate. Primers Eub341F and Eub534R (Smits 
et al., 2004) were used to estimate the total number of copies of the bacterial 16S 
rRNA in each sample. PCR was performed with an initial denaturation step of 95ºC 
for 10 min, followed by 40 cycles of 95ºC for 15 s, 60ºC for 30 s and 72ºC for 30 s. 
Primers RBR-5 and RBR-6 (Wang et al., 1997) were used to investigate the number 
of Ruminococcus bromii 16S rRNA copies in the sample with the following PCR 
program, initial step at 50 ºC for 2 min and an initial denaturation step of 95ºC for 
3 min, followed by 35 cycles of 95ºC for 15 s, 62ºC for 45 s and 74ºC for 40 s. To 
estimate the number of methanogenic Archaea the primers qmcrA-F and qmcrA-R 
and the PCR program reported by (Denman et al., 2007) was used. 
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Metabolite analysis using LC-MS
To follow the metabolite production during fermentation of [U-13C]-labeled starch 
in the same incubations as used for the RNA-SIP study a method minimizing the 
sample preparation and utilizing liquid chromatography-mass spectrometry (LC-
MS) was applied (Meesters et al., 2007). This approach allowed to determine the 
concentrations of the individual isotopomers of each SCFA. Total concentration of 
SCFA were determined by GC analysis (van Nuenen et al., 2003), and were used to 
determine the cumulative production of the labeled metabolites in the TIM-2 system. 
Results
RNA recovery and RT-PCR amplification of the 16S rRNA
To identify colonic bacteria that ferment starch, a standardized human fecal microbiota 
was supplemented with 7.4 g/l of uniformly 13C-labeled starch in the TIM-2 in vitro 
model of the human large intestine, and fermentation was followed for 8 h. A control 
study, where 7.4 g/l of non-labeled starch was tested, was performed as well. RNA 
was extracted from luminal samples taken at different time points, and yielded 48 to 
55 µg RNA per 250 μl of sample. 
The fractionated centrifugation gradients from the [U-13C]-starch experiment covered 
an average density range of 1.724 g ml-1 (fraction 14) to 1.829 g ml-1 (fraction 1) 
(Fig. 1 A). In the gradient fractions of the 0 h (control) sample all nucleic acids were 
detected at densities between 1.747 g ml-1 (fraction 11) and 1.793 g ml-1 (fraction 5). 
Four hours after the addition of the [U-13C]-labeled starch, RNA was detected even in 
fraction 4 (1.802 g ml-1), indicating the incorporation of the label in the RNA of starch-
utilizing populations. Notably, the highest amount of RNA was detected in fraction 7 
(1.777 g ml-1, Fig. 1 B), whereas the maximal RNA concentration in the non-labeled 
starch experiment, for all the gradients from 0 h, 4 h and 8 h, was detected in fraction 
8 (1.759 g ml-1). Additionally, identical distribution of the RNA in all gradients from 
the different time points for the non-labeled starch fermentation was detected (data 
not shown). Furthermore, 8 h after [U-13C]-labeled starch addition the maximal RNA 
concentration was detected in fraction 8 (Fig. 1 B). This most probably indicates 
that in this particular system all of the 13C-label has been incorporated after 8 h and 
is already replaced by unlabeled carbon as a result of the RNA turn over. This is in 
line with the observed reduction in the amount of the detected RNA 8 h after starch 
addition in fractions 5 (1.793 g ml-1) and 4 (1.802 g ml-1) (Fig. 1 B). 
52 CHAPTER 2
Comparable results were obtained by RT-PCR amplification of bacterial 16S 
rRNA fragments present in the different fractions. The amplification of the 16S 
rRNA in the fractions of the control gradient (0 h) as well as the 2 h gradient yielded 
PCR-products for the fractions 5 (1.793 g ml-1) to fraction 12 (1.739 g ml-1) (Fig. 1 
C).  However, 4 h after starch addition also fraction 4 displayed a detectable PCR 
product.
These data corroborate the incorporation of the 13C-label into the bacterial 16S rRNA. 
The amplification of the 16S rRNA from samples obtained during the course of the 
non-labeled starch fermentation yielded products for the fractions with a density 
between 1.742 g ml -1 to 1.791 g ml-1.
Figure 1. A. Densities of gradient fractions 
averaged over 4 gradients. For each 
fraction, the SEM was ≤ 0.001 g ml -1. B. 
RNA concentration in gradient fractions. 
RNA was isolated from lumen samples 
of the colon model after incubation for 0 
(control) h, 2 h, 4 h and 8 h with 7.4 g/l of 
[U-13C]-starch. Values are given in relative 
units (%) to facilitate comparison between 
the gradients; RNA concentration in the 
fractions containing most RNA (100%) were 
2.7 ng µl-1 (control), 2.5 ng µl-1 (2 h), 3.5 ng 
µl-1 (4 h) and 2.2 ng µl-1 (8 h). ♦, control; 
▲, 2 h; ■, 4 h; ●, 8 h. The fractions used 
for the creation of “light” and “heavy” clone 
libraries are indicated by a small arrow, 
respectively. Large vertical arrows indicate 
corresponding fractions in figures A and B. 
C. RT-PCR-analysis results representing an 
~900 bp fragment of bacterial 16S rRNA 
from the gradient fractions. The picture 
is assembled from 4 different stained 
agarose gels after electrophoresis of the 
amplicons. Fractions were obtained from 
ultracentrifugation gradients performed to 
density-resolve RNA isolated from lumen 
samples of the colon model after incubation 
for 0 (control) h, 2 h, 4 h and 8 h with 7.4 
g/l of [U-13C]-starch. Fraction numbers are 
indicated on top and correspond to those in 
A and B.
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Fingerprinting of the bacterial 16S rRNA in gradient fractions
To compare the microbial community in the gradient fractions at different time points, 
T-RFLP fingerprint analysis was applied. The profile obtained after AluI digestion of 
the PCR products derived from fraction 8 from the 0 h (control; unlabeled) gradient, 
where the bulk of unlabeled RNA accumulated, displayed 12 major T-RFs sized 
52, 62, 69, 131, 185, 237, 243, 246, 432, 624, 723, and 823 bp, respectively (Fig. 2 
A). Identical T-RFs were detected in fraction 8 from the 4 h (Fig. 2 B) and the 8 h 
(Fig. 2 C) gradients. Minor variations in the relative height of peaks were observed, 
as a fragment of 62-bp was most abundant after 8 h, whereas the 185-bp peak was 
highest after 0 h and 4 h of incubation (compare Fig. 2 A - C). No changes in the 
number of the major T-RF peaks were detected for fractions 6 - 7 in any of the 
analyzed gradients. A strong decrease was, however, observed in the number of the 
Figure 2. T-RFLP profiles of bacterial 16S rRNA obtained from fractions of the control (A), 4 h gradient (B) and 8 h 
gradient (C), after applying AluI as restriction endonuclease; control (D), 4 h gradient (E) and 8 h gradient (F), after 
applying MspI as restriction endonuclease. Assignment of T-RF peaks to bacterial phylotypes (Rb, Ruminococcus 
bromii; B, Bifidobacterium adolescentis; Ro, Ruminococcus obeum; C, uncultured Clostridium spp.; Er, Eubacteri-
um rectale; P, Prevotella spp.). T-RFs marked with an asterisk were assigned as pseudo T-RFs as indicated in the text.
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T-RF peaks for fractions of higher density (i.e. fractions 4 to 5; Fig. 2 A - C). A clear 
dominance of the 62-bp T-RF was detected in these fractions, surprisingly even in 
fraction 5 after 0 h incubation. Significant changes in the T-RFLP profiles of these 
high density fractions were found 4 h after 13C-labeled starch addition, where an 
increase in the relative abundance of the T-RFs with a size of 52 bp and 246 bp was 
detected (Fig. 2 B, fraction 4). 
The profile resulting after digestion of the PCR products with MspI did not 
differ in the number of peaks in fractions 6 to 9 from any of the analyzed gradients. 
However, a strong decrease in peak number was observed for fraction 5 of the control 
gradient, where the community was represented mainly by a T-RF with a size of 123 
bp (Fig. 2 D). The same peak is present in all profiles, and probably is related to the 
62-bp T-RF detected in all the T-RFLP profiles after using AluI endonuclease (see 
below). Similarity in the profiles resulting after digestion of the PCR products with 
MspI and AluI was also observed between the fractions from the 8 h gradient (Fig. 
2 C and 2 F). Four hours after addition of the 13C-labeled starch, a 7-fold increase 
in relative abundance of the T-RF with a size of 276 bp was detected only in the 
fractions containing labeled RNA (Fig. 2 E), in line with results found for AluI 
fingerprints. By contrast, the fingerprints of the community from the non-labeled 
starch experiment showed no increase in the T-RF sized 276 bp, which remained low 
in all analyzed fractions (Fig 3 A). 
Individual fractions retrieved from the gradients differed significantly in RNA 
concentration, and thus different amounts of RNA were available as template for 
initial RT-PCR reactions. It was therefore assessed whether such differences in 
concentration, i.e. the dilution of the initial template, resulted in decline in both 
the number and the height of the peaks present in a T-RFLP profile as reported by 
Egert et al., 2007. In the present study, template concentration did not significantly 
affect T-RFLP profiles, and the 237-bp T-RF observed after digestion with AluI was 
identified as the only major pseudo-T-RF using mung bean nuclease treatment (data 
not shown).
The relative abundance of the T-RFs within the T-RFLP profiles of the fractions 4 
h after addition of labeled and non-labeled starch was calculated. Only the T-RFs 
that had a relative abundance of ≥ 2% in all the analysed fractions were included for 
further analyses.  The relative abundances of T-RFs sized 52 bp after digestion with 
AluI and the corresponding 276 bp after digestion with MspI, were the only ones 
that differed significantly for the labeled starch and non-labeled starch experiments 
(Fig. 3 A and B).
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Phylogenetic analyses
In order to identify the bacteria based on the density-resolved rRNA, and to assign 
phylogenetic groups to distinct T-RFs, bacterial clone libraries were generated from 
16S rRNA template from the “heavy” (fraction 4, n = 72 clones) and “light” (fraction 
8, n = 24 clones) fractions from the 4 h gradient. After validation of insert size 
and RFLP analyses of SP6/T7 PCR products, 23 RFLP groups were defined and 
representative clones were selected for sequencing.  
The phylogenetic analyses showed that both bacterial 16S rRNA clone libraries 
consisted of phylotypes belonging to three phyla, namely Bacteroidetes, Firmicutes 
(Clostridium clusters IV and XIVa) and Actinobacteria (Bifidobacterium) (Fig. 
4). The “light” community comprised populations belonging to Bacteroidetes and 
Firmicutes, particularly to the Clostridium cluster XIVa. Here a clear predominance 
of sequences related to Prevotella spp. and Ruminococcus obeum was observed. In 
stark contrast to the clone library from the “light” fraction, bacterial clones retrieved 
from the “heavy’ fraction had prevalence of sequences related to Ruminococcus 
Figure 3. Relative abundance 
of different T-RFs, across 
the fraction density, after 4 h 
incubation with 7.4 g/l of [U-13C]-
starch (closed symbols) and 7.4 
g/l of non-labeled starch (open 
symbols). The reported data 
represent the T-RFs generated 
after applying AluI as restriction 
endonuclease (A) and MspI (B) 
as restriction endonuclease.
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bromii (Clostridium cluster IV), which represented 33% of the clones, Eubacterium 
rectale (Clostridium cluster XIVa - 18% of clones) and Bifidobacterium  adolescentis 
(Actinobacteria - 14% of clones). The number of clones affiliated to Prevotella spp. 
was relatively high in the clone libraries obtained from both fractions (Fig. 4). 
Overall, both libraries could be shown to significantly differ in the relative abundance 
of clones within the 4 major groups (Clostridium clusters IV, XIVa, Bacteroidetes, 
Actinobacteria), using a Chi Square test of independence (p = 0.03). In addition, 
trends for individual groups could be confirmed, albeit not in all cases at significance 
level due to the limited size of the libraries, using the Library Compare software 
available at the Ribosomal Database Project website (http://rdp.cme.msu.edu/); 
Cole et al., 2007), with p-values ranging between 0.02 (Ruminococcus obeum), 0.12 
(Bifidobacterium spp.) and 0.74 (Prevotellaceae) (data not shown). 
In the T-RFLP profile of bacterial 16S rRNA of fraction 8 after 4 h incubation 
digested with AluI, it was estimated that more than 80% of all major T-RFs could be 
allocated to phylogenetic groups from the constructed clone library, mainly affiliated 
to Clostridium clusters IV and XIVa. The predominant T-RF with a size of 62 bp 
was assigned to Bifidobacterium adolescentis. The obvious strong dominance of this 
T-RF in all the fractions was probably caused by the high GC-content specific for 
Bifidobacterium spp., which leads to an increase in the density and appearance of 
the corresponding RNA in the RNA fractions with higher density (Neufeld et al., 
2007). The T-RFs with a size of 52 bp and 246 bp, which increased strongly in 
fractions with labeled RNA (Fig. 2 B), could be assigned to Ruminococcus bromii 
and Eubacterium rectale, respectively. 
In addition to these two populations, analyses of the profiles resulting after MspI 
restriction indicated that a T-RF with a size of 88-bp was strongly enriched in fraction 
4 after 4 h incubation, compared to fraction 5 after 0 h incubation (Fig. 2 D and E). 
Based on phylogenetic analyses this peak corresponded to a population most closely 
related to a Prevotella species. 
Community profiling of the TIM-2 microbiota using the HITChip
The microbiota composition of the initial community of TIM-2 for the [U-13C]-starch 
experiment and that of two fractions from the 4 h gradient of the [U-13C]-starch 
study (fraction 4 and fraction 8) was compared using the HITChip, comprehensive 
phylogenetic microarray for the human intestinal tract microbiota (Rajilic-
Stojanovic, 2007). Furthermore, to assess the reproducibility of TIM-2 experiments 
using different [U-13C]-substrates, a sample representing the initial community 
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of an additional experiment with [U-13C]-inulin (Kovatcheva-Datchary et al., in 
preparation) was included as well. These analyses revealed that the initial microbiota 
in both experiments is highly similar - 98%, calculated as Pearson’s product moment 
correlation between the respective HITChip fingerprints. Despite this high similarity 
of the initial microbiota, different microbial populations were identified by T-RFLP 
analysis as primary [U-13C]-inulin degraders as compared to the [U-13C]-starch study 
(Kovatcheva-Datchary et al., in preparation). As it could be anticipated, the profile 
of fraction 4 from the 4 h [U-13C]-starch study, which represents only the part of the 
microbiota that is actively involved in starch degradation, showed lower diversity 
than the profiles of the initial samples and fraction 8 (Fig. 5).
In addition to the analysis of the total and fractions’ microbiota from TIM-2 in vitro 
model, the total rRNA-based microbiota profiles of fecal samples of four randomly 
selected adult volunteers were generated using the HITChip (Fig. 5). Similarity 
between the initial total microbiota from the TIM-2 experiment and the total 
microbiota from faecal samples of the volunteers was found to be in average 65.6% 
(Standard deviation (SD) 4.6%). This was within the 2SD confidence range of the 
inter-individual similarity of the total faecal microbiota of the volunteers (average 
74.2%, SD 4.3%). Furthermore, none of the subpopulations of the microbiota 
seemed to be majorly affected in TIM-2 in vitro experiments. More specifically, it 
was found that the similarity of the Actinobacteria-specific profiles of TIM-2 model 
samples and fecal samples was 71.3% (SD 6.8%), Bacteroidetes-specific profiles 
68.5% (SD 6.6%), and Proteobacteria-specific profiles 67.8% (SD 8.2%). Members 
of the Firmicutes phylum appeared to be somewhat more affected in the in vitro 
model as similarity values were for Bacilli 62.7% (SD 5.9%), for Clostridium cluster 
IV 58.5% (SD 3.9%) and for Clostridium cluster XIVa 56.4% (SD 3.0%).
The diversity of the total initial microbiota profiles of TIM-2 model was found to be 
1.7 (expressed as a number of the responding HITChip probes), which was, again, 
found to be in the range of diversity detected in faecal samples of volunteers (1.94 
± 0.18), further reinforcing the fact that the TIM-2 model used in this study well 
represents the human large intestinal microbiota. 
Quantitative-PCR (qPCR) of R. bromii
The 16S rRNA-based ratios of Ruminococcus bromii to total bacteria from the 
experiment with [U-13C]-starch and non-labeled starch indicated a strong increase 
in the Ruminococcus bromii population in the fraction with high density from the 
[U-13C]-starch experiment in comparison with the non-labeled starch study (Fig. 6). 
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Figure 5. Phylogenetic HITChip fingerprints of the microbiota composition of the initial community of TIM-2 
for the [U-13C]-starch (S0) and [U-13C]-inulin (I0) experiment, that of two fractions from the 4 h gradient of the 
[U-13C]-starch study - fraction 4 (C4) and fraction 8 (C8), and the faecal microbiota of four adult volunteers (Hf76, 
Hf15, Hf46 and Hf 84). The highest phylogenetic ranks of probe specificity are given at the right side of the figure. 
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These data confirm the T-RFLP data, where after comparison of the T-RF abundance 
of the major T-RFs from the experiments with labeled and non-labeled starch 
a significant increase in the T-RF assigned to Ruminococcus bromii in the heavy 
fractions after incubation in the presence of labeled starch for 4 hours was detected. 
In none of the samples analyzed, methanogenic Archaea could be detected (data not 
shown).
Figure 6. Ratio of 16S 
rRNA copy numbers across 
the fraction density after 4 
h incubation with 7.4 g/l of 
[U-13C]-starch (open symbols - 
LSt) and 7.4 g/l of non-labeled 
starch (closed symbols - NLSt). 
The reported data represent 
the copy number quantified 
after Real-Time PCR specific 
for Ruminococcus bromii and 
total bacteria, respectively. A 
standard curve was generated 
by using serially diluted 16S 
rRNA gene amplicons obtained 
from Ruminococcus bromii 
51896 ATCC.
13C-labeled metabolite production
LC-MS analyses were used to follow the production of metabolites from the 
13C-labeled starch in the same incubations as used for the RNA isolation. Acetate 
(~ 5 mmol), butyrate (~ 2 mmol) and propionate (~ 1 mmol) were identified as 
main fermentation products (Fig. 7 A). A strong increase of acetate, butyrate and 
propionate concentrations was detected particularly 4 h after starch addition. 
LC-MS analysis allowed for the detection of the different isotopomers of acetate 
(M+0 [all 12C-isotopomer]; M+1 [one 13C atom, one 12C]; and M+2 [both 13C]), 
propionate (M+0, M+1, M+2 and M+3) and butyrate (M+0 through M+4).
The major acetate-isotopomer produced from the labeled starch was the M+2 
isotopomer (Fig. 7 B), whereas there was only limited production of the M+1-
isotopomer. The LC-MS method cannot discriminate between 13C1-acetate or 
13C2-
acetate. However, both are formed through the Wood-Ljungdahl reaction of coupling 
two CO2 molecules, one of which is 
13C-labeled. 
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Figure 7. Cumulative production of the metabolites produced during fermentation of 7.4 g/l [U-13C]-starch, 
analyzed by LC-MS. A. Sum of all isotopomers produced (M+1 and M+2 for acetate; M+1 – M+3 for propionate; 
M+1 – M+4 for butyrate). B. Acetate-isotopomers produced from labeled starch (acetate M+1 and acetate M+2). 
C. Butyrate-isotopomers produced from labeled starch (butyrate M+1, butyrate M+2, butyrate M+3 and butyrate 
M+4).
The major butyrate-isotopomer after 8 h was the M+2-isotopomer, the production of 
which was bi-phasic with an intermediate lag-phase during the first 2 h of incubation 
(Fig. 7 C). The M+3- and M+4-isotopomers were first detected after 2 h. Strikingly, 
the production of the M+1 isotopomer of butyrate showed a different profile, with 
a relatively rapid production during the first 2 h, and then a slower phase for the 
remaining 6 h. In both phases equivalent amounts were produced. 
It should be noted that during the full 8 h of incubation unlabeled isotopomers of 
acetate and butyrate (M+0) were present as well (not shown in Fig. 7), due to either 
i) their production from other (unlabeled, non-carbohydrate) substrates, or ii) their 
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presence in the system at the start of addition of the labeled starch. Compared to 
acetate and butyrate, propionate production was relatively low, with approximately 
equal amounts of the M+1, M+2 and M+3 isotopomer, and similar kinetics of 
production (data not shown).
Discussion
Dietary carbohydrates, such as resistant starch, represent a substantial part of the 
human diet (Annison and Topping, 1994), and are known to affect the functioning 
of the human colon. Data from several animal studies showed increased large 
bowel butyrate levels and counts of Bifidobacterium, Lactobacillus, Eubacterium 
and Bacteroides spp. after consumption of resistant starch (Kleessen et al., 1997; 
Jacobasch et al., 1999; Bird et al., 2000; Le Blay et al., 2003; Wong et al., 2006). 
However, there is still lack of knowledge with respect to the key microbes involved 
in colonic breakdown of these carbohydrates. The objective of our study was to use 
[U-13C]-potato starch as a substrate for the microbial community of an in vitro model 
system of the human colon, and to apply RNA-based stable isotope probing (RNA-
SIP) to phylogenetically identify bacteria involved in the colonic fermentation of 
starch.
Clone libraries constructed from both unlabeled and labeled 16S rRNA constituted the 
most abundant bacterial groups normally found in human fecal samples. Additional 
analysis by the HITChip phylogenetic microarray confirmed these data and showed 
that our experimental model is in fact well-representing the fecal microbiota present 
in vivo, in human volunteers. Furthermore, HITChip analysis also revealed high 
similarity between experiments performed with different [U-13C]-substrates with 
regard to initial composition, further supporting the good reproducibility of the model 
(Fig. 5). The Clostridium cluster XIVa was found to be predominant in the “light” 
library. According to previous reports on the human colonic microbiota composition, 
this cluster comprises 24 to 59% of the total bacterial phylotypes isolated from 
human fecal samples (Suau et al., 1999; Hold et al., 2002; Hayashi et al., 2003). A 
strong numerical increase in the Clostridium cluster IV was detected in the “heavy” 
library, especially concerning clones related to the Ruminococcus bromii. Significant 
changes in the “heavy” clone library were also detected in the Bacteroidetes phylum, 
mostly due to an increase in phylotypes related to Prevotella species. 
The heavy fraction (fraction 4) appears to represent only a tiny percentage of the total 
RNA at the 4 h time point. This is based on the fact that only a very small amount 
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of rRNA becomes strongly labeled due to the high numbers of bacteria present, the 
fact that TIM is an open system, as well as the presence of other substrates. It is the 
fundamental principle of SIP that the sequences found here represent a snapshot 
of the most active substrate consumers in the system (Egert et al., 2006). Thus the 
amount of strongly labeled rRNA does not provide information with respect to the 
relative abundance of these groups in the system. This can be estimated from the 
fingerprints generated from the unlabeled RNA. 
The Bifidobacterium group is also a vital member of the human fecal microbiota 
(Matsuki et al., 2004). Bifidobacterium adolescentis represented 7% of all sequences 
retrieved from both libraries. Most of the studies investigating 16S rRNA gene 
libraries of human adult colonic microbiota detected lower levels of Bifidobacterium 
species (Suau et al., 1999; Hayashi et al., 2002; Hold et al., 2002; Schwiertz et al., 
2002). This has in general been explained by the high GC-content in Bifidobacterium 
species, resulting in incomplete DNA denaturation during the PCR reaction (Suau 
et al., 1999). However, a possible explanation of the relative high presence of 
Bifidobacterium spp. in our clone libraries in comparison with the studies mentioned 
above could be the selection of a suitable forward primer (35f), which increases 
the sensitivity in detection of bifidobacteria in human fecal samples. Similar results 
were reported by (Hayashi et al., 2004) after using the same forward primer for the 
construction of a 16S rRNA gene clone library from fecal samples of five healthy 
individuals. 
An important function of the human colonic microbial community is the degradation 
and fermentation of dietary carbohydrates, which escape digestion in the upper 
intestinal tract (Guarner and Malagelada, 2003). To this end, the contribution 
of different groups of microorganisms linked in a food chain is necessary for 
performing of this fermentative process. Several studies reported Bacteroides and 
Bifidobacterium species as the major saccharolytic bacteria in experiments targeting 
human fecal microbiota (Macfarlane et al., 1997; Wang et al., 1999; Cummings et 
al., 2001). In a recent study, it was observed that Ruminococcus bromii, Eubacterium 
rectale, Bifidobacterium adolescentis and Bifidobacterium breve are able to attach to 
and colonize starch particles (Leitch et al., 2007). Our results based on 16S rRNA-
SIP corroborate the involvement of Ruminococcus bromii in the starch fermentation 
under the in vitro conditions (Leitch et al., 2007). This is also in line with recent 
observations made by Abell et al. 2008 in an in vivo study, where the effect of non-
starch polysaccharides (NSP) and resistant starch (RS) on microbiota composition 
was tested, revealing a significant increase of Ruminococcus bromii and closely 
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related phylotypes particularly with the RS diet. Comparison of the T-RF abundance 
of the major T-RFs from the experiments with labeled and non-labeled starch 
showed a significant increase in the T-RF assigned to Ruminococcus bromii in the 
heavy fractions after incubation in the presence of labeled starch for four hours. 
This was furthermore confirmed by quantitative PCR targeting total bacterial and 
Ruminococcus bromii-specific 16S rRNA fragments (Fig. 6). The most plausible 
explanation for this observation is that this species represents the population most 
actively assimilating starch in the studied system. Notably, these results are in 
agreement with the high frequency of clones related to Ruminococcus bromii detected 
in the “heavy” library. Whereas analysis of fingerprints generated from heavy and 
light fractions of RNA from the [U-13C]-starch experiment suggested populations 
related to Eubacterium rectale, Prevotella spp. and Bifidobacterium adolescentis to 
be directly involved in the starch degradation, a comparison of the relative abundance 
of the T-RFs representing these species generated from the experiments performed 
with labeled and non-labeled starch did not reveal significant changes. Possibly 
these populations are not the primary [U-13C]-starch degraders in the studied model, 
but rather consume metabolites of primary degradation by Ruminococcus bromii 
related species. The presence of species related to Bifidobacterium adolescentis to 
be relatively abundant not only in the fractions with heavier density but also in those 
with lower density could be related to a GC-bias that is known to affect SIP analyses 
(Rangel-Castro et al., 2005).
Amylolytic bifidobacterial strains are known to produce mostly acetate and 
lactate as end products from carbohydrate fermentation (Duncan et al., 2004b). 
Lactate is rarely detected as major fermentation end product of complex microbial 
communities (Le Blay et al., 2003), and some reports suggest that a considerable 
part of the lactate is converted to butyrate in the human colon (Duncan et al., 2004a; 
Bourriaud et al., 2005; Belenguer et al., 2006). The complete absence of lactate after 
starch fermentation in our experiment further supports this, but does not allow us to 
conclude with certainty whether amylolytic bifidobacteria are involved in the starch 
degradation in these experiments. In a separate experiment the TIM-2 microbial 
community was probed to ferment glucose, which is a common, natural substrate 
for microbial fermentations especially for the human small intestine microbiota. 
Here, [U-13C]-glucose was fermented within 2 h, yielding mostly lactate, but also 
acetate, formate and butyrate as main metabolic products (Egert et al., 2007). This 
obvious difference in metabolites indicates that distinct microbial populations are 
responsible for microbial fermentations of the different substrates tested, which was 
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also confirmed with RNA-base stable isotope probing. 
Starch is a substrate, which is known to stimulate the abundance of butyrate-forming 
bacteria, mostly belonging to the Eubacterium rectale group (Barcenilla et al., 2000), 
but the mechanisms are not yet clearly defined. Several studies have suggested that 
the major butyrogenic bacteria depend on other species, mostly acetate producers, 
but also initial degraders of complex carbohydrates (Duncan et al., 2002; Belenguer 
et al., 2006). The increase in the production of acetate and butyrate concomitant with 
enrichment of labeled 16S rRNA particularly for Ruminococcus bromii, suggests that 
the latter might interact with Eubacterium rectale by cross-feeding. It is tempting 
to hypothesize that in our system the butyrogenic effect is stimulated through a 
cooperative food-web, comprising Ruminococcus bromii and Eubacterium rectale, 
where Ruminococcus bromii. is degrading the starch and producing acetate, which 
the known butyrate-producer Eubacterium rectale uses to convert to butyrate. The 
main butyrate isotopomer observed was the M+2-isotopomer (56% of the 13C-label, 
Fig. 7 C), indicating coupling of a fully 13C-labeled acetate to a fully unlabeled 
acetate. This is most likely to occur when the labeled and unlabeled metabolite pool 
of acetate mix extracellularly, and corroborates our hypothesis of cross-feeding 
between Ruminococcus bromii and Eubacterium rectale. This also explains the lack 
of strong labeling of Eubacterium rectale RNA. This is further supported by the 
observation of an intermediate lag-phase during the 2 h in the production of the M+2 
butyrate isotopomer, as well as the fact that the M+3 and M+4 isotopomers were 
detected only after 2 h. It is unclear whether the M+4 metabolite is produced by 
coupling of two labeled M+2-acetate molecules by cross-feeding, or that the M+4 
butyrate is produced by a microorganism that feeds on the labeled starch directly. 
However, due to the time-lag of production of this M+4 isotopomer, the appearance 
of which coincides with the second phase of production of the M+2 butyrate 
isotopomer, it is likely to be formed due to cross-feeding. We hypothesize that the 
time-lag in production of these isotopomers is due to the fact that it takes time for 
the M+2 acetate isotopomer (required for production of M+2 and M+4 butyrate) to 
reach those microorganisms that cross-feed on this metabolite.
In conclusion, we could show that RNA-SIP can be used to identify bacteria 
involved in carbohydrate fermentation under conditions simulating those in the 
human colon. Additional fermentation studies are currently performed to reveal 
whether these allow to confirm the primary substrate consumers and to define 
possible cross-feeding processes. Furthermore, by extending the in vitro models to 
human feeding trials, in which relevant dietary oligo- and polymeric carbohydrates 
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will be delivered to the human colon, will allow the exploration of the real power of 
this molecular approach.
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Abstract 
Using 16S ribosomal RNA (rRNA)-based Stable Isotope Probing (SIP) we identified bacteria fermenting inulin and lactose under human colon-like conditions. Two separate studies were performed to test the activity of the microbiota of the TIM-2 in vitro model of the human colon. 
Either 7.4 g/l of [U-13C]-inulin or 7.4 g/l of [U-13C]-lactose were added to the system. Lumen and dialysate 
samples were taken at frequent intervals and processed for metabolic and molecular analyses. RNA 
was extracted from luminal samples and was further subjected to density-gradient ultracentrifugation 
and subsequently separated into fractions of increasing density. Terminal-restriction fragment length 
polymorphism (T-RFLP) fingerprinting of 16S rRNA in these fractions suggested populations related to 
Dorea longicatena, a member of Clostridium cluster XIVa, and Bifidobacterium adolescentis, belonging 
to the Actinobacteria, to be most actively involved in inulin and lactose metabolism, respectively. 
These findings were confirmed and extended by analyzing the 13C–enriched 16S RNA amplicons by 
a phylogenetic microarray, the Human Intestinal Tract Chip (HITChip). Moreover, the contribution 
of Actinobacteria to the inulin fermentation was detected as well. The HITChip analysis of selected 
fractions from the lactose experiment indicated that Actinobacteria, particularly Bifidobacterium spp. 
and Collinsella spp., were the main taxa involved in lactose fermentation. LC-MS analyses of the 
lumen and dialysate samples showed that both inulin and lactose fermentation primarily yielded acetate, 
butyrate and propionate. Additionally, NMR data indicated the presence of lactate 15 min after the start 
of both fermentations. Integration of molecular and metabolite data suggests members of Clostridium 
cluster XIVa and Actinobacteria to be involved in the fermentation of inulin and lactose, either as a 
direct degrader of the studied substrates or as being associated in the trophic chain. 
Manuscript in preparation
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Introduction
The human body is inhabited by a complex microbial consortium, which represents 
only 1% to 2% of the body mass of a healthy human, but has immense impact on its 
health. The number of microbial cells associated with us is estimated to outnumber 
the human cells by 10-fold and the number of microbial genes is suggested to exceed 
those of the host by a factor of more than 100 (Savage, 1977; Berg, 1996; Backhed et 
al., 2005; Qin et al., 2010). Particularly in the human colon up to 100 trillion microbes, 
representing more than 1000 species, structure a microbiome that possesses many 
metabolic capabilities, which are lacking in the human host and make it essential for 
human life (Suau et al., 1999; Eckburg et al., 2005; Xu et al., 2007). Fermentation 
of dietary carbohydrates, such as plant polysaccharides like inulin and a variety of 
oligosaccharides, which escape digestion in the upper gastro-intestinal (GI) tract 
and reach the colon, is one of these vital microbial activities. This fermentation 
allows the microbiota to use these otherwise indigestible carbohydrates as an energy 
source, leading to the production of metabolites that are believed to contribute to 
maintaining gut health (Savage, 1986; Hooper et al., 2002; Guarner and Malagelada, 
2003; Xu and Gordon, 2003). The end products from these microbial fermentations 
are short-chain fatty acids (SCFA) such as butyrate, propionate and acetate, as well 
as other intermediate products such as lactate. Increase in the production of SCFAs 
was reported to lower the luminal pH. This modifies the microbial composition in the 
colon as it suppresses the activity of pathogenic bacteria and stimulates the growth of 
bacteria such as bifidobacteria and lactobacilli, leading to an increase in the biomass 
and fecal bulk respectively (Cummings and Macfarlane, 1997; Topping and Clifton, 
2001; Le Leu et al., 2005). 
Dietary fructans such as inulin and fructo-ologosaccharides are well-studied 
prebiotics, and their health-promoting effect has been reported in a number of studies, 
using animals and humans (Djouzi and Andrieux, 1997; Kleessen et al., 1997; Reddy 
et al., 1997; Gallaher and Khil, 1999; Kleessen et al., 2001; Perrin et al., 2001; 
Oberreuther-Moschner et al., 2004). As a direct outcome of the inulin ingestion, 
the stimulation of bifidobacteria, known as bifidogenic effect, and an increase in 
butyrate concentration (butyrogenic effect) have been reported in in vivo studies 
(Gibson et al., 1995; Kleessen et al., 1997; Bouhnik et al., 1999; Kruse et al., 1999; 
Tuohy et al., 2001; Bouhnik et al., 2004; Kleessen et al., 2007; Ramirez-Farias et 
al., 2009). Different carbohydrates are digested to various degrees in the GI tract, 
and some enter the colon or pass through the entire intestine comparatively intact 
(Scheppach et al., 2001). Most disaccharides are completely digested in the small 
76 CHAPTER 3
intestine, however, the host genetic background can influence digestive efficacy 
significantly. Lactose is one of these disaccharides, and lactose intolerance results 
from insufficient or even absent lactase activity in the small intestine (Henslee and 
Jones, 1982; de Vrese et al., 2001; Vonk et al., 2003). In lactase-deficient individuals, 
consumption of lactose can cause variable abdominal symptoms, but also can have 
a positive effect on microbial fermentation, as lactose was proposed to be prebiotic 
when host lactase activity is limited (Gudmand-Hoyer, 1994; Szilagyi, 2002, 2004). 
Obviously, the diet affects colonic nutrition mainly through its effect on the gut 
microbiota. Hence, studies should unravel the in situ functionality of this microbiota 
and aim to contribute to our understanding of the impact of the intestinal microbiota 
on human health.
Numerous microbes inhabit the human intestine, many of which still remain 
uncharacterized or uncultured, which keeps their in situ functions largely unknown. A 
recently introduced molecular approach, which allows linking the metabolic activity 
and diversity of microbial communities in a complex environment, is nucleic acid-
based Stable Isotope Probing (SIP) (Radajewski et al., 2000; Dumont and Murrell, 
2005; Egert et al., 2006; de Graaf et al., 2007; Neufeld et al., 2007). This approach 
involves the incorporation of stable-isotope label into cellular biomarkers (including 
DNA and RNA), which are used to identify the microorganisms assimilating a 
labeled substrate and are involved in particular processes of interest. Especially the 
introduction of RNA-based SIP represented a significant advancement, as it does 
not require microbial growth, and has been used to link microbial function with 
phylogeny in a broad spectrum of different environments. Recently, RNA-based SIP 
was applied to identify acetate-metabolizing bacteria in the presence of iron oxides 
as electron acceptors (Hori et al., 2010), phenol-assimilating bacteria (Sueoka et al., 
2009), or butyrate-producing bacteria under methanogenic conditions (Hatamoto et 
al., 2008). Furthermore, RNA-based SIP was also applied to study human intestinal 
bacteria in an in vitro model of the human colon in presence of [U-13C]-glucose (Egert 
et al., 2007) and in the presence of [U-13C]- potato starch (Kovatcheva-Datchary et 
al., 2009b). 
The aim of the present study was to identify the microbes involved in inulin 
and lactose fermentation under conditions simulating the in situ situation in the 
human colon, using 16S rRNA based-SIP together with high-throughput diagnostic 
microarray-based phylogenetic profiling and metabolic flux analysis. Our study 
showed that RNA based-SIP combined with metabolic analyses is a useful tool for 
identifying colonic bacteria that metabolize inulin and lactose and linking these to 
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metabolites in the course of in vitro experiments. The current study also provides the 
basis for experiments to determine microbial functionality in vivo in human subjects.
Experimental Procedures
In vitro model of the large intestine
The validated TNO in vitro model of the human colon (TIM-2), representing the 
conditions in the proximal colon and tested with a variety of fermentable substrates 
(Minekus et al., 1999; Rajilic-Stojanovic, 2007; Kovatcheva-Datchary et al., 2009a) 
was used in the current study. The inoculation of the in vitro colon model with a fresh 
standardized microbiota and the further preparation of the microbiota was performed 
as described (van Nuenen et al., 2003; Egert et al., 2007; Kovatcheva-Datchary et 
al., 2009b). After overnight stabilization and a 2 h starvation (Egert et al., 2007), 7.4 
g/l of 98% [U-13C]-labeled inulin (Degree of polymerization (DP) 3 - >40 measured 
by Dionex HPLC), isolated from the taproots of chicory grown in the presence of 
13CO2 (IsoLife, Wageningen, The Netherlands) or 7.4 g/l of 98% [U-
13C]-labeled 
lactose (Omicron Biochemicals, Inc., South Bend, USA), was administered to the 
in vitro model, corresponding to a concentration of 40 mM hexose units. Luminal 
and dialysate samples (each approximately 2 ml) were taken at time points 0 h, 
15 min, 30 min, 1 h, 2 h, 4 h and 8 h after substrate addition and stored at -80°C. 
Additional control experiments were performed with non-labeled inulin (Sensus, 
The Netherlands) and lactose (Sigma Aldrich, L-1768) as well. 
RNA-extraction, purification and fractionation by density gradient 
centrifugation
Total RNA was extracted and purified from 250 µl of luminal samples collected 
at the different time points as described previously (Egert et al., 2007). After 
purification and quantification approximately 1 μg of total RNA was loaded in cesium 
trifluoroacetate (CsTFA) centrifugation medium and resolved by density gradient 
centrifugation. Gradients were subsequently fractionated as described earlier (Egert 
et al., 2007), albeit using a KDS200 syringe pump (KD Scientific Inc., Holliston, 
MA, USA) for fractionation. Afterwards, RNA from each fraction was precipitated 
for subsequent community analyses.
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Amplification and fingerprinting of 16S rRNA
Amplification of the bacterial 16S rRNA for terminal restriction fragment length 
polymorphism (T-RFLP) analysis was done using a one-step reverse transcription-
PCR (RT-PCR) system (Access Quick, Promega, Leiden, The Netherlands) as 
described previously (Egert et al., 2007). Primers and conditions for RT-PCR used 
to amplify the bacteria 16S rRNA have also been described previously (Kovatcheva-
Datchary et al., 2009b). 
For T-RFLP analysis, aliquots (50 ng) of purified PCR products were restricted for 
3 h at 37ºC with 2.5 U of AluI (Promega) in a 10 µl reaction mixture following 
instructions of the supplier. Size separation of terminal restriction fragments 
(T-RFs) was performed at VHL (Wageningen, The Netherlands). T-RFs ≤ 50 bp 
were excluded from the analysis to exclude artifacts caused by primer-dimers. The 
relative abundance of the T-RFs within a given T-RFLP profile was calculated as the 
peak area of the respective T-RF divided by the total peak area of all T-RFs detected 
within a fragment length range between 50 and 900 bp.
Cloning, sequencing and phylogenetic analysis of bacterial 16S rRNA 
fragments
A clone library generated in a previous study (Kovatcheva-Datchary et al., 2009b), 
where the same microbial community was examined to ferment [U-13C]-starch was 
used in the current experiments to assign phylogenetic groups to distinct T-RFs.
HITChip analysis
For phylogenetic analysis of the microbiota in the TIM-2 samples from the [U-13C]-
inulin and [U-13C]-lactose studies, the HITChip was used. This phylogenetic 
microarray consists of more than 4,800 oligonucleotide probes based on 16S rRNA 
gene sequences targeting over 1,100 human intestinal microbial phylotypes (Rajilic-
Stojanovic et al., 2009). Target preparation, hybridization and washing, and data 
analysis were essentially performed as described before (Kovatcheva-Datchary et 
al., 2009b; Rajilic-Stojanovic et al., 2009). Gradient fractions stemming from the 
samples taken 15 min, 30 min and 1 h after addition of inulin and 30 min and 1 h 
after lactose supplementation were analysed with the HITChip. The selection of the 
fractions was based on the data from the metabolite profiling. 
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Metabolite analysis using LC-MS and NMR
To follow the metabolite production during fermentation of [U-13C]-labeled inulin 
and  [U-13C]-labeled lactose in the same samples as used for the RNA-SIP study 
a method minimizing the sample preparation and utilizing liquid chromatography-
mass spectrometry (LC-MS) was applied (Meesters et al., 2007). LC-MS analysis 
allowed to determine the concentrations of the individual mass isotopomers including 
acetate (M+0 [all 12C-isotopomer], M+1 [one 13C atom, one 12C]; and M+2 [both 
13C]), propionate (M+0, M+1, M+2 and M+3) and butyrate (M+0 through M+4). 
For determination of positional isotopomers as well as for profiling of non-SCFA 
metabolites, one- and two-dimensional NMR was used as described previously (de 
Graaf et al., 2010). Total concentrations of SCFA were determined by GC analysis 
(van Nuenen et al., 2003), and were used to determine the cumulative production of 
the labeled metabolites in the TIM-2 system as described previously (de Graaf et al., 
2010).
Results
RNA recovery and RT-PCR amplification of the 16S rRNA
In two independent studies a fresh standardized human fecal microbiota, populating 
the TIM-2 in vitro model of the human large intestine, was supplemented with 7.4 g/l 
of uniformly 13C-labeled inulin or uniformly 13C-labeled lactose. In parallel, control 
studies with the  same amounts of non-labeled inulin and lactose were done. All 
fermentations were followed for 8 h, and luminal and dialysate samples were taken 
at 0 h, 15 min, 30 min, 1 h, 2 h, 4 h and 8 h after substrate addition. The amount of 
RNA extracted from luminal samples taken at different time points amounted to 50 
to 86 µg and 20 to 43 µg RNA per 250 μl of sample for the 13C-inulin and 13C-lactose 
in vitro fermentations, respectively. 
The fractionated isopycnic centrifugation gradients from the [U-13C]-inulin 
experiment covered an average density range of 1.721 g ml-1 (fraction 15) to 1.832 g 
ml-1 (fraction 1) (Fig. 1 A), while from the [U-13C]-lactose fermentation the average 
density ranged from 1.725 g ml-1 (fraction 14) to 1.833 g ml-1 (fraction 1) (Fig. 1 B). 
In the gradient fractions of the 0 h sample from the [U-13C]-inulin fermentation, all 
nucleic acids were detected at densities between 1.750 g ml-1 (fraction 11) and 1.787 
g ml-1 (fraction 6), whereas for the [U-13C]-lactose fermentation RNA was found in 
80 CHAPTER 3
the range between 1.753 g ml-1 (fraction 10) and 1.784 g ml-1 (fraction 6). Fifteen 
minutes after the addition of [U-13C]-labeled inulin, presence of RNA was detected 
in high density fraction 5 (1.796 g ml-1), indicating the incorporation of the label into 
the RNA of inulin-utilizing populations. The highest amount of RNA at the same 
time point was detected in fraction 8 (1.772 g ml-1, Fig. 1 A), as was the case for the 
0 h time point. Furthermore, the RNA distribution in the gradients from the 30 min, 
1 h, 2 h, 4 h and 8 h time points was similar to that reported for the 15 min sample. 
The only difference was observed for the 2 h gradient, where the maximal RNA 
concentration was detected in one of the high density fractions, i.e. fraction 7 (1.779 
g ml-1, Fig. 1 A).
Figure 1. RNA concentration in 
gradient fractions. RNA was isolated 
from lumen samples of the colon 
model after incubation for 0 h, 15 
min, 30 min, 1 h, 2 h, 4 h and 8 h 
with 7.4 g/l of [U-13C]-inulin (A) or 
7.4 g/l of [U-13C]-lactose (B). Values 
are given in relative units (%) to 
facilitate comparison between the 
gradients; RNA concentration in 
the fractions containing most RNA 
(100%) for inulin were 3.1 ng µl-1 (0 
h), 3.0 ng µl-1 (15 min), 2.4 ng µl-1 (30 
min), 2.6 ng µl-1 (1 h),   2.8 ng µl-1 (2 
h), 3.4 ng µl-1 (4 h) , 3.6 ng µl-1 (8 h) 
and for lactose were 3.0 ng µl-1 (0 h), 
3.5 ng µl-1 (15 min), 3.4 ng µl-1 (30 
min), 2.9 ng µl-1 (1 h),   2.8 ng µl-1 
(2 h), 3.1 ng µl-1 (4 h), 2.9 ng µl-1 (8 
h). ♦, 0 h; ● 15 min, ○ 30 min, ■ 1 h, 
▲ 2 h, □ 4 h, ◊ 8 h. Vertical arrows 
indicate corresponding fractions 
in the figure. Densities of gradient 
fractions from the [U-13C]-inulin 
(A) and [U-13C]-lactose (B) studies 
are averaged over 7 gradients, the 
standard deviation of the densities 
of the different gradients were in the 
range of 0.002 and 0.003 g ml-1  for 
the inulin study and between 0.001 
and 0.003 g ml-1 for the lactose (data 
not shown). 
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In contrast to the inulin fermentation, in the [U-13C]-labeled lactose experiment, 
presence of RNA in fraction with higher density as compared to the 0 h sample was 
initially detected for the first time 30 min after the beginning of the study, namely 
in fraction 5 (1.795 g ml-1, Fig. 1 B). The highest amount of RNA at the 0 h and 15 
min time points was detected in fraction 8 (1.769 g ml-1, Fig. 1 B), whereas for all 
other  time points the maximal RNA concentration was detected in fraction 7 (1.777 
g ml-1, Fig. 1 B).
Identical distribution of the RNA in all gradients from the different time 
points was observed for both non-labeled inulin and lactose experiments. For the 
non-labeled inulin fermentation the average density range was 1.718 g ml-1 (fraction 
15) to 1.825 g ml-1 (fraction 1) , while for the non-labeled lactose fermentation the 
values were in the range of 1.719 g ml-1 (fraction 14) to 1.821 g ml-1 (fraction 1) 
(data not shown). For all analyzed gradients from the non-labeled inulin and lactose 
experiments, the maximal RNA concentration was detected in fraction 9 (1.759 and 
1.755 g ml-1, respectively; data not shown). 
Subsequently, the RNA from each of the fractions was recovered and the 16S 
rRNA was amplified by RT-PCR. The amplification of the 16S rRNA in the fractions 
of the 0 h gradient from the [U-13C]-inulin fermentation yielded PCR-products from 
fraction 6 (1.787 g ml-1) to fraction 11 (1.751 g ml-1) (Fig. 2 A). However, 15 min after 
Figure 2. RT-PCR-analysis 
results representing an ~900 
bp fragment of bacterial 
16S rRNA from the gradient 
fractions from the [U-13C]-
labeled inulin study (A) 
and from the [U-13C]-
labeled lactose study (B). 
The picture is assembled 
from 7 different ethidium 
bromide-stained agarose 
gels after electrophoresis 
of the amplicons. Fractions 
were obtained from 
ultracentrifugation gradients 
performed to density-resolve 
RNA isolated from lumen 
samples of the colon model 
after incubation for 0 h, 15 
min, 30 min, 1 h, 2 h, 4 h and 8 h with 7.4 g/l of [U-13C]-inulin and [U-13C]-lactose. Fraction numbers are 
indicated on top and correspond to those in Fig. 1A and 1B. 
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inulin addition a detectable product was also obtained for the high density fraction 5 
(1.796 g ml-1). As to the [U-13C]-lactose fermentation, 16SrRNA RT-PCR performed 
with the fractions from the 0 h and 15 min gradients yielded PCR-products from the 
high density fraction 6 (1.784 g ml-1) to fraction 10 (1.753 g ml-1) (Fig. 2 B). Thirty 
minutes after [U-13C]-lactose addition, an RT-PCR-product was detected also from 
the high density fraction 5 (1.795 g ml-1). In summary, these data corroborate the 
incorporation of the 13C-label into the bacterial 16S rRNA. 
Fingerprinting of the bacterial 16S rRNA in graient fractions
T-RFLP fingerprints were generated for each gradient fraction from the different time 
points. The profile obtained after AluI restriction of the 16SrRNA RT-PCR products 
derived from fraction 8 from the 0 h gradient from the [U-13C]-inulin fermentation, 
where the bulk of unlabeled RNA accumulated, displayed 12 major T-RFs sized 51, 
60, 68, 128, 185, 242, 244, 428, 476, 623, 708, and 820 bp, respectively (Fig. 3 A). 
Identical T-RFs were detected in fraction 7 and 8 from all analyzed time points (Fig. 
3 A). Only for the sample taken at 1 h, the fraction 7 fingerprint was not identical to 
the one from fraction 8 (Fig. 3 A). Minor variations in the relative height of peaks 
were observed, as fragments of 185 bp, 242 bp and 244 bp were most abundant after 
8 h (Fig. 3 A). A clear dominance of the T-RF sized 60 bp was detected particularly in 
each of the fractions 15 min after 13C-labeled inulin addition (Fig 3 A). However, for 
the 30 min sample, this peak was dominant in fractions 7 and 8, but not in fraction 
5 and 6 (Fig 3 A). Changes in the T-RFLP profiles in fractions containing RNA with 
high density were found 30 min after 13C-labeled inulin addition, where an increase 
in the T-RF sized 623 bp was detected (Fig. 3 A). 
Additionally, the relative abundance of the T-RFs of the  profiles of the fractions 15 
min and 30 min after addition of labeled inulin and non-labeled inulin experiments 
was calculated. Only the T-RFs that had a relative abundance of ≥ 2% in all the 
analysed fractions were included for further analyses. A significant increase in the 
relative abundance of the T-RF sized 60 bp, was observed 15 min after addition of 
labeled and non-labeled inulin (Fig. 4 A). Furthermore, the relative abundance of the 
623 bp T-RF was the only one that differed notably for the labeled inulin and non-
labeled inulin experiments at 30 min (Fig. 4 A). 
The fingerprint generated after AluI restriction of the 16S rRNA RT-PCR products 
derived from fraction 8 of the 0 h gradient from the [U-13C]-lactose fermentation, 
where the bulk of unlabeled RNA accumulated, displayed 9 major T-RFs sized 51, 
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Figure 3. T-RFLP profiles of bacterial 16S rRNA obtained from [U-13C]-inulin fractions (A) and from [U-13C]-
lactose fractions (B) of the 0 h, 15 min, 30 min, 1 h, 2 h, 4 h and 8 h gradients, after applying AluI as restriction 
endonuclease; Assignment of T-RF peaks to bacterial phylotypes (RB, Ruminococcus bromii, 51 bp; B, 
Bifidobacterium adolescentis, 61 bp; RO, Ruminococcus obeum, 185 bp; C, uncultured Clostridium spp., 242 bp; 
ER, Eubacterium rectale, 244 bp; DL, Dorea longicatena, 623 bp. 
84 CHAPTER 3
Figure 4. Relative abundance of T-RFs sized 60 bp and 623 bp, across the fraction density, (A) after 15 min (closed 
symbols) and 30 min (open symbols) incubation with 7.4 g/l of [U-13C]-inulin (full line) and 7.4 g/l of non-labeled 
inulin (dashed line). (B) after 30 min (open symbols) and 1 h (closed symbols) incubation with 7.4 g/l of [U-13C]-
lactose (full line) and 7.4 g/l of non-labeled lactose (dashed line)
60, 68, 129, 185, 243, 246, 428, 476 and 623 bp, respectively (Fig. 3 B). Similar to 
the [U-13C]-inulin study, the T-RFs detected in fraction 7 and 8 from all analyzed 
time points were identical (Fig. 3 B). A T-RF with a size of 60 bp was abundant in 
all profiles generated for the [U-13C]-lactose experiment (Fig. 3 B). However, the 
relative abundance of the T-RF sized 60 bp was significantly different for the labeled 
lactose and non-labeled lactose experiments after 30 min and 1 h incubation (Fig. 4 
B).
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Phylogenetic analyses
The observed T-RFs were mapped to a reference set of 16S rRNA amplicons and the 
predominant T-RF with a size of 623 bp, which was detected to increase in fractions 
with high density (fraction 5) from the [U-13C]-inulin fermentation, was assigned to 
Dorea longicatena (Fig. 3 A). The 60 bp T-RF, found to be strongly abundant in each 
profile generated for the [U-13C]-lactose fermentation, but also in few fingerprints 
from the [U-13C]-inulin experiment, was assigned to Bifidobacterium adolescentis 
(Fig. 3). Additionally, few T-RFs which were found to be abundant during the 8 h in 
vitro fermentations and which showed minor variations in relative height during the 
experiment, in particular the T-RFs sized 185 bp, 242 bp and 244 bp, were assigned 
to Ruminococcus obeum, Clostridium spp. and Eubacterium rectale, respectively 
(Fig. 3). 
13C-labeled metabolite production
To complement the microbial community analyses, LC-MS and NMR analyses of 
the metabolites produced during the [U-13C]-inulin and [U-13C]-lactose fermentations 
were performed using the same samples as used for the RNA isolation. During the 
[U-13C]-inulin experiment, we identified as main fermentation products acetate (~ 4 
mmol cumulative production), propionate (~ 2 mmol) and butyrate (~ 0.4 mmol), 
whereas during the [U-13C]-lactose study mainly acetate (~ 6 mmol), propionate (~ 2 
mmol) and butyrate (~ 0.4 mmol) were produced (Fig. 5). The LC-MS data showed 
an increase of acetate, butyrate as well as propionate concentrations particularly 15 
min after inulin addition. In contrast to the [U-13C]-inulin study, during the [U-13C]-
lactose fermentation the peak production of acetate was detected 1 h after the addition 
of the substrate, and for butyrate and propionate after approximately 2 h (Fig. 5 
B). During both experiments, a continuous increase in butyrate concentrations was 
observed until the end of the incubation. In contrast, acetate and propionate increased 
during the [U-13C]-inulin study for the first 2 h but then remained stable during the 
rest of the incubation. Similarly, during the [U-13C]-lactose study, acetate reached 
rapidly the maximal concentrations after 1 h, while propionate continued to increase 
until 4th h. 
LC-MS analysis allowed determination of the concentrations of the individual 
mass isotopomers of acetate, propionate and butyrate. The major acetate isotopomer 
produced from the labeled inulin and lactose was the M+2 isotopomer (Fig. 5 
A), whereas there was no production of the M+1-isotopomer detected with either 
substrate. With both substrates, the major butyrate-isotopomer after 8 h was the 
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Figure 5. Cumulative production of different isotopomers of the main produced SCFA during the fermentation of 
7.4 g/l [U-13C]-inulin (A), or 7.4 g/l [U-13C]-lactose (B), analyzed by LC-MS. 
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M+2 isotopomer, which for the inulin experiment started to accumulate 15 min after 
addition of the 13C-labeled substrate, whereas for lactose it appeared only after 1 h, 
and also in lower amounts in comparison with the inulin experiment (Fig. 5).
The M+4 butyrate isotopomer was first detected after 30 min in the inulin experiment 
and after 2 h with lactose, albeit in typically more than 10-fold smaller amounts than 
the M+2 isotopomer (Fig. 5). The production of the M+1 isotopomer of butyrate 
showed a profile similar to that of the M+2-isotopomer in both studies. In the inulin 
experiment the M+1 isotopomer concentration started to increase 15 min after 
substrate addition, whereas with lactose an increase was only observed after 1 h. 
Finally, in both experiments a relatively rapid production of the M+1 isotopomer 
was observed during the first 2 h, and then a slower phase for the remaining 6 h (Fig. 
5). 
During the full 8 h of incubation, unlabeled isotopomers of acetate and butyrate 
(M+0) were present in addition to the labeled ones in both fermentations. These 
isotopomers most probably were produced from other than the 13C-labeled substrates, 
e.g. from proteins present in the system already at the start of the experiment. 
In addition to the LC-MS analysis, NMR analysis was used to quantify non-
SCFA metabolites derived from the 13C-labeled substrates. Specifically lactate and 
succinate were observed and their production increased 15 min after the addition 
of either 13C-labeled substrate. The concentrations of the 13C-lactate in the [U-13C]-
inulin and [U-13C]-lactose fermentations at time point 15 min were 1.2 mM and 4.6 
mM, respectively. Increase in the 13C-lactate at the 30 min was measured only in the 
[U-13C]-lactose fermentation, where it reached a value of 7.3 mM. The measured 
13C-lactate at 30 min in the [U-13C]-inulin fermentation was 0.4 mM. The time 
profiles of the 13C succinate qualitatively mimicked those of lactate. 
Community profiling of the TIM-2 microbiota during [U-13C]-inulin and 
[U-13C]-lactose fermentation using the HITChip
To provide information on the composition of the TIM-2 microbial community of 
the [U-13C]-inulin and [U-13C]-lactose studies at higher resolution, selected fractions 
were compared using the HITChip, a comprehensive phylogenetic microarray for the 
human intestinal tract microbiota (Rajilic-Stojanovic et al., 2009). For the [U-13C]-
inulin experiment fractions containing labeled (fraction 5) and unlabeled (fraction 
8) RNA from time point 15 min, 30 min and 1 h were included in the analysis. 
Cluster analysis of the HITChip profiles indicated clear separation of the profiles 
of the fractions containing labeled RNA from those with unlabeled RNA (data not 
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Figure 6. Relative contribution of phylotypes detected with the HITChip in fractions containing labeled (fraction 
5) or unlabeled (fraction 7 for the [U-13C]-lactose experiment and fraction 8 for the [U-13C]-inulin experiment) 
RNA from three selected time points 15 min, 30 min and 1 h from the [U-13C]-inulin study (A) and two selected 
time points 30 min and 1 h from the [U-13C]-lactose study (B). I- higher taxonomic level – Class; II- lower 
taxonomic level – family. 
shown). HITChip analysis indicated a strong increase of Clostridium cluster XIVa 
in fraction 5 of the 15 min sample of the [U-13C]-inulin experiment (Fig. 6 A-I). 
The same dominance of this group was also observed for labeled RNA-containing 
fractions from the 30 min and 1 h samples, albeit with a slight decrease in relative 
abundance after 1 h. Furthermore, the most abundant subpopulation of Clostridium 
cluster XIVa in the heavy fractions belonged to the group of Dorea formicigenerans 
et rel., which also includes Dorea longicatena (Fig 6 A-II). This is in agreement 
with results from the T-RFLP fingerprinting analysis. Moreover, an increase in the 
Bifidobacterium group was detected as well, particularly in fraction 5 from the 15 
min time point, again confirming the T-RFLP data (Fig. 6 A-II). An increase in the 
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relative abundance in fraction 5 was detected also for other members of Clostridium 
cluster XIVa, particularly in the groups of Ruminococcus obeum, Coprococcus 
eutactus and Eubacterium rectale, 15 min after addition of [U-13C]-inulin (Fig. 6 
A-II). 
For the [U-13C]-lactose study, fractions containing labeled (fraction 5) and unlabeled 
(fraction 7) RNA from 30 min and 1 h time points were included in the HITChip 
analysis, as an increase in the SCFA concentrations was detected only 30 min after 
13C-lactose addition. Cluster analysis of the HITChip profiles from the selected 
fractions indicated clear separation of the profiles of the fractions containing 
labeled RNA from those with unlabeled RNA (data not shown). In the fractions 
with heavy RNA, a strong increase in the group of Actinobacteria (Fig. 6 B-I), 
particularly Bifidobacterium and to a lesser extend Collinsella, was detected (Fig. 
6 B-II), confirming the T-RFLP analysis. Additionally, an increase in Prevotella 
melaninogenica, Prevotella oralis and Mitsuokella multiacida was observed 30 min 
after [U-13C]-lactose addition, however, after 1 h these groups increased also in the 
fractions containing unlabeled RNA (Fig. 6 B-II).
One hour after addition of [U-13C]-lactose, an increase in Clostridium cluster 
XIVa was detected in the fractions with labeled RNA (Fig. 6 B-I), particularly 
populations belonging to Ruminococcus obeum, Dorea formicigenerans, Clostridium 
symbiosium and Anaerostipes caccae (Fig. 6 B-II).
Discussion
The human gut microbiota plays an important role in maintaining human 
health, among other mechanisms also through its ability to digest food compounds 
and to produce specific metabolites. Particularly in the human colon, a number of 
food components that escape digestion in the upper GI tract, serve as substrate for 
the colonic microbiota. Inulin is one of these complex compounds, and the vast 
majority (around 95% of the consumed polymer) reaches the colon in an unmodified 
form (Nilsson and Bjorck, 1988; Bach Knudsen and Hessov, 1995). A number of 
in vitro and in vivo animal and human studies have demonstrated a stimulatory 
effect of inulin not only on the colonic bifidobacterial population (Roberfroid et 
al., 1998; Kolida et al., 2002; Gibson et al., 2004), but also on butyrate production 
(Campbell et al., 1997; Le Blay et al., 1999; Tsukahara et al., 2003). Besides the 
above-mentioned complex molecules, also less complex carbohydrates can escape 
digestion in the stomach and the small intestine, and be further processed in the colon. 
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One example is the disaccharide lactose, which is normally digested in the small 
intestine by the enzyme lactase (Arola and Tamm, 1994), however, in individuals 
with insufficient or lack of enzyme activity, lactose is mostly fermented in the 
large intestine. Furthermore, recent studies have indicated a role of the colonic 
microbiota in lactose intolerance (He et al., 2006). Nevertheless, there is still lack 
of knowledge with respect to the key microbes involved in colonic breakdown 
of different relevant dietary carbohydrates. In the present study RNA-based SIP 
was used to identify bacteria involved in the fermentation of [U-13C]-inulin and 
[U-13C]-lactose under human colon like conditions as implemented in an in vitro 
model of the large intestine. Previously, using the same fecal inoculum, i.e. the 
same microbial community, we identified microbial populations involved in the 
fermentation of [U-13C]-starch (Kovatcheva-Datchary et al., 2009b). Furthermore, 
based on phylogenetic microarray (HITChip) and sequence analysis of 16S rRNA 
gene fragments, we were able to show that the model we used in our experiments 
well-represents the human fecal microbiota present in human volunteers. In the 
present study, primary [U-13C]-inulin and [U-13C]-lactose degraders were identified 
by T-RFLP fingerprinting, and further characterized by HITChip analysis. These 
active populations were different from those previously shown to be involved in 
degradation of [U-13C]-starch. 
Microbial taxa involved in colonic inulin fermentation
Fingerprinting analysis of fractions containing heavy and light RNA indicated a 
strong increase in relative abundance of Bifidobacterium adolescentis 15 min after 
addition of inulin. However, this effect was observed in all fractions from this 
particular time point. This could be related to a G+C-bias that is known to affect 
SIP analyses, especially concerning populations with high G+C content in their 
nucleic acids, such as bifidobacteria (Rangel-Castro et al., 2005). However, 30 
min after substrate addition no increase in the T-RF representing B. adolescentis 
was detected in fractions with higher density, arguing against a possible G+C bias. 
This observation could be confirmed by HITChip analysis, which also indicated 
an increase in the Bifidobacterium group in fraction 5 (i.e. heavy RNA) at 15 
min, in comparison with the fraction with light RNA, and no raise after 30 min. 
Furthermore, quantitative real time PCR analysis was used to confirm the increase 
in Bifidobacterium in the heavy fraction at 15 min, but not after 30 min (data not 
shown). This temporal trend is in line with that observed for lactate production, 
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which peaked after 15 min, followed by a decrease after 30 min. Additionally, an 
increase in butyrate was observed at the same time when lactate decreased, which 
is an indication for a cross-feeding in the studied microbial community (Duncan et 
al., 2004a; Belenguer et al., 2006). Hence, our molecular data, in combination with 
metabolite analysis, indicate that Bifidobacterium spp. are mostly active in the first 
15 min of the inulin fermentation, contributing to the lactate pool formed by inulin 
fermentation. This is in good agreement with the well-established bifidogenic effect 
of inulin (Kleessen et al., 1997; Falony et al., 2006; Kleessen et al., 2007; van de 
Wiele et al., 2007; Ramirez-Farias et al., 2009). 
By analysing the temporal development of the microbiota in the heavy fractions 
following addition of the [U-13C]-inulin, we found with HITChip analysis an increase 
of Clostridium cluster XIVa after 15 min.  Particularly, the biggest difference between 
heavy and light fractions was observed for Dorea formicigenerans et rel., which 
includes Dorea longicatena. With T-RFLP analysis an increase in a T-RF assigned to 
Dorea longicatena in the labeled fractions was also detected. It thus seems that this 
member of Clostridium cluster XIVa is another key inulin degrader in the studied 
model. This extends previous studies that pointed to the involvement of members 
of this particular cluster in inulin degradation (Duncan et al., 2003; Langlands et 
al., 2004). Dorea species were recently designated in a novel genus (Taras et al., 
2002), with Dorea longicatena and Dorea formicigenerans being the best described 
members. It has been described that Dorea spp. can form lactate as end product from 
glucose depending on the growth conditions, but not butyrate (Taras et al., 2002). 
However, Dorea longicatena might play an important function in the gut as in a 
recent study it has been reported to be one of the species that has a higher ratio of 
adult- as well as infant gut-enriched genes than other environmental bacteria (Hattori 
and Taylor, 2009). 
Inulin is known to increase butyrate production in the colon, which could 
be due to several mechanisms. Firstly, butyrate could be produced directly in the 
colon by butyrate producing bacteria, mostly reported to be members of Clostridium 
cluster IV (e.g. Faecalibacetrium prausnitzii) and Clostridium cluster XIVa (e.g. 
Roseburia intestinalis, Roseburia inulinivorans, Eubacterium rectale) some of 
which have previously been reported to utilize inulin in vitro (Duncan et al., 2004b; 
Ramirez-Farias et al., 2009; Louis et al., 2010). Secondly, cross-feeding between 
different members of the colonic microbiota has been suggested as another possible 
mechanism for increased butyrate production in the colon (Kanauchi et al., 1999; 
Pryde et al., 2002; Duncan et al., 2004a; Belenguer et al., 2006). Nevertheless, fully 
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labeled butyrate was not detected at the beginning of the [U-13C]-inulin fermentation. 
The mainly detected butyrate isotopomer was the M+2 isotopomer, which can 
be formed by coupling of one fully 13C-labeled acetate to unlabeled acetate, or 
alternatively from lactate. This indicates that the butyrate produced in the studied 
system most probably is derived from cross-feeding. In contrast, the major acetate 
and propionate isotopomers from the 13C-inulin fermentation were fully labeled M+2 
acetate and M+3 propionate. These isotopomers accumulated from the beginning of 
the fermentation and most probably resulted from the direct degradation of inulin by 
Dorea longicatena and Bifidobacterium adolescentis.
Butyrate can not be produced by bifidobacteria (Makras et al., 2006), 
however, lactate, acetate, formate, ethanol and small amounts of succinate are known 
products of the fermentative metabolism of these bacteria (Wolin et al., 1998; van 
der Meulen et al., 2004; van der Meulen et al., 2006). It is tempting to speculate 
that in our system the butyrogenic effect is the result of a cooperative food-web, 
comprising Dorea longicatena, Bifidobacterium adolescentis, and species related 
to Coprococcus eutactus and Eubacterium rectale, found to be abundant in both 
labeled and unlabeled RNA fractions. Previous studies reported that Coprococcus 
related species are net producers of acetate, and harbor butyrate kinase and butyryl-
CoA:acetate-CoA transferase activity, indicating that these species can produce 
butyrate directly, but also via acetate (Duncan et al., 2002; Duncan et al., 2004b). 
Most probably, D. longicatena and B. adolenscentis constitute initial inulin degraders, 
producing acetate, propionate and lactate. These metabolites could then be used by 
the known butyrate-producer Eubacterium rectale and possibly additional members 
of Clostridium cluster XIVa, also known as butyrate-producers. As the main detected 
butyrate isotopomer was the M+2 isotopomer, probably no direct conversion of 
inulin into butyrate took place. Several studies suggest that a considerable part of the 
lactate in the human colon is converted to butyrate (Duncan et al., 2004a; Bourriaud 
et al., 2005; Belenguer et al., 2006). This is experimentally supported in the present 
study, as in the first 15 min of the fermentation a considerable amount of lactate is 
accumulated, which decreased again after 30 min, concomitant with detection of 
the M+2 butyrate isotopomer, supporting our hypothesis for possible cross-feeding. 
However, further detailed isotopomer kinetic analysis is required to discriminate 
between M+2 acetate and M+3 lactate as precursors for M+2 butyrate. A decrease 
in the Clostridium cluster IV and Bacteroidetes group in the fractions with heavy 
RNA in comparison with the light fractions was observed for all the analyzed time 
points, indicating that these groups are not directly involved in inulin fermentation in 
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the studied system, which is in line with human in vivo trials (Kleessen et al., 1997; 
Kleessen et al., 2007).
Fermentation of lactose under human colon-like conditions
In a second set of incubations, we studied lactose fermentation. Lactose is a 
disaccharide, which becomes available to the colonic microbiota only in case of specific 
disaccharide-digestion deficiencies or as a result of defects in the corresponding 
transport system (Southgate, 1989). The importance of studying lactose in our study 
is mostly related to the lack of knowledge on the effect of this substrate on the 
colonic microbiota. This is surprising in view of the fact that lactose mal-digestion 
is very common around the world (Sahi, 1974; Scrimshaw and Murray, 1988; Sahi, 
1994).  T-RFLP analysis indicated a strong increase only in the population related 
to Bifidobacterium adolescentis during the whole in vitro fermentation in fractions 
containing labeled and unlabeled RNA. However, HITChip analysis, providing 
compositional data at higher resolution than T-RFLP fingerprinting, pointed towards 
enrichment of 16S rRNA of several other taxa in the fraction containing heavy 
RNA, 30 min after addition of the labeled substrate. The biggest changes were 
detected in the Actinobacteria group, where an approximately 3 fold increase in 
the relative contribution to the total signal was observed for Bifidobacterium and 
Collinsella populations. This increase reached 4-fold in the heavy fraction 1 h after 
[U-13C]-lactose addition. The bifidogenic effect of lactose has been reported in 
several studies, addressing the direct effect of lactose (Makivuokko et al., 2006), 
oligosaccharides derived from lactose (Cardelle-Cobas et al., 2009), or fermented 
milk (Sairanen et al., 2007). The increase of Bifidobacterium and Collinsella spp. 
in the fractions with heavy RNA from the beginning of the experiment indicates 
that these species represent the key players in lactose degradation in the studied in 
vitro model. Moreover, during the first hour of [U-13C]-lactose fermentation, a strong 
increase in the production of fully labeled acetate and lactate was detected, which 
most probably were derived from the direct conversion of [U-13C]-lactose by the two 
members of the Actinobacteria, that are known to convert carbohydrates to acetate, 
lactate and formate (Kageyama and Benno, 2000; Jacobs et al., 2010). It has been 
suggested that members of the genus Collinsella are an indicator of a healthy intestinal 
microbiota as a higher incidence of Collinsella aerofaciens was found in subjects 
with a low risk of colon cancer (Moore and Moore, 1995), and a lower abundance 
of Collinsella sp. has been associated with samples from irritable bowel syndrome 
(IBS) subjects (Kassinen et al., 2007). Prevotella melaninogenica is another member 
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of the TIM-2 microbiota, which was observed to increase in the heavy fraction 30 
min after addition of [U-13C]-lactose as compared to the light fractions from the 
same time point. Contradictory to this, after 1 h, P. melaninogenica was detected to 
increase only in the fractions containing light RNA comparing with the 30 min time 
point. A similar trend was also observed for other members of the Bacteroidetes, 
including Prevotella oralis and Mitsuokella multiacida. The latter has recently been 
reclassified to Clostridium cluster IX (Jousimies-Somer and Summanen, 2002) but 
is a known acid-utilizing bacteria (Tsukahara et al., 2002). M. multiacida, probably 
together with the two Prevotella spp., is involved in propionate production either 
directly from lactose, or alternatively via the acrylate pathway, during which lactate 
is converted to propionate. Both metabolic routes lead to fully labeled propionate, 
which was indeed the major detected propionate isotopomer.
T-RFLP analysis indicated 16S rRNA of populations related to Ruminococcus 
obeum, Eubacterium rectale and a member of Clostridium cluster XIVa to be 
abundant in all fractions from the 0 h time point, but also in all fractions containing 
unlabeled RNA after the first 15 min of the experiment. The HITChip profiles did not 
indicate differences in Clostridium cluster XIVa between the fractions with heavy 
and light RNA after 30 min. However, after 1 h an approximately 3-fold increase of 
Clostridium cluster XIVa was detected in the labeled fraction compared to the 30 min 
time point fraction with labeled RNA. A recent study in which 11 lactose-intolerant 
subjects were fed a diet supplemented with yogurt and bifidobacteria, reported an 
increase in the Eubacterium rectale/Clostridium coccoides group as determined by 
fluorescent in situ hybridization (FISH) analysis of the fecal microbiota (He et al., 
2008). The detected raise in Clostridium cluster XIVa in the current study was largely 
attributed to groups known as butyrate-producers, such as Clostridium symbiosium 
and Anaerostipes caccae, the latter of which is a well studied lactate-utilizer, known 
to convert lactate to butyrate (Belenguer et al., 2006). These two groups might 
be involved in a similar food web as the one detected in the inulin study, where 
the produced lactate was further converted to butyrate. In accordance, an increase 
in the M+2 isotopomer of butyrate was detected also 1 h after beginning of the 
lactose fermentation. Besides this, some other members of Clostridium cluster XIVa, 
including Ruminococcus obeum and Dorea formicigenerans, which also contributed 
to the increase in Clostridium cluster XIVa observed after 1 h in the fractions with 
heavy RNA, are likely to be involved in the propionate production. The increase 
detected in the propionate M+1, M+2 and M+3 isotopomers, particularly at 1 h after 
[U-13C]-lactose addition, supports this conclusion.
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In conclusion, to explore the in situ functions of the human colonic microbiota 
we applied RNA-based SIP in combination with high-throughput microarray-based 
phylogenetic profiling and metabolic flux analysis. This allowed us to identify 
bacteria directly involved in the fermentation of relevant dietary carbohydrates under 
conditions simulating those in the human colon. Human feeding trials, in which 
carbohydrates are delivered directly to the human colon, are going to reinforce the 
great potential of this methodology for the elucidation of metabolic interactions in 
complex food webs such as represented by the colonic microbiota.
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Abstract
Resistant dietary carbohydrates, including potato starch, are not digested in the upper gastro-intestinal (GI) tract, but are fermented to short-chain fatty acids (SCFAs) and other organic acids by the colonic microbiota. These substrates are comprised of a complex assortment 
of macromolecules with diverse structures, the degradation of which requires an array of hydrolytic 
enzymes produced by various bacteria. Here we examine the ability of two bacterial species belonging 
to the Firmicutes that are abundant in the human colon, Eubacterium rectale and Ruminococcus 
bromii, to convert potato starch in mono- and co-cultures. Previously we identified populations closely 
related to these organisms as key players in starch degradation in an in vitro model of the human 
colon. The mono-culture experiments indicated that R. bromii is able to grow better on potato starch 
than E. rectale. The fermentation primarily yielded glucose, acetate, formate, hydrogen and ethanol. In 
contrast, pure cultures of E. rectale ferment potato starch poorly and yield only small amounts of lactate 
and propionate in the initial phase of growth. However, during the co-cultivation of both species, lower 
amounts of glucose and ethanol accumulated than in the R. bromii mono-culture, and a strong increase 
in propionate and acetate production was detected. Quantitative PCR indicated an increase in R. bromii 
16S rRNA gene copy number in both mono- and co-culture studies. Increase in the E. rectale copy 
number was detected only in the co-culture. In conclusion, potato starch fermentations with mono- 
and co-cultures of R. bromii and E. rectale confirmed that R. bromii is a key player in  resistant starch 
conversions in the large bowel. A cross-feeding relation between both bacteria was found, where the 
conversion of carbohydrates by the co-culture resulted in the accumulation of acetate and propionate. 
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Introduction
A vital function of the colonic microbiota is the utilization of dietary substrates, 
which have not been digested by the human digestive enzymes in the upper gastro-
intestinal (GI) tract and reach the large intestine, where they are fermented by the 
colonic microbiota (Savage, 1986; Guarner and Malagelada, 2003; Xu and Gordon, 
2003). The end products from these microbial fermentations are short-chain fatty 
acids (SCFA), such as butyrate, propionate and acetate, which have an important 
function in the host physiology (Scheppach, 1994; Mortensen and Clausen, 1996). 
Fermentation of non-digested carbohydrates causes a lowering of the luminal pH, 
increase in bacterial biomass and fecal bulk, and modification of the microbial 
composition, especially by stimulating the growth of potentially beneficial bacteria, 
including bifidobacteria and lactobacilli (Young and Le Leu, 2004; Le Leu et al., 
2005). Resistant starch (RS) is such a dietary compound, which provides a source 
of fermentable substrate for the colonic microbiota (Cummings and Englyst, 1987; 
Asp, 1992; Topping et al., 2003). Moreover, RS has been shown to reduce the 
accumulation of harmful by-products from protein fermentation (Birkett et al., 1996). 
Several animal studies have reported that RS also can modify the colonic microbiota 
and may reduce the risks of developing colorectal cancer  (Silvi et al., 1999; Bauer-
Marinovic et al., 2006; Toden et al., 2006; Clarke et al., 2008). The effect of RS on 
human gut microbiota is however unclear, but essential to understand gut microbiota 
functionality in the colon. In a previous in vitro study using 16S ribosomal RNA 
(rRNA)-based stable isotope probing (SIP) we identified a population closely related 
to Ruminococcus bromii as the primary degrader of potato starch, a specific type of 
RS (Kovatcheva-Datchary et al., 2009). Furthermore, after integration of molecular 
and metabolite data we obtained evidence for a cross-feeding process during the 
fermentation of potato starch, where R. bromii is the primary starch degrader and 
Eubacterium rectale is further involved in the trophic chain. In the present study we 
addressed the role of R. bromii and E. rectale growing in pure cultures and in co-
culture in the degradation of potato starch and explored the cross-feeding relationship 
between the two species.
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Experimental Procedures
Microorganisms and media
R. bromii (ATCC 51896) and E. rectale (ATCC 33656) were purchased from the 
American Type strain Culture Collection (ATCC). Both bacterial cultures were 
maintained in a medium composed of the following (concentration per 1 L): 1 g 
cellobiose, 4 g glucose, 1 g maltose, 1 g starch, 50 ml rumen fluid, 12.5 g beef extract 
(Oxoid, Basingstoke, UK), 30 g peptone (Oxoid), 5 g yeast extract (Oxoid), 1 mg 
resazurin, 0.5 g L-cystein, 0.005 g Vitamin K1 and 5 mg hemin, 150 ml mineral 
solution I (composition per 1 L solution – 6 g K2HPO4), 150 ml mineral solution II 
(composition per 1 L solution – 6 g KH2PO4, 12 g (NH4)SO4, 12 g NaCl, 1.2 g MgSO4, 
1.2 g CaCl2) and 2 ml trace element solution (composition per 100 ml solution - 0.5 
mg ZnSO4.7H2O, 0.15 mg MnCl2.4H2O, 1.5 mg H3BO3, 1 mg CoCl.6H2O, 0.1 mg 
NiCl2.6H2O, 0.15 mg Na2MO4.2H2O, 7.5 mg FeCl2.4H2O). The pH of the medium 
was adjusted to 6.7 with 1M NaOH, the medium was shortly boiled to remove O2 
and cooled down under oxygen-free N2 flow to prevent oxygen diffusion into the 
medium prior to distribution into 120-ml serum bottles. Subsequently, the gas phase 
in the closed serum bottles was replaced by a gas mixture of H2/CO2 (80/20 % v/v). 
The bacterial cultures were stored at - 80˚C in serum tubes containing the media 
mentioned earlier, supplemented with 25% (vol/vol) glycerol as a cryoprotectant.
Fermentation experiments
Mono- and co-culture fermentations were carried out in a basal bicarbonate-buffered 
medium composed of the following (concentration per 1 L): 0.9 g K2HPO4, 0.9 g 
KH2PO4, 1.8 g (NH4)SO4, 1.8 g NaCl, 0.09 g MgSO4, 0.09 g CaCl2, 4 g NaHCO3, 
2 g yeast extract (Oxoid), 1 mg resazurin, 1 g L-cystein, 5 mg Vitamin K1 and 5 
mg hemin, 2 ml trace elements (composition as mentioned above). The pH of the 
medium was adjusted to 6.5. Before the medium were distributed to 120-ml serum 
bottles 2.5 g of potato starch (Sigma, Cat. No.S4251, Zwijndrecht, The Netherlands) 
was added. Subsequently, the gas phase in the closed serum bottles, which contained 
40 ml of the fermentation media, was replaced by a gas mixture of H2/CO2 (80/20 
% v/v). Before inoculation 2.5 ml of filter-sterilized calcium-vitamins solution and 
the same volume of bicarbonate solution were added to the batches. Additionally 
for the 13C-glucose fermentation filter sterilized 1M [U-13C]-glucose (Sigma, Cat. 
No.389374) was added to a final concentration of 20 mM to the serum bottles as a sole 
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C-source. The calcium-vitamins solution composition was as follow (concentration 
per 100 ml): 0.22 g CaCl2.2H2O, 0.20 g MgCl2.6H2O and 2 ml vitamins solution. The 
vitamins solution had the following composition (per 100 ml solution): 20 mg biotin, 
100 mg pyridoxamine, 50 mg thiamine, 50 mg nicotinamide, 50 mg cobalamin, 50 
mg p-aminobenzoic acid, 50 mg lipoic acid, 20 mg folic acid and 50 mg riboflavine. 
The bicarbonate solution contained 0.88 g NH4HCO3, 7.46 g NaHCO3 and 0.40 g 
Na2SO4 dissolved in 100 ml demineralized water. Inocula were prepared as follows: 
strains were transferred from -80˚C stock culture to maintenance medium and 
incubated anaerobically at 37˚C for 48 h. During the fermentation experiment the 
transferred volume was 10% (vol/vol). Before being transferred to the fermentation 
media R. bromii and E. rectale were subcultured twice on maintenance medium and 
also on fermentation medium to be adapted to the experimental condition. The purity 
of the culture was checked by molecular and microscopic analysis. The fermentation 
of potato starch was followed for 96 h at 37˚C. Triplicate bottles were inoculated, 
and samples were taken from the same bottles at 0 h, 2 h, 6 h, 10 h, 24 h, 48 h, 72 h 
and 96 h to measure metabolite production, protein content and for quantification of 
the two bacterial species in mono- and co-cultures. All samples were stored at -20°C 
for further analysis.
DNA extraction and quantitative PCR
One milliliter aliquots of well-homogenized microbial cultures were concentrated by 
centrifugation (15 700 RCF, 5 min). DNA was extracted using a FastDNA SPIN Kit 
for Soil (MP Biomedicals, Germany) with mechanical cell disruption by repeated 
bead beating, following the instruction of the manufacturer. 
Quantitative PCR (qPCR) was performed on an iCycler IQ real-time 
detection system associated with the iCycler optical system interface software 
version 2.3 (Bio-Rad, Veenendaal, the Netherlands). A reaction mixture (25 µL) 
consisting of 12.5 µL of IQ SYBR Green Supermix (Bio-Rad), 0.2 µM of each 
primer set and 5 µL of the template DNA diluted in water (10-fold to avoid PCR 
inhibition). The standard curves for quantification of R. bromii and E. rectale were 
generated by using serially diluted 16S rRNA gene amplicons obtained from R. 
bromii (ATCC 51896) and E. rectale (ATCC 33656), respectively. All qPCR assays 
were performed in triplicate. Primers Rflbr730F and Clep866mR (Ramirez-Farias et 
al., 2009) were used to estimate the number of copies of the 16S rRNA gene of R. 
bromii in the samples from the mono- and co-cultures. PCR was performed with an 
initial denaturation step of 95ºC for 3 min, followed by 40 cycles of 95ºC for 30 s, 
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60ºC for 30 s and 72ºC for 30 s.  Primers E.rec-F and E.rec-R (Balamurugan et al., 
2008b; Balamurugan et al., 2008a) were used to investigate the number of copies of 
the 16S rRNA gene of E. rectale in the samples collected during the potato starch 
fermentation in mono- and co-cultures with the following PCR program: an initial 
denaturation step of 95ºC for 10 min, followed by 44 cycles of 95ºC for 30 s, 60ºC 
for 30 s and 72ºC for 30 s. 
Analytical procedures 
pH and protein concentration 
The high starch concentration interfered with the ability to assess bacterial growth in 
the mono- and co-cultures directly, by following the absorption at 600 nm (OD600). 
Therefore, Lowry colorimetrical protein assay was applied to follow bacterial 
growth in mono- and co-cultures. For this purpose 1 ml bacterial suspension was 
immediately centrifuged after sampling for 15 min at 15 700 RCF in the presence 
of 1 ml 0.6 M NaCl. Subsequently, cell pellets were hydrolyzed by adding 1 ml 
of 1 M NaOH and incubating for 30 min at 50ºC. The hydrolysates were further 
analyzed for protein content following the Lowry protein assay (Lowry et al., 1951). 
Additionally, as an indication for bacterial growth and metabolite production, the pH 
of  the mono- and co-cultures of R. bromii and E. rectale during the potato starch 
fermentation was measured in 1 ml bacterial culture. 
Analysis of the produced metabolites during the fermentation of potato starch 
and 13C-glucose 
For the potato starch fermentation 1 ml aliquots of well-homogenized microbial 
cultures were harvested by centrifugation (15 700 RCF, 15 min). Subsequently 500 
µl of the supernatant were transferred into a crimp cap vial and was mixed with 500 
µl 0.2N H2SO4 solution containing 20 mM crotonate as internal reference standard. 
The metabolites produced during the fermentation of potato starch were determined 
by injection of 20 μl supernatant into a high pressure liquid chromatography (HPLC) 
equipped with refractive index detector (Spectra System, RI-150) and CromoQuest 
4.2.34 software. We used an organic acid column MetaCarb 67H (6.5 by 300 mm, 
Varian Inc., Palo Alto, USA), maintained at 30ºC, and 0.01N H2SO4 as eluent at a 
flow rate of 0.8 ml/min. Quantification of organic acids, glucose and ethanol was 
done by using calibration curves of acetate, propionate, lactate, formate, glucose and 
ethanol in concentrations between 2.5 and 100 mM.  
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During the [U-13C]-glucose fermentation 5 ml aliquots of well-homogenized 
microbial cultures were harvested by centrifugation (15 700 RCF, 15 min). To the 
total volume of the collected sample 0.5 ml D2O was added in a 10 mm NMR tube. 
13C 
NMR spectra were recorded at room temperature on a Bruker AV 300 wb spectrometer 
located at the Wageningen NMR Centre. Chemical shifts were measured relative to 
β glucose C-1 calibrated at 96.8 ppm. Additionally, the metabolites production from 
the 13C-glucose fermentation was determined by HPLC as described above.  
Results
Bacterial growth during potato starch fermentation
The anaerobic degradation of potato starch by R. bromii and E. rectale in pure 
cultures was determined and compared with that in co-culture experiments (Fig. 
1). The inoculum ratio used for the co-culture fermentation was 1:1. The growth 
was followed by protein determinations and no significant growth of E. rectale was 
observed during 96 h of incubation (Fig. 1 A). However, a two-fold increased protein 
yield was observed in the samples from the R. bromii mono-culture and the co-
culture (Fig. 1 A). The pH of the mono-culture of E. rectale did not change during 
the whole fermentation, while for the mono-culture of R. bromii the pH dropped 
from 6.5 to 5.5 (Fig. 1 B) until the end of the experiment. A strong decrease in the pH 
value was observed for the co-culture, where it changed from 6.5 to 4.25 (Fig. 1 B).
Quantification of R. bromii and E. rectale populations in mono- and co-
cultures during the fermentation of potato starch
Real-time PCR analysis indicated an increase in R. bromii 16S rRNA gene copy 
numbers 24 h after the beginning of the incubation in the mono-culture, and after 48 
h in the co-culture fermentation. At the end of the experiment the quantified R. bromii 
copy number in the co-culture incubation were approximately 2-fold more than in 
the monoculture (Fig. 2 A). In corroboration with the data from the protein assay, E. 
rectale showed poor growth in the mono-culture on potato starch from the beginning 
of the study. A 2-fold increase in the E. rectale 16S rRNA gene copy number in the 
mono-culture was measured only 10 h after incubation with potato starch, followed 
by a fast decrease until the end of the experiment, probably as a result of cell lysis 
(Fig. 2 B). However, in the co-culture incubation a 3-fold increase was measured in 
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the E. rectale 16S rRNA gene copy number at the end of the experiment (Fig 2 A). 
The increase in the number of 16S rRNA gene copies of both bacteria during the 
co-culture incubation corroborate with the data from the protein assay and observed 
acidification of the media (Fig 1). 
Quantification of metabolites produced during the anaerobic conversion of 
potato starch in mono- and co-cultures of R. bromii and E. rectale
The utilization of potato starch by the mono-culture of R. bromii yielded glucose (~ 
110 mM), ethanol (~ 16 mM), acetate (~ 10 mM) and formate (~ 7 mM) (Fig. 3). 
During the first 10 h of the R. bromii mono-culture incubation an approximately 3-fold 
increase of only ethanol was observed (Fig. 3 F). From 24 h, a strong accumulation 
of continuously produced glucose was detected until the end of the experiment (Fig. 
Figure 1. Protein concentration 
(A) and pH (B) changes during the 
anaerobic degradation of potato 
starch from Ruminococcus bromii 
(RB) and Eubacterium rectale (ER) 
in mono- and co-cultures. Error bars 
represent the standard deviation of 
triplicate measurements. When the 
standard deviation is smaller than the 
symbol, it is not presented.
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3 A). Additionally, an increase in acetate production and appearance of formate 
was observed after 24 h of incubation in the presence of potato starch. The acetate 
concentrations increased from about 2.5 mM after 10 h to 4.3 mM after 24 h, and 
at the end of the experiment approximately 10 mM acetate were measured in the R. 
bromii mono-culture fermentation (Fig. 3 B). About 6.5 mM formate was formed 
after 24 h, while at the end of the incubation only small changes in the formate 
concentration were measured (Fig. 3 D). During potato starch utilization by E. rectale 
mono-cultures, small amounts of lactate were detected, with higher concentration 
than in the co-culture after 10 h of incubation (3.5 mM, Fig. 3 E). Additionally, in 
the E. rectale mono-culture, about 2.6 mM lactate was detected from the beginning 
of the experiment, which most probably was residual from the inoculum (Fig. 3 E). 
The level of lactate detected in the E. rectale mono-culture increased within 2 h, but 
thereafter decreased again. These results confirm data obtained by the protein assays, 
Figure 2. Changes in the 
16S rRNA gene copies of 
Eubacterium rectale (ER)  (A) 
and Ruminococcus bromii 
(RB) (B) during the anaerobic 
degradation of potato starch in 
mono- and co-cultures. Error bars 
represent the standard deviation 
of triplicate measurements. 
When the standard deviation is 
smaller than the symbol, it is not 
presented.
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pH measurements and qPCR analyses, indicating that E. rectale grows poorly in 
high concentration of potato starch. 
The metabolites pattern of the conversion of potato starch in the co-culture was 
different from that obtained with the different mono-cultures. The co-culture 
incubation yielded glucose (~ 22 mM), ethanol (~ 9 mM), acetate (~ 27 mM), formate 
(~ 6 mM), propionate (~ 55 mM) and lactate (~ 3 mM) (Fig 3). During the incubation 
of potato starch in the co-culture, the detected glucose concentration was 5-fold 
lower than the levels detected in the R. bromii mono-culture (Fig. 3 A). Similarly, 
ethanol production was observed to increase in the R. bromii mono-culture after 24 h 
and while initially about 4.9 mM ethanol was found, at the end of the experiment its 
concentration increased to 16 mM (Fig. 3 F). However, in the co-culture incubation 
after 24 h the concentration of ethanol was similar to that in the mono-culture 
(~ 4.9 mM), but at the end of the experiment approximately 8.9 mM of ethanol 
were measured (Fig. 3 F). No changes in the formate pattern in comparison with 
the R. bromii mono-culture were observed in the co-culture incubation (Fig. 3 D). 
However, a strong increase in the production of acetate and particularly propionate 
was observed in the co-culture. Accumulation of propionate in the E. rectale and R. 
bromii mono-culture incubations with potato starch was not observed. In contrast, in 
the co-culture a strong increase in the propionate concentration was measured after 
48 h, which reached approximately 55 mM at the end of the study (Fig. 3 C). The 
level of acetate after 48 h in the co-culture with potato starch was approximately 3.5 
fold higher in comparison with the mono-culture of R. bromii (Fig. 3 B). During the 
potato starch utilization by the co-culture, no lactate was detected at 0 h, the level of 
lactate after 6 h was about 2.3 mM and it reached approximately 3.2 mM at the end 
of the incubation (Fig. 3 E). 
H2 was calculated from the redox balance. The fermentation balance calculated for 
the R. bromii mono-culture fermentation was as follows:
7.75 glucose à 7.8 acetate + 7.1 formate + 14.8 ethanol + 15.5 CO2 + 8.5 H2
Consequently, when growth is neglected in the mono-culture experiment the R. 
bromii forms 8.5 mM hydrogen. The fermentation balance calculated for the co-
culture fermentation was as follows:
43.45 glucose à 24.7 acetate + 6.4 formate + 3.2 lactate + 49.4 propionate + 7.7 
ethanol + 26 CO2 
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Figure 3. Metabolites produced from the coversion of potato starch by mono- and co-cultures of Ruminococcus 
bromii (RB) and Eubacterium rectale (ER). (A) glucose; (B) acetate; (C) propionate; (D) formate; (E) lactate; (F) 
ethanol. Error bars represent the standard deviation of triplicate measurements. When the standard deviation is 
smaller than the symbol, it is not presented. Cultures for which specific metabolites were not detetced at any time 
throughout the incubation were not included in the respective graph.
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Quantification of the metabolites produced during the fermentation of 
[U-13C]-glucose in mono-culture of R. bromii and co-culture of R. bromii and 
E. rectale
The HPLC data showed that R. bromii is able to degrade potato starch, however, 
strong accumulation of glucose was observed until the end of the experiment, 
which could be an indication that R. bromii can not grow on glucose or there is 
another factor, which limits the conversion of carbohydrates by R. bromii.  Hence 
the conversion of 13C-labeled glucose by R. bromii was tested and the metabolites 
formed were analyzed by NMR (Fig. 4). The NMR profiles of the mono-culture of 
R. bromii grown in presence of 20 mM of 13C-glucose indicated poor conversion of 
glucose during 50 h of fermentation (Fig. 4 A-I). However, after 168 h of growth in 
the presence of 13C-labeled glucose, we detected appearance of 13C enriched acetate, 
formate and ethanol. But still the feature of the 13C-labeled glucose was detected 
indicating that less than 60% of the added glucose is converted. Subsequently, a co-
culture incubation of R. bromii and E. rectale (inoculated in ratio 1:1) in presence 
of 13C-glucose was performed. The conversion of glucose by the co-culture was 
faster, and after 24 h the presence of enriched metabolites was detected, particularly 
acetate, propionate, succinate, lactate and ethanol (Fig. 4 B-I). In comparison with 
the R. bromii mono-culture no 13C-glucose remained after 168 h of incubation (Fig. 3 
B-II). Rather, after 50 h of incubation 13C-glucose was already almost depleted (data 
not shown). 
Discussion
The degradation of complex carbohydrates, including potato starch used here, 
requires a set of enzymatic activities, which are usually displayed by mixed microbial 
communities rather than by single species. In order to fully understand and explore 
the metabolic food-webs that are active within the human gut ecosystem, it is essential 
to identify bacteria that are key to the utilization of dietary carbohydrates. To this 
end, defined pure and mixed cultures are excellent tools to study the metabolism of 
individual bacterial populations as well as interspecies interactions (Belenguer et al., 
2006; van der Meulen et al., 2006). 
R. bromii is one of the predominant bacterial species in the human fecal 
microbiota and is known to ferment carbohydrates, but it was also reported to grow 
poorly on glucose (Moore et al., 1972; Herbeck and Bryant, 1974). A number of 
studies performed in the early 1980’s pointed to the nutritional requirements of 
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Figure 4 -A. Occurrence of 13C-label as measured in NMR-spectra after 50 h (A-I) and 168 h (A-II) anaerobic 
conversion of 13C-glucose by mono- culture of Ruminococcus bromii (RB).  Chemical shifts (ppm): 61.19 – 97.09 
glucose; 17.43, 17.92, 58.1 and 58.59 ethanol; 23.75, 24.44, and 181.9 acetate; 161.08 CO2; 171.82 formate. 
A-I
A-II
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Figure 4 -B. Occurrence of 13C-label as measured in NMR-spectra after 24 h (B-I) and 168 h (B-II) incubation of 
13C-glucose by co- culture of Ruminococcus bromii and Eubacterium rectale (mix). Chemical shifts (ppm): 61.19 – 
97.09 glucose; 17.43, 17.92, 58.1 and 58.59 ethanol; 23.75, 24.44, and 181.9 acetate; 161.08 CO2; 171.82 formate; 
10.79, 11.24, 30.94-32.07, 185.4 – 186.1 propionate; 35.2 succinate; 68.7 and 69.3 lactate. 
B-I
B-II
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this bacterium and its strong amylolytic capacity (Moore et al., 1972; Herbeck and 
Bryant, 1974), but the potential of this species to degrade complex carbohydrates 
was not clarified (Moore et al., 1972; Leitch et al., 2007). Recent studies reported 
on the effect of RS on human colonic microbiota in vivo and in vitro, and further 
suggested R. bromii as key player in the conversion of RS (Leitch et al., 2007; Abell 
et al., 2008; Kovatcheva-Datchary et al., 2009).
In the current study we explored the potential of R. bromii to degrade potato 
starch. Furthermore, a co-culture experiment with R. bromii and E. rectale was 
performed to get insight into interspecies interactions of the two bacteria. Our data 
indicated that R. bromii degrades potato starch, whereas E. rectale hardly grew 
in mono-culture on this substrate. Furthermore, in the R. bromii mono-culture 
experiment considerable accumulation of glucose was detected until the end of the 
experiment, indicating that R. bromii has the enzymatic potential to break down 
potato starch to monosaccharides, whereas the further conversions of the generated 
glucose occurs only slowly. This was confirmed by the very inefficient utilization of 
glucose by a R. bromii in mono-culture (Fig. 4 A).
During utilization of potato starch by the co-culture, the level of accumulated 
glucose dropped significantly, indicating the further conversion of the glucose to 
other metabolites. The data from the qPCR analysis for the mono- and co-cultures 
pointed at a delay in the growth of R. bromii. Additionally, we also detected a delay in 
the accumulation of the produced metabolites (Fig 4 B). A possible explanation could 
be that growth of R. bromii is inhibited by the accumulation of products from the 
primary potato starch degradation. This could be caused by the increased production 
of H2 during starch conversion. Similar effects were observed with Ruminococcus 
albus growing on cellulose (5 g) in mono- and co-culture (Miller and Wolin, 1995). 
In mono-culture R. albus ferments cellulose to acetate, ethanol, CO2 and H2. When a 
H2-utilizing bacteria was grown together with R. albus an increased acetate formation 
and decreased ethanol formation was measured. We also observed a decrease in 
the ethanol production and an increase in the acetate formation of the co-culture 
during the degradation of potato starch, which is in relation to the effect mentioned 
above. Ruminococcus spp. are known to produce H2 during the fermentation of 
carbohydrates (Miller and Wolin, 1973, 1979). In a separate experiment, mono- and 
co-cultures of R. bromii and E. rectale were grown in the presence of glucose, during 
which we observed the accumulation of H2 in the mono-culture but its depletion in 
co-culture (data not shown). The inhibitory effect of H2 is likely to prevent R. bromii 
from growing on glucose in mono-culture, and explains the further accumulation of 
glucose during the utilization of potato starch. 
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The strong increase in the level of accumulated glucose and the increase 
measured after qPCR analysis in the E. rectale population in the co-culture is strong 
evidence for an interaction between the two species. It is likely that R. bromii breaks 
down the potato starch to glucose, which is further used by E. rectale as carbon and 
energy-source. Another explanation for the decreased level of glucose in the co-
culture could be that E. rectale utilizes the H2 produced by R. bromii during the potato 
starch degradation and opening its capacity to convert the accumulated glucose. 
Numerous species belonging to the Clostridium cluster XIVa (Collins et al., 
1994) are able to utilize starch and produce butyrate (Barcenilla et al., 2000; Sharp 
and Macfarlane, 2000). Clostridium spp. are a very diverse group whitin the human 
gut bacteria, which based on 16S rRNA gene sequence analysis are distributed over 
ten distinct phylogenetic clusters,  (Collins et al., 1994; Stackebrandt et al., 1999). 
Ruminococcus bromii is the first isolated human intestinal Ruminococcus species 
(Moore et al., 1972), which based on the 16S rRNA gene sequencing is grouping 
within one of these clusters known as Clostridium cluster IV (Collins et al., 1994). 
Eubacterium rectale belongs to the Eubacterium genus, similar to Clostidium, and 
further related to Clostridium cluster XIVa (Collins et al., 1994). It has been reported 
that butyrogenic species, mostly saccharolytic clostridia, better adapt to fast growth 
rate and high concentrations of the substrate, while for examples Bacteroides spp. 
compete better in complex communities at low growth rates under conditions of 
limiting substrate availability (Sharp and Macfarlane, 2000). However, E. rectale 
showed poor growth in the presence of 5 g of potato starch (Fig. 1). Similar results 
were obtained when even a higher concentration of RS (15 g) was used in a pilot 
human study (Schwiertz et al., 2002). Earlier studies with RS reported an increase in 
acetate, propionate and butyrate concentrations (Jenkins et al., 1998; Le Blay et al., 
1999; Schwiertz et al., 2002). In the present study we detected high levels of acetate 
and propionate in the co-culture, but no accumulation of butyrate, neither in the 
mono-cultures nor in the co-culture. Unexpectedly, in the E. rectale mono-culture, 
the production of propionate from potato starch was detected. We could speculate 
that E. rectale does not produce butyrate under the tested conditions, because of the 
high potato starch concentration. This could be analogous to earlier observations 
showing that Eubacterium spp. do not play a major role in butyrate formation from 
high concentrations of RS in vivo (Schwiertz et al., 2002). Alternatively, it could be 
possible that the produced butyrate reported in previous studies is generated not from 
the carbohydrate sources but from other ingredients of the media (e.g. yeast extract) 
or available nutrients in the colon. Additionally, most of the in vitro studies where the 
            
121        Cross-feeding
Cross-feeding  relation between R. bromii and E. rectale
butyrogenic effect of RS was reported were performed with fecal inoculum and/or in 
complex media, which could also be linked to the butyrate increase. Interestingly, in 
a recent study, where the effect of potato starch on the human fecal microbiota and 
SCFAs was tested on minimal media, no significant changes after fluorescent in situ 
hybridization (FISH) analysis in the E. rectale population were detected during the 
fermentation. In contrast, a decrease in the E. rectale population was detected after 
5 h when the starch was the sole carbohydrate, but after 10 h a slight increase was 
observed (Lesmes et al., 2008). Additionally, these authors reported the production of 
acetate throughout the entire experiment, the appearance of propionate after 10 h and 
the production of  butyrate only after 24 h in 5-fold smaller amounts than propionate 
(Lesmes et al., 2008). Nevertheless, it is difficult to link the propionate production 
from RS to the activity of E. rectale in this system, as for the inoculum fecal material 
was used. The authors reported an increase in the populations of Bacteroides spp., 
Bifidobacterium spp. and Atopobium spp. in presence of RS after 5 h, where still 
no propionate is measured, which could indicate that the accumulated propionate 
is produced by the E. rectale population, or is an intermediate product from cross-
feeding activity (Lesmes et al., 2008). 
In summary, we conclude that most probably in the studied co-culture system 
of R. bromii and E. rectale, both species are equally involved in the conversion of 
the potato starch. R. bromii actively degrades the potato starch to glucose, ethanol, 
H2, acetate and formate, while E. rectale further utilizes the H2 to convert the ethanol 
and lactate to propionate. Additionally, the lower concentrations of H2 due to the 
activity of E. rectale facilitates R. bromii to grow on glucose and further produce 
higher amounts of acetate.
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Abstract 
The importance of the gut microbiota and its immense metabolic potential that affects health and disease, is receiving extensive attention. However, due to the difficulty to access the complex human colon ecosystem it is still an open question, which microbes are responsible for specific 
fermentation processes. Here we report a pilot study, where the ability of the human gut microbiota to 
ferment lactose was explored in situ. A multi-lumen feeding catheter was introduced naso-duodenally in 
two healthy individuals (male and female, Caucasian). After positioning into the duodenum, progression 
of the catheter through the small intestine by normal peristaltic movements was followed by fluoroscopic 
imaging. After positioning in the terminal ileum, a bolus of 1 g [U-13C]-labeled lactose was infused into 
the intestinal lumen. Luminal samples were taken through the catheter at different time points over 
a period of 4 h following the infusion. RNA was extracted from the samples and density-resolved 
by ultra-centrifugation in caesium trifluoracetate. The extracted heavy and light RNA was subjected 
to phylogenetic analysis using the HITChip, a comprehensive diagnostic microarray for the human 
intestinal tract microbiota. Comparison of unlabeled RNA-derived profiles obtained from fractions with 
the lowest density, inter-individual variation and stability of the intestinal microbiota was observed 
for both volunteers. Principle component analysis of the HITChip profiles indicated that the luminal 
samples taken from volunteer A had an ileum-like microbial composition whereas those from volunteer 
B were more fecal-like, which could indicate positioning of the catheter in the proximal colon instead 
of in the terminal ileum. Most probably because of this difference in location of substrate infusion and 
sampling, different bacterial populations were found to be involved in the lactose conversion in the 
two volunteers. The fractions with RNA with higher density showed minor increases in populations 
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related to Akkermansia, Atopobium, Megasphaera elsdenii and Faecalibacterium prausnitzii for 
volunteer A. Additionally after 2 h, strong increase in signals indicative of Lactobacillus plantarum, 
Bacteroides stercoris and a Desulfovibrio sp. was observed. For volunteer B, in fractions with higher 
density, increase was observed of Megasphaera elsdenii, which most probably is a key player in the 
lactose metabolism. Confirming our previous result from lactose in vitro fermentation an increase in 
Bifidobacterium and Collinsella after 4 h was found in volunteer B. In conclusion, inter-individual 
differences were found with respect to populations involved in lactose degradation in vivo. However, 
in both volunteers, similar cross-feeding processes are probably involved in the further assimilation of 
metabolites from the lactose conversion, which remains to be confirmed by metabolite analyses. 
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Introduction
The human colon comprises a complex and dynamic microbial consortium with 
large numbers, considerable diversity, and significant metabolic activity that are 
essential for human life (Backhed et al., 2005; Qin et al., 2010), including a range 
of metabolic activities which are lacking in the human host (Suau et al., 1999; 
Eckburg et al., 2005; Xu et al., 2007). Recently, a first comprehensive analysis of 
the coding capacity has been reported and found to exceed by far that of the human 
genome (Qin et al., 2010). However, a large fraction of the microbiota still remains 
unexplored thus making the relationship between colonic microbial activity, and 
health and disease a controversial issue. Dietary carbohydrates are important energy 
sources and are known for their interactions with the microbiota in the intestinal tract 
(Savage, 1986; Hooper et al., 2002; Guarner and Malagelada, 2003; Xu and Gordon, 
2003). The main fermentation products that are produced from carbohydrates are 
the short-chain fatty acids (SCFA), such as butyrate, propionate and acetate, as well 
as other intermediate products such as lactate (Macfarlane and Gibson, 1997). The 
bacterially-produced SCFA constitute an important energy source for the body (Roy 
et al., 2006; Wong et al., 2006). Different carbohydrates are digested to various 
degrees in the intestinal tract, and while some are fermented in the colon, others pass 
through the entire intestine in a relatively intact form (Scheppach et al., 2001). Most 
disaccharides are completely digested in the small intestine, however, host genetic 
background can influence digestive efficacy significantly. Lactose is one of these 
disaccharides, and lactose intolerance results from insufficient or even lack of lactase 
activity in the small intestine (Henslee and Jones, 1982; de Vrese et al., 2001; Vonk 
et al., 2003). Colonic metabolism of lactose has been suggested to play a role in the 
degree of intestinal discomfort associated with lactose intolerance. Data from in vitro 
lactose fermentation studies indicate higher rates of SCFA and lactate production in 
lactose intolerant subjects compared to tolerant subjects, when translated into an 
in vivo situation may result in temporary accumulation of SCFA into the lumen, 
causing symptoms associated with lactose intolerance (Vonk et al., 2003; He et al., 
2006; He et al., 2008). Therefore, it is important to unravel the lactose metabolism in 
situ and understand the contribution of the colonic microbiota.
Recently, a molecular approach, termed nucleic acid-based stable isotope 
probing (SIP), has been developed that allows linking the metabolic activity and 
microbial diversity of communities in complex ecosystems (Radajewski et al., 2000; 
Dumont and Murrell, 2005; Egert et al., 2006; de Graaf et al., 2007; Neufeld et al., 
2007). This approach involves a process of exposing microorganisms to a substrate 
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of interest enriched with stable isotopes (usually 13C) and analyzing the subsequent 
isotopic incorporation into cellular biomarkers including DNA and RNA. Subsequent 
characterization of the labeled biomarkers allows identifying the microorganisms 
assimilating the labeled substrate. Especially the introduction of RNA-based SIP 
represented a significant advancement, as it does not require microbial growth, and 
has been used to link microbial function with phylogeny in a broad spectrum of 
different environments. Examples include, but are not limited to, identification of 
acetate-metabolizing bacteria in the presence of iron oxides as electron acceptors 
(Hori et al., 2010), phenol-assimilating bacteria (Sueoka et al., 2009), or butyrate-
producing bacteria under methanogenic conditions (Hatamoto et al., 2008). 
Furthermore, RNA-based SIP was also applied to study human intestinal bacteria 
in an in vitro model of the human colon in the presence of [U-13C]-glucose (Egert 
et al., 2007) and in the presence of [U-13C]-potato starch (Kovatcheva-Datchary et 
al., 2009). As a next step, application of SIP in vivo, in which the labeled substrates 
of interest is delivered directly to the human colon, will allow to test hypotheses 
based on observations made in in vitro model experiments, providing a more 
comprehensive understanding of nature and inter-individual variation of metabolic 
activities and interactions within the gut microbiota. 
Here we report, to the best of our knowledge, the first human trial with a 
substrate that is suitable for RNA-SIP. We selected lactose as the substrate as 
we aimed to identify the microbes responsible for the in situ degradation of this 
disaccharide in the terminal ileum. The substrate was infused in the terminal ileum 
through a naso-gastric catheter. We show that RNA based-SIP together with high-
throughput diagnostic microarray-based phylogenetic profiling is a useful tool for 
identifying metabolically active human gut bacteria in human studies. The current 
study also provides the basis for further experiments to determine the microbial 
functionality in vivo in human subjects.
Experimental Procedures
Subjects
Two healthy subjects, a 28-year old male and 24-year old female (using 
contraceptives), both lean individuals, with normal BMI (18-25) and no history 
of bowel disorders or surgery, took part in the study. None of them had received 
antibiotic treatment for at least 2 months prior to inclusion, both were non smoking, 
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had no known history of use of drugs, and had no known diabetes type 1 or 2. Both 
volunteers gave their written informed consent prior to participation. The study was 
approved by the Medical Ethics Committee of University Hospital Maastricht and 
conducted in accordance with the principles of the ‘Declaration of Helsinki’ (52nd 
WMA General Assembly, Edinburgh, Scotland, Oct 2000). 
Design
The day prior to the study, the subjects consumed a standardized meal. After an 
overnight fast, a catheter was positioned as described below. Once the catheter was 
in position in the terminal ileum, a bolus of 5 ml containing 1 g [U-13C]-lactose 
(Omicron Biochemicals, Inc., South Bend, USA) was infused through the catheter 
into the terminal ileum. Luminal samples were collected for further analysis.  
Catheter design
The catheter was constructed of a multilumen pvc tubing (Mui Scientific, Ontario, 
Canada) with a length of 2.5 m. The outer diameter of the catheter was 4.6 mm. It 
consisted of a large central lumen with a diameter of 2.2 mm, surrounded by 12 small 
lumina with an inner diameter of 0.4 mm each. At the tip of the catheter an inflatable 
latex balloon was attached with a volume of maximally 10 ml. The infusion port was 
located 11 cm proximal to the balloon and was connected to two of the small lumina. 
The sampling port was connected to the large central lumen and was located 1 cm 
proximal to the balloon. The balloon itself was connected to a small lumen to enable 
inflation and deflation of the balloon. The other 9 lumina were closed.
Catheter positioning
The catheter was introduced naso-duodenally by a gastroenterologist and aided 
through the pylorus using a guide wire in the catheter. The position of the tip of 
the catheter was checked by intermittent fluoroscopy. After the position of the tip 
was well beyond the pylorus, the guide wire was withdrawn from the catheter and 
the balloon attached at the tip of the catheter was inflated with 10 ml of air. The 
progression of the catheter was then aided by the natural peristalsis of the intestine. 
To prevent fluid accumulation in the intestinal lumen due to the blockade caused by 
the balloon, which may result in abdominal complaints, the balloon was deflated for 
a few minutes every 20 minutes. Lunch (coffee and a sandwich with jam) and dinner 
(pasta bolognese) were offered. This stimulated the peristaltic movements of the 
132 CHAPTER 5
intestine. The position of the catheter was checked again after dinner by fluoroscopy. 
At 9 PM the volunteers received a last snack (sugar waffle) before going to sleep. 
Catheter position was checked again fluoroscopically in the morning. If the target 
position was not reached yet, the subjects were offered a breakfast (sandwich with 
marmalade) to stimulate peristalsis. Once the catheter reached the terminal ileum 
(Fig. 1), the infusion of the [U-13C] lactose started. At the end of the test day, a 
gastroenterologist gently pulled out the catheter, after intravenous infusion of 1 ml of 
Buscopan® 20 mg/ml (butylscopalamine bromide for intramuscular or intravenous 
injection, Registration number for medication: RVG 03837, Boehringer Ingelheim, 
Alkmaar, The Netherlands).
Sampling of luminal contents
Luminal content was sampled through the ileal catheter each hour until 4 h after start 
of 13C-lactose infusion. If fluid sampling was unsuccessful, 5 ml of deoxygenated 
water (prepared under O2 free conditions) was injected to dilute the luminal content 
and facilitate sampling. The samples were immediately placed in sterile eppendorf 
tubes. To the luminal samples intended for RNA-SIP analysis an equal volume of 
RNA later was added, and samples were further stored on ice until the end of the 
experiment. After arrival in the laboratory, the samples were immediately stored at - 
80ºC until they were further processed for RNA extraction.
RNA-extraction, purification and fractionation by density gradient 
centrifugation 
Total RNA was extracted and purified from 250 µl luminal samples collected at the 
different time points as described previously (Egert et al., 2007). After purification 
and quantification approximately 1 μg of total RNA was loaded in cesium 
trifluoroacetate (CsTFA) centrifugation medium and resolved by density gradient 
centrifugation. Gradients were subsequently fractionated as described by (Egert 
et al., 2007), but using a KDS200 syringe pump (KD Scientific Inc., Holliston, 
MA, USA). Afterwards, RNA from each fraction was precipitated for subsequent 
community analyses. 
Amplification of 16S rRNA and HITChip analysis
To examine all the fractions for presence of rRNA, we amplified the 16S rRNA 
by RT-PCR using a one-step reverse transcription-PCR (RT-PCR) system (Access 
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Figure 1. A fluoroscopic image of a volunteer indicating the positioning of the catheter through the gastro-
intestinal tract. The picture shows the catheter tip entering the proximal colon. Colon structures were made visible 
for fluoroscopic imaging by administering of 10 ml of Lipiodol ® Ultra Fluide 480 mg Jood/ml (Guerbet Nederland 
BV, Gorinchem, The Netherlands). The Lipiodol® was diluted in Saline in ratio 1:3. In the experiments described 
here, the catheter was placed with the tip positioned in the terminal ileum.
Quick, Promega, Leiden, The Netherlands) with primers and conditions for RT-
PCR as described previously (Egert et al., 2007; Kovatcheva-Datchary et al., 2009). 
Subsequently, phylogenetic analysis of the amplicons was performed using the 
HITChip (Rajilic-Stojanovic et al., 2009). This phylogenetic microarray consists 
of more than 4,800 oligonucleotide probes based on 16S rRNA gene sequences 
targeting over 1,100 human intestinal microbial phylotypes. Based on the data from 
the RNA recovery assay and the 16S rRNA RT-PCR analysis gradient fractions 
for further HITChip analysis were selected. Subsequently, cDNA was synthesized 
from the RNA from the selected fractions with different density. Reaction mixtures 
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consisting of SuperScript™ III Reverse Transcriptase (Invitrogen), 8 μl RNA solution, 
1 μl 50 µM random hexamer primer and 1 μl 10 mM dNTPs were incubated at 
65°C for 5 min and then placed on ice for at least 1 min. The cDNA synthesis mix 
containing 4 μl 5 × First-Strand Buffer, 1 μl rRNasin® (40 U/μl), 1 μl SuperScript™ 
III RT (200 U/μl) and 1 μl 0.1 M DTT was then added to each RNA/primer sample 
which were then incubated first at 25°C for 5 min and afterwards at 55°C for 60 
min. Reactions were terminated by exposure to 70°C for 15 min. Afterwards, the 
cDNA was used as template for 16S rRNA PCR analysis for further preparation 
of the samples for the HITChip analysis as described before (Rajilic-Stojanovic et 
al., 2009). After purification of the PCR products (High Pure PCR Cleanup Micro 
kit, Roche Diagnostics GmbH, Mannheim, Germany) the DNA concentration 
was measured using a NanoDrop spectrophotometer (NanoDrop® Technologies, 
Wilmington, USA). Target preparation, hybridization and washing, and data analysis 
was essentially performed as described before (Kovatcheva-Datchary et al., 2009; 
Rajilic-Stojanovic et al., 2009). Similarly, all bioinformatic analyses were performed 
as described previously (Kovatcheva-Datchary et al., 2009; Rajilic-Stojanovic et al., 
2009). 
Results
Volunteer A
RNA recovery and RT-PCR amplification of the 16S rRNA
In a pilot study a multi-lumen feeding catheter was introduced into the terminal ileum 
of two healthy individuals and a total amount of 1 g of [U-13C]-lactose was infused. 
The conversion of the [U-13C]-lactose by the intestinal microbiota was followed for 
4 h. Luminal samples were taken for the first volunteer (A) at 0 h, 0.5 h, 1 h, 2 h, 
3 h and 4 h. The amount of RNA extracted from luminal samples taken at different 
time points amounted from 2.4 µg/ml to 12 µg/ml. In previous in vitro studies with 
[U-13C]-lactose the extracted RNA concentrations were 80 µg/ml to 172 µg/ml RNA 
(Chapter 3 of this thesis).
The extracted RNA was further isopycnically centrifuged to resolve the 
13C-labeled rRNA (heavy) from the background of 12C-unlabeled rRNA (light). The 
fractionated gradients of rRNA extracted from the samples of volunteer A covered 
an average density range of 1.730 g ml-1 (fraction 14) to 1.835 g ml-1 (fraction 1) 
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(Fig. 2 A). In the gradient fractions of the 0 h sample all nucleic acids were detected 
at densities characteristic for unlabeled RNA between 1.746 g ml-1 (fraction 12) and 
1.775 g ml-1 (fraction 8). The highest amount of RNA at this time point was detected 
in fraction 10 (1.759 g ml-1). One hour after the addition of [U-13C]-labeled lactose 
presence of heavy labeled RNA was detected in fraction 7 (1.783 g ml-1), and the 
highest amount of RNA shifted to fraction 9 (1.767 g ml-1, Fig. 2 A). Furthermore, 
the RNA distribution in the gradients from the 2 h, 3 h and 4 h time points, was 
similar to that for the 1 h sample. The only difference was observed for the maximal 
RNA concentration which was detected again in fraction 10 (1.759 g ml-1) from the 
2 h time point onwards as it was observed for 0 h (Fig. 2 A). 
Subsequently, the bacterial 16S rRNA fragments present in the different fractions 
were amplified by RT-PCR and quantified (Fig. 2 B). It was observed that the 16S 
rRNA in the fractions of the 0 h gradient for both volunteers yielded detectable 
Figure 2. A. RNA concentration 
in gradient fractions for volunteer 
A. RNA was isolated from lumen 
samples of the human intestine at 0 
h, 0.5 h, 1 h, 2 h, 3 h and 4 h after 
infusion with 1 g of [U-13C]-lactose. 
Values are given in relative units (%) 
to facilitate comparison between the 
gradients; ♦, 0 h; ■ 0.5 h, ▲ 1 h, ● 
2 h, □ 3 h,  4 h. Vertical arrows 
indicate corresponding fractions 
in the figure. Densities of gradient 
fractions from the [U-13C]-labeled 
lactose study are averaged over 6 
gradients, and standard deviations of 
the densities of the different gradients 
were in the range of 0.003 and 0.004 
g ml-1(data not shown). B. RT-PCR-
analysis results representing an 
~900 bp fragment of bacterial 16S 
rRNA from the gradient fractions. 
The picture is assembled from 6 
different ethidium bromide-stained 
agarose gels after electrophoresis 
of the amplicons. Fractions were 
obtained from ultracentrifugation gradients performed to density-resolve RNA isolated from lumen samples 
after incubation for 0 h, 0.5 h, 1 h, 2 h, 3 h and 4 h with 1 g of [U-13C]-lactose. Fraction numbers are indicated 
on top and correspond to those in A.
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products from fraction 8 (1.775 g ml-1) to fraction 12 (1.746 g ml-1) (Fig. 2 A). 
However, after 1 h a detectable product was also obtained with the high density 
fraction 7 (1.783 g ml-1), confirming the results from the RNA recovery analysis.
Community profiling of the human intestinal microbiota
To specify the composition of the microbial communities in the fractions with low 
and high density, the extracted RNA was reverse transcribed into cDNA and analyzed 
on the HITChip, a phylogenetic microarray (Rajilic-Stojanovic et al., 2009). From 
each time point, two fractions were analyzed, viz. the one with the highest density 
and the one which contained the highest amount of RNA, according to RNA recovery 
analysis (Fig. 2). 
The HITChip analyses of the selected fractions for volunteer A indicated 
that the Proteobacteria constitute the most abundant bacterial group in both fractions 
at the beginning of the experiment (Fig. 3 A). However, after 0.5 h, the profile 
completely changed particularly for the fraction with lower density, where members 
of Clostridium cluster XIVa and Bacilli were most dominant (Fig. 3 B). The relative 
abundance of Proteobacteria spp. was still high in the fraction with higher density, 
however, Bacilli were the dominant group in the low density fraction, particularly 
species related to Streptococcus bovis et rel., Streptococcus intermedius et rel. and 
Streptococcus mitis et rel.. The presence of members of Clostridium cluster XIVa 
was also detected (Fig. 3 A). After 1 h, a shift of the RNA from low density fraction 
to the higher density fraction (Fig. 2) was detected. 
Members of Bacilli and Clostridium cluster XIVa were still the dominant groups in 
the fraction with lower density (Fig. 3 B). Increase in the abundance of bifidobacteria 
was observed in the fraction with higher density, followed by a decrease after 1 h 
from the [U-13C]-lactose infusion (Fig. 3 A). A minor increase (approximately 2-fold) 
was detected in several specific genus-level phylogenetic groups in the fractions with 
higher density. These included in particularly, the taxa Akkermansia, Atopobium, 
Megasphaera elsdenii et rel. and Feacalibacterium prausnitzii et rel., which dropped 
immediately at 2 h (Fig. 4). Other changes in the microbial composition related to 
the increase at genus-level in fractions with higher density were observed also after 
2 h. More specifically, the relative abundance increased in the fraction with higher 
density for Lactobacillus plantarum (>10 fold) and Lactobacillus gasserii (~5 fold), 
Bacteroides stercoris (> 10 fold), Desulfovibrio et rel. (>10 fold) and Roseburia 
intestinalis et rel. (> 2.7 fold) (Fig. 4). Furthermore, at 4 h a strong increase in 
Bacteroidetes was observed in both fractions (Fig. 3). 
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Figure 3. Relative contribution of phylotypes detected with the HITChip in fractions with higher density (A) and 
those with lower density containing the highest RNA concentration (B), for volunteer A from the [U-13C]-lactose 
in vivo trial, collected at different time points. In the legend the 40 genus-level phylogenetic groups contributing 
most to the profiles are indicated. 
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Figure 4. Development in time of the differences in relative abundances of the genus-like bacterial groups 
expressed as natural logarithm of the fraction 7 to fraction 9 ratio. The grey area visualizes minor ratios, which 
are between -2.72 and 2.72 (natural logarithm = 1). Dashed horizontal lines are drawn at no differences between 
the relative abundances of fraction 7 and 9 (natural logarithm = 0), and at differences of 5 and 10 fold between the 
relative abundances of the fractions. 
In order to assess to what extent the microbiota profiles obtained from the volunteers 
resembled those normally observed for human intestinal samples, principal 
component analysis (PCA) of the fractions with higher and lower density was 
performed. For volunteer A, this indicated a clear grouping of the low and high 
density samples taken at 4 h with fecal samples and samples from a previous in-vitro 
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study with [U-13C]-lactose (Fig. 5). In contrast, the samples with higher density from 
time points 0.5 h, 1 h, 2 h and 3 h were more closely clustered with ileal effluent 
samples from individuals with an ileostoma (Booijink, 2009) (Fig. 5 A). The samples 
with higher density and lower density from the 0 h time point did not cluster with 
any of the samples (Fig. 5). Additionally, only the samples from the 1 h and 3 h with 
lower density grouped together with the ileostoma samples (Fig. 5 B). 
Species belonging to Clostridium cluster IV, particularly Clostridium leptum et rel., 
Clostridium cellulosi et rel. and Ruminococcus callidus et rel. showed to be positively 
correlated with the lower density fraction from 1 h and 3 h, while species belonging 
Figure 5. PCA plot depicting 
the microbiota of the 
fractions 8 from time point 
0 h and fraction 7 from 0.5 
h, 1 h, 2 h, 3 h and 4 h, from 
the [U-13C]-lactose in vivo 
trial with volunteer A. (A), 
and fractions 9 from time 
point 0 h, 0.5 h, 1 h, 2 h, 3 
h and 4 h (B). Additionally, 
ileal effluent microbiota 
of 4 individuals with an 
ileostoma (ileo), microbiota 
of the fecal material of four 
healthy human subjects (Hf) 
and the microbiota from three 
samples from a previously 
performed in vitro study 
with [U-13C]-lactose (TIM-
2) were included. Percentage 
values at the axes indicate 
contribution of the principle 
component to the explanation 
of the total variance in the 
dataset. The phylogenetic 
groups that contributed at 
least 98% (A.) and at least 
97% (B.) to the explanatory 
axis used in the plot are 
presented as vectors. 
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to Bacteroidetes were positively correlated with the 4 h low density fraction (Fig. 5 
B), which had a more fecal like composition.  
Volunteer B
RNA recovery and RT-PCR amplification of the 16S rRNA
RNA was extracted from luminal samples taken at 0 h, 1 h, 2 h, 3 h, 4 h and 4.5 
h, as sampling at 30 min for this volunteer was not possible. The amount of RNA 
extracted from the luminal samples taken at different time points amounted from 3.2 
µg/ml to 16 µg/ml, which was higher than for volunteer A.
The fractionated isopycnic centrifugation gradients of RNA extracted from samples 
of volunteers B covered the same average density range as for volunteer A: 1.730 g 
ml-1 (fraction 14) to 1.835 g ml-1 (fraction 1) (Fig. 6 A). The presence of RNA after 
isopycnic centrifugation in the gradient fractions of the 0 h sample was detected (as 
for volunteer A), at densities between 1.746 g ml-1 (fraction 12) and 1.775 g ml-1 
(fraction 8), with the highest amount of RNA being found in fraction 10 (1.759 g 
ml-1). The presence of RNA in fractions with higher density in comparison to the 0 
h sample was detected only 4 h after the beginning of the study, namely in fraction 
7 (1.783 g ml-1, Fig. 6 A). This contrasts with the kinetics observed with volunteer A 
where labeled RNA could already be detected after 1 h. The highest amount of RNA 
for all time points was measured in fraction 10 (1.759 g ml-1, Fig. 6 A), as for 0 h. 
The RT-PCR amplification of bacterial 16S rRNA fragments present in the different 
fractions was in agreement with the results from the RNA recovery measurements. 
RT-PCR amplification of the 16S rRNA in the fractions of the 0 h gradient yielded 
PCR-products from fraction 8 (1.775 g ml-1) to fraction 12 (1.746 g ml-1) (Fig. 6 
B). A detectable product was also obtained for fraction 7 (1.783 g ml-1) after 4 h and 
4.5 h (Fig. 6 B).
Community profiling of the human intestinal microbiota 
For volunteer B, fractions 8 and 10 from 0 h, 1 h, 2 h and 3 h were included for HITChip 
analysis. For the 4 h and 4.5 h time point fraction 7 and fraction 10 were analysed. 
A relatively stable profile of the composition of the microbiota in the fractions with 
lower density was detected over the entire experimental period of 4.5 h with volunteer 
B (Fig. 7 B). Phylotypes belonging to Bifidobacterium, Bacilli and Clostridium 
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Figure 6.  A. RNA concentration in 
gradient fractions for volunteer B. 
RNA was isolated from lumen samples 
of the human intestine at 0 h, 1 h, 2 h, 
3 h, 4 h and 4.5 h after infusion with 
1 g of [U-13C]-lactose. Values are 
given in relative units (%) to facilitate 
comparison between the gradients; ♦, 0 
h; ■ 1 h, ▲ 2 h, ● 3 h, □ 4 h,  4.5 h. 
Vertical arrows indicate corresponding 
fractions in the figure. Densities of 
gradient fractions from the [U-13C]-
labeled lactose study are averaged over 
6 gradients, the standard deviation of the 
densities of the different gradients was 
0.003 g ml-1 for all the fractions (data 
not shown). B. RT-PCR-analysis results 
representing an ~900 bp fragment of 
bacterial 16S rRNA from the gradient 
fractions. The picture is assembled from 
6 different ethidium bromide-stained 
agarose gels after electrophoresis of the 
amplicons. Fractions were obtained from 
ultracentrifugation gradients performed 
to density-resolve RNA isolated from 
lumen samples after incubation for 0 h, 1 h, 2 h, 3 h, 4 h and 4.5 h with 1 g of [U-13C]-lactose. Fraction numbers 
are indicated on top and correspond to those in A. 
cluster XIVa dominated the community. The contribution of Proteobacteria spp. to 
the signal intensity in fractions with low density was more pronounced at the 0 h 
time point in comparison to the other time points (Fig. 7 B). However, differences 
between the lower and higher density fractions were observed at later time points. 
Bacilli were the dominant members in the higher density fractions until the end of 
the experiment. At the 0 h time point Bacteroidetes contributed approximately 10% 
to the signal intensity. However, after 1 h this group contributed to a lesser extend 
to the signal intensity in the fraction with higher density. Interestingly, after 2 h the 
presence of Bacteroidetes was detected again and an increase of several members of 
this group was observed in the fraction with higher density in comparison with the 
low density fraction. A particularly strong increase in B. fragilis et rel. (> 10-fold) 
and B. ovatus (> 10-fold) was observed (Fig. 8). Additionally, a more than 5-fold 
increase was observed for Megasphaera elsdenii in the fraction with higher density 
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Figure  7. Relative contribution of phylogenetic groups detected with the HITChip in fractions with higher density 
(A) and lower density, which contain the highest RNA concentration (B) for volunteer B, collected at different 
time points. In the legend the 40 genus-level phylogenetic groups contributing most to the profiles are indicated. 
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Figure 8. Development in time of the differences in relative abundances of the genus-like bacterial groups 
expressed as natural logarithm of the fraction 8 to fraction 10 ratio. The grey area visualizes minor ratios, which 
are between -2.72 and 2.72 (natural logarithm = 1). Dashed horizontal lines are drawn at no differences between 
the relative abundances of fraction 8 and 10 (natural logarithm = 0), and at differences of 5 and 10 fold between 
the relative abundances of the fractions. 
in comparison to the lower density fraction (Fig. 8). Unexpectedly, at the 4 h time 
point in the fraction with higher density the presence of Proteobacteria was detected. 
After comparing the fraction with higher density at the 4.5 h time point with 
the fraction with lower density, a strong increase in Bifidobacterium (~8-fold), 
Collinsella (> 5-fold) and Anaerostipes caccae (~4-fold) (Fig. 8). Additionally, an 
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increase in Akkermansia spp. and Faecalibacterium prausnitzii was detected also 
with volunteer B after the 4 h time-point where label incorporation in 16S rRNA was 
first observed using RT-PCR (Fig. 6).
After visualizing the bacterial composition of the samples with higher density on a 
PCA plot, only the sample from the 1 h time with high density grouped with ileal 
effluent samples from subjects with an ileostoma and faecal samples. The higher 
density fraction from the 4 h sample did not group with any of the samples, and 
showed a positive correlation with a species belonging to Proteobacteria, particularly 
Figure 9. PCA plot depicting 
the microbiota of the fractions 8 
from time points 0 h, 1 h, 2 h, 
3 h, and fraction 7 for 4 h and 
4.5 h, from the [U-13C]-lactose 
in vivo trial with volunteer B 
(A), and fractions 10 from time 
points 0 h, 1 h, 2 h, 3 h, 4 h 
and 4.5 h (B). Additionally, the 
microbiota of 4 individuals with 
an ileostoma (ileo), microbiota 
of the faecal material of four 
healthy human subjects (Hf) 
and the microbiota from three 
samples from a previously 
performed in vitro study with 
[U-13C]-lactose (TIM-2) were 
included. Percentage values at 
the axes indicate contribution of 
the principle component to the 
explanation of the total variance 
in the dataset. The phylogenetic 
groups that contributed at least 
99% to the explanatory axis 
used in the plot are presented as 
vectors, valid for the both plots.
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Heamophilus (Fig. 9 A). Additionally, the samples with lower density also did not 
group with the ileum and fecal samples. Moreover, the 0 h sample with lower density 
did not group with the other samples and a positive correlation with a number of 
groups within the Proteobacteria was observed (Fig. 9 B).
Discussion
The objective of this study, which describes pioneer experiments towards the 
application of RNA-based SIP under in vivo conditions in the human intestinal tract, 
was to explore the functionality of the microbiota in the conversions of relevant 
dietary carbohydrates in the terminal ileum of healthy individuals. The substrate 
tested in the current study was lactose. There is limited knowledge on the effect of 
lactose on the gut microbiota, even though it has been well established that lactose 
intolerance is endemic around the world (Sahi, 1974; Scrimshaw and Murray, 1988; 
Sahi, 1994). It has been reported that 2% of lactose is the theoretical daily maximum 
of lactose reaching the colon in lactase positive populations (Männistö et al., 2003), 
whereas most of the lactose reaches the colon in lactose maldigesters, the largest part 
of the world population. 
Here we applied RNA-based stable isotope probing to identify members of 
the human intestinal microbiota involved in in situ lactose degradation in the human 
terminal ileum. After isopycnic separation of the RNA the range of the measured 
density was in agreement with previously reported data from in vitro studies, where 
ileal-like and fecal microbiota were studied (Egert et al., 2007; Kovatcheva-Datchary 
et al., 2009). Based on the data from the RNA quantification, for volunteer A, we 
observed presence of RNA with higher density in comparison with the 0 h sample 
from 1 h after infusion of [U-13C]-lactose, whereas for volunteer B this occurred 
only after 4 h. From our previous experiments, where the fermentation of [U-13C]-
lactose was studied under in vitro conditions simulating the human colon using 
fecal material as inoculum, incorporation of the 13C-label was detected 30 min after 
addition of the substrate (Kovatcheva-Datchary et al., manuscript in preparation). 
Because of the lack of knowledge on the optimal concentration of the 13C-labeled 
substrate, in similar studies performed with humans, we used 1 g of [U-13C]-lactose 
as was previously applied during the in vitro experiments. 
Focusing on the changes that appear in the fractions with higher density from the 
1 h time point, where heavy RNA was detected in volunteer A, with those containing 
RNA with lower density, minor changes could be detected. More specifically, 
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increase in Akkermansia, Atopobium, Megasphera elsdenii and Faecalibacterium 
prausnitzii, was observed. However, Akkermansia spp. are not reported to ferment 
lactose, and the preferable growth substrate for this bacteria is mucin (Derrien et al., 
2004). It has been recently reported that Akkermansia muciniphila starts to colonize 
the human intestinal tract from early life  (Collado et al., 2007). Additionally it has 
been described that Akkermansia and Faecalibacterium prausnitzii are present in 
the microbial community of humans with acute appendicitis, but their increase was 
not found to be related to the severity of the appendicitis (Swidsinski et al., 2009). 
Interestingly, an increase in both of these species was observed with volunteer B 
as well, albeit only after 4 h. Also higher concentrations of Atopobium have been 
reported in the faces of Asian infants after administration of probiotic product (Mah 
et al., 2007).
In the current study we followed the in situ conversion of lactose in the 
human intestine for a period of 4 - 4.5 h and we directly sampled from the location 
where the substrate was infused via a multi-lumen catheter. After comparison of the 
microbial community of both individuals in the fractions with lower density, the 
presence of species belonging to Bacilli and Clostridium cluster XIVa was detected 
in most of the fractions. In general, the microbial community in the fractions with 
lower density derived from volunteer B was more stable than that from volunteer 
A. However, further analysis on the composition of the microbiota in fecal samples 
from the two volunteers is needed to confirm this status. Unexpectedly, for volunteer 
A at the 0 h time point in both gradient fractions, Proteobacteria represented the 
major taxa in the community. However, 2 h after infusion of the labeled substrate, 
changes related to increase of phylotypes in the fraction with higher density were 
detected for two taxa of lactic acid bacteria, particularly Lactobacillus plantarum 
and Lactobacillus gasserii, and one Bacteroides sp. for volunteer A. Also an increase 
in Desulfovibrio spp. was observed at the same time point. Desulfovibrio spp., are 
well known sulfate reducing colonic bacteria, which in complex systems have been 
shown to outcompete for the lactate-producing  members of Clostridium cluster 
XIVa, particularly Eubacterium halii and Anaerostipes caccae, converting lactate 
to acetate with concomitant production of H2S (Marquet et al., 2009). Lactose is a 
compound, which can be converted by a number of bacteria, making it difficult to 
draw a final conclusion, but based on the data presented here it is most likely that 
in this study the lactobacilli are converting the lactose. In addition, we observed 
that the profile at 4 h for both fractions for volunteer A changed into a more fecal-
like composition. The reason for this could be that during the in vivo experiment 
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the catheter continued to progress further in the intestinal tract and reached the 
colon. Additionally, the PCA analysis indicated that the microbial composition of 
the samples from the 1 h is similar to those of ileal effluent from individuals with an 
ileostoma, which could indicate that at this time point the catheter was positioned in 
the terminal ileum. 
Interestingly, for volunteer B different members of the community were 
shown to be involved in the lactose degradation. Also here after 2 h changes were 
observed, indicating increases in phylotypes in the community in the fraction with 
higher density. Members of Bacteroidetes increased in the fractions with higher 
density (more than 10 fold) but also a species related to Megasphaera elsdenii. The 
latter microorganism is a well known lactate-utiliser, and it has been shown that it is 
able to counteract hyperlactate production in the large intestine (Hashizume et al., 
2003). However, data from the metabolite profiling have to be analyzed, which will 
help to build the hypothesized cross-feeding relation between the identified species. 
Focusing on time point 4.5 h, where the presence of RNA was detected in the fraction 
with higher density, a strong increase in Bifidobacterium and Collinisella was 
detected in addition to the changes observed in Akkermansia and Faecalibacterium 
prausnitzii. Similar observations are described in Chapter 3, where we address the 
fate of 13C labeled lactose in a laboratory in vitro colon model. Moreover, a member 
of Clostridium cluster XIVa related to Anaerostipes caccae et rel., also increased 
at the 4.5 h time point in the fraction with higher density. This latter species is also 
known to utilize lactate and convert it to butyrate (Marquet et al., 2009). PCA analysis 
grouped the samples with lower density from the different time points with fecal 
samples, which could indicate that for volunteer B the catheter progressed distally 
during the experiment, with the catheter tip located in the proximal colon, whereas 
the catheter remained in the terminal ileum throughout the test in volunteer A. This 
could also explain the observed differences on the microbial composition level. 
In conclusion, using a multi-lumen catheter we were able to access and sample 
the human lower intestinal tract and applying RNA-based SIP together with high-
throughput microarray-based phylogenetic profiling to explore the potential of the 
intestinal microbiota to convert lactose in the human intestine. Furthermore, the 
current human feeding trial will serve as starting point for further similar studies, 
which will allow to dig deep into the great microbial potential of the gut microbiota.
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Introduction
An astonishing microbial diversity thrives on our planet and its activities are essential 
for the functioning of all ecosystems, including the human body. Consequently, a 
detailed understanding of the functions of microbes in their natural environment is 
required to understand our biology and the biology of the world around us. The aim 
of the work presented in this thesis was to explore the functionality of the human 
gastrointestinal (GI) tract microbiota, particularly in the fermentation of dietary 
carbohydrates. RNA-based stable isotope probing was applied together with high 
throughput phylogenetic analysis and metabolite profiling to expand our knowledge 
on key microbial functions related to healthy a gut status. The obtained results 
presented in this thesis contribute to a sound basis for the development of nutritional 
strategies for intestinal disease prevention and health promotion. 
The role of gut microbiota in carbohydrate fermentation
The human GI tract microbiota has an important role in maintaining gut health. It 
has been suggested that the gut microbiota should be treated as a separate organ 
- “microbial organ”, based on its collective metabolic potential (O’Hara and 
Shanahan, 2006; Cani and Delzenne, 2007). Furthermore, this metabolic repertoire 
delicately affects our physiology with functions that we have not had to evolve 
on our own (Backhed et al., 2005; Gill et al., 2006; Turnbaugh et al., 2007). The 
complex microbiota residing in the gut possess an array of activities associated with 
the fermentation of dietary compounds that escape digestion in the upper GI tract, 
processing of mucosal cells shed in the small intestine, and degradation of intestinally 
secreted mucus (Xu and Gordon, 2003; Noverr and Huffnagle, 2004; Ouwehand et 
al., 2005; Fava et al., 2006; Srikanth and McCormick, 2008) (Table 1). The ability 
to process nondigestible dietary fiber and related carbohydrates (resistant starch or 
oligosaccharides) is a crucial function of the colonic microbiota that significantly 
influences the gut environment and the host, by providing the means to use the 
carbohydrates as an energy source and in the maintenance of gut health (Savage, 
1986; Guarner and Malagelada, 2003; Xu and Gordon, 2003; O’Hara and Shanahan, 
2006). 
The microbiota has access only to those dietary residuals that escape digestion 
by the host enzymes in the upper GI tract. A vast range of polysaccharide substrates 
from the diet reach the colon and is further converted by the colonic microbiota 
(Young et al., 1996). Plant cell-wall polysaccharides, storage polysaccharides (e.g. 
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inulin), oligosaccharides and resistant starch are the main compounds that reach 
the colon (Macfarlane and Gibson, 1997) and further serve as food for the colonic 
microbiota. These substrates consist of a complex assortment of macromolecules with 
diverse structures, the degradation of which requires an array of bacterial hydrolytic 
enzymes produced by various bacterial members of the colonic community. 
There are only few colonic bacteria known to date that are able to initiate the 
breakdown of insoluble substrates and these predominantly belong to Bacteroides 
spp. and Ruminococcus spp. (Rincon et al., 2005; Flint et al., 2008; Jindou et al., 
2008) (Chapter 2). Furthermore, during the sequential breakdown of complex 
carbohydrates, cooperation via metabolic cross-feeding is an important process 
(Fig. 1). Several classes of microbial activities can be observed to occur during 
such fermentations. As a first step, enzymatic activities of the primary degraders 
of complex carbohydrates result in the release of large amounts of polysaccharides 
(Fig. 1 I), which serve as substrates mostly for planktonic microbiota (Dehority, 
Figure 1. Schematic representation of the conversions of non-digestible carbohydrates by the anaerobic 
gut microbiota. I. Primary substrates degradation; II. Sequential degradation of dietary substrates; III. 
Substrate utilization by different populations in the colon; IV. Cross-feeding interactions between primary 
carbohydrate degraders and other members of the colonic microbiota. SRB - sulfate reducing bacteria. 
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1991). Furthermore, planktonic bacteria break down the polysaccharides and 
oligosaccharides that are released (Fig. 1 II). Oligosaccharides are one of the most 
studied carbohydrates, and it has been shown that bacteria that primarily utilize 
oligosaccharides do not grow on polysaccharides (Rossi et al., 2005). Additionally, 
cross-feeding during which the fermentation products released by one microorganism 
are utilized or serve as a growth factor for another population, often has impact on the 
energy metabolism of one or both partners (Wolin et al., 1997; Samuel and Gordon, 
2006) (Fig. 1 IV) (Chapters 2-4). The main products from the anaerobic microbial 
fermentations occurring in the human colon are SCFAs, such as butyrate, propionate 
and acetate, which have an important function in host physiology (Scheppach, 1994; 
Mortensen and Clausen, 1996). It has been recognized that the composition of the 
gut microbiota is crucial for the relationship between the fermentable carbohydrate 
and the produced metabolites (Pryde et al., 2002). 
A number of bacteria belonging to Clostridium cluster XIVa, form the group of 
butyrate-producers, based on their ability to produce butyrate as major product from 
carbohydrate fermentation (Barcenilla et al., 2000; Pryde et al., 2002) (Table 1). 
However, different fermentation pathways could be involved in butyrate synthesis 
in the human colon. The most widely spread pathway among different butyrate 
producing bacteria of the Clostridium cluster XIVa is the pathway known as the 
CoA-transferase route (Chapter 2), whereas another pathway involving butyrate-
kinase activity is less common (Louis et al., 2004). Acetate is a co-substrate in the 
reaction where CoA-transferase activity is used for butyrate synthesis. There are a 
number of other fermentation pathways, where the synthesis of the other SCFA is 
involved, such as the succinate decarboxylase pathway and acrylate pathway (Louis 
et al., 2007), and the recently described propanediol pathway (Scott et al., 2006) for 
propionate synthesis. To investigate the use and importance of these pathways, it has 
been shown that the use of isotopically labeled substrates in fermentation studies 
is a suitable strategy in defining these different routes (Chapter 3). Additionally, 
molecular hydrogen (H2) plays an important role in anaerobic ecosystems, such as 
the gut. Increase in H2 production often decreases the metabolic activity of bacteria. 
However, such inhibition can be overcome by addition of a H2-utiliser to the system, 
upon which for instance an increase in acetate  is measured (Miller and Wolin, 1995). 
In Chapter 4 such cross-feeding interaction is reported and further visualized in 
Figure 2. Based on experimental evidence we concluded that the H2 produced by 
R. bromii during the starch degradation serves as electron donor for E. rectale, 
leading to an increase in SCFA amounts and the production of lactate. Additionally, 
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carbohydrate fermentation by bifidobacteria has been reported to involve another 
cross-feeding relation, as a result of which the lactate-utilizing E. halii produces 
butyrate (Belenguer et al., 2006). An earlier study described the mechanism of butyrate 
formation by colonic butyrate producers as Roseburia spp. and Faecalibacterium 
prausnitzii, which showed to be among the most active butyrate producers in the 
colon (Duncan et al., 2002).
Exploring the functionality of the human gut microbiota in the anaerobic 
fermentation of dietary carbohydrates
An effective strategy to delve into the functionality of the gut microbiota is to elucidate 
the role of individual species within the community in their natural environment. To 
explore the capacity of the gut microbiota in the fermentation of relevant dietary 
carbohydrates, we applied RNA-based Stable Isotope Probing (SIP), which in 
combination with molecular identification tools, provide a direct link between the 
structure of a microbial community and the function of its members (Kovatcheva-
Datchary et al., 2009). In Chapter 2 and Chapter 3, the capacity of the human fecal 
microbiota to ferment dietary carbohydrates such as starch, inulin and lactose was 
explored with RNA-based SIP analysis. Differences in the set of microbes involved 
in the conversion of carbohydrates in in situ conditions of the human colon were 
Figure 2. Interaction of a potato 
starch degrading R. bromii strain 
with hydrogen utilizing E. rectale-
like bacterium (Chapter 4). I. 
Primary starch degradation; II. 
Cross-feeding interaction between 
the primary starch degrader and a 
hydrogen utilizing bacteria. 
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described, by combining RNA-based SIP with high-throughput microarray-based 
phylogenetic profiling using the HITChip (Chapter 3 and Chapter 5) (Rajilic-
Stojanovic et al., 2009). With the presented research we additionally confirmed the 
power of the HITChip technology for high- throughput fingerprinting, phylogenetic 
and quantitative community analysis. To this end, the TIM-2 model of the human 
colon was used (Minekus et al., 1999) (Chapter 1). Moreover, RNA-based SIP 
allowed us to identify the primary degraders of the tested substrates, as it is reported 
in Chapter 2, where a phylotype related to Ruminococcus bromii was reported to 
be the primary degrader of potato starch, corroborating results that were reported 
in other in vivo and in vitro experiments (Leitch et al., 2007; Abell et al., 2008). 
Furthermore, more information on the functionality of the different microbes, found 
to be active in the colon ecosystem, could be generated after combining the data 
from the SIP technique with NMR and liquid-chromatography-mass spectrometry. 
The detection of (partially) labeled metabolites allowed the identification of active 
metabolic pathways and delineation of food webs that may influence human health (de 
Graaf et al., 2007; Egert et al., 2007; Kovatcheva-Datchary et al., 2009). In Chapter 
2, the integration of the molecular and metabolite data suggested metabolic cross-
feeding in the system during potato starch degradation, where populations related to 
Ruminococcus bromii are the primary starch degraders, while other members of the 
community, which were related to Prevotella spp., Bifidobacterium adolescentis and 
Eubacterium rectale, might be further involved in the trophic web.
Moving towards SIP in vivo, Chapter 5 describes a pioneering and pilot in vivo trial, 
addressing the ability of the human intestinal microbiota to ferment carbohydrates 
in situ in the human colon. This study serves as a starting point for further in vivo 
experiments and further optimization on decisive issues for the SIP application in vivo, 
such as delivery of the labeled substrate, improvement of the sampling procedure, as 
well as the amount of the labeled substrate needed for unequivocal identification of 
microbial populations actively involved in the degradation of a given carbohydrate 
of interest, which is further discussed in Chapter 5. 
 
Future perspectives
The comprehensive understanding of the metabolic activity of the gut microbiota 
will enable the development of direct strategies to treat or prevent intestinal disorders 
caused by microorganisms in humans but also in animals. Particularly in ruminants, the 
composition of the microbial community involved in degradation of polysaccharides 
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is quite similar to the human colonic microbiota. The knowledge derived from the SIP 
studies described here, may be a starting point in the optimization of the food intake 
of animals to improve their performance after acute acidosis, which is caused by 
increased lactate production after fermentation of readily fermentable carbohydrates. 
New animal nutritional supplements could also be developed based on the research 
described in the current thesis. Additionally, the data from the in vivo trial, described 
in Chapter 5, could help to clear the mechanism of acute acidosis based on the high 
lactate concentration. 
Furthermore, new in vivo trials are expected to follow, which will benefit from 
the accumulated data from the in vitro but also the in vivo studies. The application 
of the SIP approach as a tool in medical research may bring new information for 
disease treatment, and prevention, and further contribute to describe the impact 
of gut microbiota on human health and well-being. Identification of the prime 
functions of the human gut microbiota in maintaining human health requires a better 
understanding of its diversity and functionality, which can facilitate its manipulation. 
Most intestinal microbes have not been cultured and the in situ functions of distinct 
groups of the gut microbiota are largely unknown but pivotal to understand their 
role in health and disease. Another part of the gut microbiota functionality, which 
needs to be further explored, is the conversion of protein that occurs usually in the 
distal colon, producing metabolites that are known to have toxic effects on the host 
(Macfarlane and Macfarlane 1995). Moreover, during carbohydrate fermentation, 
proteins are converted to microbial biomass (Birkett et al., 1996). In contrast, most 
carbohydrate fermentations occur in the proximal colon. Therefore it has been 
suggested that prolonged carbohydrate fermentation, mostly by the use of more 
slowly fermentable dietary carbohydrates, could reduce the incidence of proteolytic 
fermentations (Gibson, 1998; Gibson et al., 2004). This hypothesis needs to be 
further tested. It can be considered that with the current thesis, and particularly with 
the experiments described in Chapter 2 and Chapter 3, we have generated the 
relevant knowledge, which can be used for optimizing carbohydrate fermentations. 
Additionally, further exploration of protein fermentations using the SIP approach, or 
even the new developments in stable isotope-based approaches described in Chapter 
1, can be used in the identification of key players of the gut microbiota. Furthermore, 
the accumulated knowledge from both types of fermentations could serve in the 
development of new functional food components. 
Finally, the use of metagenomics as a tool to analyse genomic DNA of 
the microbiota has expanded our knowledge on the microbial diversity, but also 
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functionality (Qin et al., 2010). The application of metagenomics with DNA-based 
SIP will facilitate the identification of functions from the targeted environment. 
Additionally, the combination of these approaches will allow to detect very rare 
and particular populations. Moreover the combination of SIP with metaproteomics, 
which is a very direct link for identification of proteins involved in specific metabolic 
processes (Jehmlich et al., 2008; Jehmlich et al., 2010), will further increase the 
sensitivity of this approach and allow to identify specific metabolic activities that 
can be linked to the phylogenetic identity of involved microorganisms.
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SUMMARY
The human gastrointestinal (GI) tract comprises a series of complex and dynamic organs that are involved in food intake, food perception and food conversion. 
The colon embodies the most distal part of the GI tract, which is the main site of 
microbial colonization, and harbors immense microbial assemblages, known to be 
vital for human well-being. The human gut microbiota directly impacts on human 
physiology, in a beneficial or harmful manner through its collective metabolic 
activity. 
The work presented in this thesis focused on deciphering the functional 
capacity of the human intestinal microbiota for the fermentation of relevant [13-C]-
labeled dietary carbohydrates using 16S ribosomal RNA (rRNA)-based Stable Isotope 
Probing (SIP). To this end, we combined RNA-based SIP with molecular identification 
tools and metabolite profiling. This resulted in identification of the primary degraders 
of potato starch, inulin and lactose under human colon-like conditions. Furthermore, 
metabolic cross-feeding networks were proposed, involving secondary fermentation 
processes. Ruminococcus bromii was identified as the key player in the degradation 
of potato starch based on molecular analysis of samples taken during the fermentation 
in the TIM-2 model of the human colon, but also through fermentation studies 
in mono-culture or co-culture with Eubacterium rectale. We further explored the 
metabolic conversion of potato starch in a simple co-culture fermentation system. 
This revealed a cross-feeding relationship between the two species that involved the 
consumption by E. rectale of H2 produced by R. bromii from the starch degradation, 
leading to increased production of propionate and acetate. Furthermore, species 
related to Dorea longicatena and Bifidobacterium adolescentis were identified as 
key members of the tested community in inulin degradation. Moreover, species 
within the Actinobacteria, particularly B. adolescentis and Collinsella, were further 
described to be involved in lactose degradation at conditions simulating the human 
colon. Moving beyond in vitro studies we explored the role of the gut microbiota in 
lactose fermentation with a pioneering study, where [U-13C]-lactose was delivered 
directly to the terminal ileum of healthy human volunteers using a multi-lumen 
catheter that was also used for sampling of luminal content to explore the community 
involved in lactose degradation directly in the human intestine. Individual patterns 
of the microbiota involved in the lactose fermentation were observed, showing 
that in both volunteers different microbial populations were involved, which 
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could be attributed to differences in the sampling location. A population related to 
Lactobacillus plantarum was found to be most pronounced in one of the volunteers 
during the trial, while with the other volunteer most probably members of the genera 
Bifidobacterium and Colinsella were the primary lactose degraders, in agreement 
with the in vitro model study. Furthermore, Ananerostipes caccae was found to be 
involved in the trophic chain, which could be related to its capacity to convert the 
lactate produced by the primary lactose degraders into butyrate. Further analysis of 
the accumulated metabolites during the lactose degradation will help to reconstruct 
the metabolic pathways involved in intestinal metabolism.
In conclusion, the results obtained in the framework of this thesis indicate 
that the integration of the RNA-based SIP approach and high-throughput diagnostic 
microarray-based phylogenetic profiling with metabolic flux analysis, appears a 
promising approach to reveal bacteria that are actually involved in the carbohydrate 
fermentations, not only in model systems, but more importantly also in the intestinal 
tract of man.
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SAMENVATTING
Het menselijk maag-darmstelsel bestaat uit een serie van complexe en dynamische organen die betrokken zijn bij de opname, perceptie en vertering 
van voedingsstoffen. Het colon, ofwel de dikke darm, belichaamt het meest distale 
gedeelte van het maag-darmstelsel, is de voornaamste plaats van microbiële 
kolonisatie en huisvest immense verzamelingen van bacteriën, waarvan bekend is 
dat ze belangrijk zijn voor de gezondheid van de mens. Door hun gezamenlijke 
metabole activiteit heeft deze menselijke darm microbiota een directe invloed op de 
fysiologie van de mens, hetzij bevorderlijk of nadelig.
Het werk dat gepresenteerd is in dit proefschrift richtte zich op het 
ontrafelen van het functionele vermogen van de menselijke darm microbiota om 
relevante [13-C]-gelabelde voedselkoolhydraten te fermenteren, gebruik makend 
van 16S ribosomaal RNA (rRNA)-gebaseerd Stabiele Isotoop Probing (SIP). 
Hiertoe hebben we RNA-gebaseerd SIP gecombineerd met moleculaire identificatie 
methodes en analyse van gevormde metabolieten. Dit resulteerde in de identificatie 
van de primaire verantwoordelijken voor de afbraak van aardappelzetmeel, inuline 
en lactose, onder omstandigheden die het menselijke colon het dichtst benaderen. 
Daarnaast zijn metabole cross-feeding netwerken voorgesteld, mede gebaseerd 
op secundaire fermentatie processen. Ruminococcus bromii werd aangetoond een 
sleutelrol te spelen bij de afbraak van aardappelzetmeel, gebaseerd op de moleculaire 
analyse van monsters die genomen zijn tijdens de fermentatie in het TIM-2 model 
van het menselijke colon, alsmede middels studies van mono-cultuur fermentaties 
of co-cultuur fermentaties met Eubacterium rectale. Uit laatstgenoemde co-cultuur 
experimenten kwam een cross-feeding relatie naar voren tussen de twee soorten, 
waarbij de waterstof die wordt geproduceerd door R. bromii bij de afbraak van 
zetmeel door E. rectale wordt gebruikt voor productie van propionaat en acetaat. 
Verder zijn soorten gerelateerd aan Dorea longicatena en Bifidobacterium 
adolescentis geïdentificeerd als belangrijkste micro-organismen, binnen de geteste 
microbiota, bij de afbraak van inuline. Bovendien is beschreven dat soorten binnen 
de Actinobacteria, met name B. adolescentis en Collinsella, betrokken zijn bij 
de afbraak van lactose onder condities die de menselijke colon simuleren. In een 
baanbrekende studie waarbij we verder zijn gegaan dan in vitro studies hebben we 
de rol van de microbiota onderzocht bij lactose fermentatie. Hierin werd [U-13C]-
            
173        
Ndederlandse Samenvatting
SAMENVATTING
lactose direct in het laatste gedeelte van het ileum ingebracht bij gezonde vrijwilligers 
middels een multi-lumen katheter welke ook gebruikt werd voor monstername van 
de darminhoud om de microbiota, die betrokken is bij de afbraak van lactose, direct 
in de menselijke darm te bestuderen. In beide vrijwilligers werden verschillende 
patronen van de microbiota betrokken bij de fermentatie van lactose waargenomen, 
wat onder andere toegeschreven zou kunnen worden aan verschillen in locatie van 
monstername. Een populatie gerelateerd aan Lactobacillus plantarum werd gevonden 
als meest geprononceerd in een van de vrijwilligers tijdens de testperiode, terwijl 
bij de andere vrijwilliger meest waarschijnlijk leden van de genera Bifidobacterium 
en Colinsella primair verantwoordelijk zijn voor de afbraak van lactose, wat in 
overeenstemming is met de in vitro model studie. Daarnaast werd gevonden dat 
Ananerostipes caccae betrokken is bij lactose fermentatie in een latere fase. Dit 
zou gerelateerd kunnen worden aan zijn vermogen om lactaat, wat gevormd wordt 
door de voornaamste lactose afbrekende bacteriën, om te zetten in butyraat. Verdere 
analyse van de opgebouwde metabolieten tijdens de afbraak van lactose zal helpen 
om de metabole routes te reconstrueren die betrokken zijn bij het metabolisme in de 
darmen.
Concluderend kunnen we stellen dat de resultaten die verkregen zijn in 
het kader van dit proefschrift aangeven dat de integratie van de RNA–gebaseerde 
SIP benadering en de fylogenetische beschrijving, gebaseerd op high-throughput 
diagnostische mirco-arrays,  samen met de metabole flux analyse een veelbelovende 
benadering blijkt te zijn om bacteriën te identificeren die werkelijk betrokken zijn bij 
de koolhydraat fermentaties, niet alleen in modelsystemen, maar, belangrijker nog, 
ook in het maag-darmstelsel van de mens.
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RÉSUMÉ
Le tube digestif de l’homme comprend une série d’organes complexes qui sont impliqués dans la perception des aliments, la digestion du bol alimentaire, ainsi 
que son assimilation. Le colon représente la partie distale du tube digestif qui est 
le site principal de colonisation microbienne et abrite d’immenses assemblages 
microbiens, connus pour être vitaux pour le bien-être de l’Homme. Le microbiote 
du tube digestif humain influences directement la physiologie humaine de façon 
positive ou négative en fonction de l’activité métabolique collective. 
Le travail présenté dans cette thèse se concentre sur le décodage de la capacité 
fonctionnelle du microbiote intestinal humain dans la fermentation d’hydrates de 
carbone diététiques [13-C] marqués en utilisant un échantillonnage d’isotopes stables 
(Stable Isotope Probing, SIP)  basé sur l’ARN 16S ribosomale. A cette fin, nous 
avons combiné la technique SIP basée sur l’ARN avec des outils d’identification 
moléculaire et de profilage de métabolites. Cette étude a permis une identification de 
dégradeurs primaires de l’amidon de pomme de terre, de l’inuline et du lactose dans 
des conditions semblables au colon humain. En outre, un croisement des réseaux 
métaboliques ont été effectué en incluant des procédés de fermentation secondaire. 
Ruminococcus bromii a été identifié comme le principal responsable de la dégradation 
de l’amidon de pomme de terre en se basant sur l’analyse moléculaire d’échantillons 
prélevé durant la fermentation du modèle du colon humain TIM-2, mais également 
par des études en mono-culture ou co-culture de fermentation d’Eubacterium rectale. 
Nous avons en outre exploré la conversion métabolique d’amidon de pomme de 
terre dans une fermentation en co-culture. Cela a révélé une relation d’alimentation 
croisée (cross feeding) entre les deux espèces. Le H2 produit par R. bromii à partir 
de la dégradation de l’amidon accroît la production de propionate par E. rectale. De 
plus, les espèces liées à Dorea longicatena et Bifidobacterium adolescentis assimilent 
l’inuline et les bactéries B. adolescentis et Collinsella dégradent le lactose dans des 
conditions similaires au colon humain. 
Une étude pionnière ‘in-vivo’ avec des volontaires ayant consommé du lactose a 
permis d’établir que Lactobacillus  plantarum, Bifidobacterium et Colinsella sont les 
principales bactéries qui dégradent le lactose.
En conclusion, les résultats présentés dans cette thèse indiquent que 
l’intégration de différentes techniques novatrices ont permis d’identifier les bactéries 
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qui sont impliquées dans la fermentation des glucides et ce, non seulement, dans le 
cadre de modèles in-vitro mais également dans le tube digestif humain.
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Човешката храносмилателна система се състои от сложни и функционални органи, които участвуват в поемането, възприемането и преработването 
на храната. Дебелото черво e най-отдалечената част на стомашно-чревния 
тракт, което е главното място на микробиално колонизиране и убежище на 
големи микробиални струпвания, доказали жизненоважнaтa си функция върху 
здравето ни. Изследванията върху активността на човешката чревна микробиота 
в стомашно-чревния тракт са необходими за да опознаем по-добре ролята на 
микроорганизмите върху човешкото здраве и болести. Toвa ще позволи да бъдат 
разработени стратегии, които да повлияят на/ или предотвратят стомашно-
чревни заболявания. Консумирането на пребиотични въглехидрати е една от 
стратегиите, чрез която се стимулират полезни чревни ферментации.
Целта на настоящата докторантура е дешифрирането на функционалния 
капацитет на човешката чревна микробиота по време на разграждането 
на сложни въглехидрати. За целта бе използвана методика, известна като 
16S рибозомна РНК (рРНК) стабилно изотопно сондиране, където [13-C]-
белязани диетични въглехидрати бяха тествани. За да бъдат идентифицирани 
микроорганизмите, които директно разграждат пребиотични въглехидрати, 
като картофено нишесте, инулин и лактоза, в условията на дебелото черво, 
РНК-стабилно изотопно сондиране беше комбинирано с молекулярни методи и 
метаболитно профилиране. Установени бяха метаболитни системи на кръстосано 
хранене, включващи вторични ферментационни процеси. Беше установено, 
че Ruminococcus bromii e ключовият микроорганизъм в разграждането на 
картофеното нишесте, въз основа на молекулярен анализ на проби, взети по 
време на ферментация в модел, стимулиращ условията в човешкoтo дебело 
черво, а също и посредством ферментационни изследвания с монокултура или 
с ко-култура нa Eubacterium rectale. Показано беше взаимодействие по време на 
кръстосано хранене между двата вида микроорганизми, където произведения 
H2 от R. bromii при директното разграждане на нишестето бe инкорпориран 
и резултираше в повишeнo продуциране на пропионат и ацетат от E. rectale. 
В допълнение микроорганизми, сродни с Dorea longicatena и Bifidobacteriun 
adolescentis бяха идентифицирани като ключови бактерии при разграждане на 
инулина. A видове от Actinobacteria, в частност B. adolescentis и Collinsella бяха 
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показани, че разграждат лактозата при същите условия и в същата микробна 
популация.
За да проучим ролята на чревната микробиота в разграждането на 
лактоза, ние проведохме in vivo изследвания със здрави доброволци. Това е 
първото по рода си изследване, където изотоп на лактоза беше директно 
доставен в последната част на тънкото черво на доброволците чрез мулти-
каналов катетър. Същият бе използван и за взимане на проби от съдържанието 
на лумена, за да се изследва чревната микробиота, разграждаща лактозата 
в условията на човешкия чревен тракт. Hаблюдавани бяxa индивидуални 
особености на микробиотата, кoято ферментирa лактозата, показващи че и при 
двамата доброволци участват различни микробиални популации, което може 
би е свързано и с различната локализация на катетъра при взимане на пробата. 
Беше открита популация Lactobacillus plantarum, която беше сред най-срещаната 
микробна група, разграждаща лактозата при единия от доброволците по време 
на опита, докато при другия доброволец - най-вероятно видове от родовете 
Bifidobacterium и Colinsella, което бeше доказано и с in vitro изследване. Освен 
това беше показано, че Ananerostipes caccae се включваше в трофичната 
верига най-вероятно чрез неговата способност да превръща продуцирания 
лактат от основните разграждачи на лактозата в бутират. Следващи анализи 
на акумулираните метаболитни продукти по време на лактозната деградация 
ще бъдат от помощ за пренасочване на метаболитните пътища, включени в 
чревния метаболизъм.
В заключение, получените резултати от тази дисертация показват, че 
интегрирането на РНК-стабилно изотопно сондиране c високо-диагностични 
анализи на база филогенетично профилиране и метаболитни анализи e 
надежден подход за идентифициране на бактерии, които в действителност 
участват във ферментацията на въглехидратите, не само в моделни системи, но 
и с по-голяма значимост в чревния тракт на човека.
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